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1. Introduction 
  
1.1 THE IMPACT OF ALZHEIMER’S DISEASE, A CHALLENGE TO SCIENCE AND 
SOCIETY  
 
 In 1907, Alois Alzheimer, a German Psychiatrist, described at a meeting in Tübingen the 
symptoms as well as the neuropathological features of a strange degenerative disease of the 
brain cortex (Alzheimer 1907).  His original patient, a woman referred to as Auguste D. in his 
report, suffered from several symptoms like progressive memory impairment; disordered 
cognitive function; altered behaviour including paranoia, delusions, loss of social 
appropriateness and a progressive decline in language function. 
Neither he nor his audience could expect the impact of this disease for the 21th century. Due 
to an improved medical care, life expectancy increased dramatically within the last century. 
This resulted in a burgeoning number of individuals achieving the age at which 
neurodegenerative disorders become evident. Today, Alzheimer’s disease (AD) is recognized 
as a major public health problem in developed nations and the most common cause of 
dementia among people aged 65 and older. The impact of AD for the major public health 
acquires a growing importance for our society: 
•  According to the American National Institut of Aging, AD affects probably 20–30 
million people worldwide. 
•  An estimated 10 percent of Americans over the age of 65 and half of those over age 85 
have AD. 
•  Currently, more than four million Americans currently suffer from this disease, and 
the number is projected to balloon to 10-15 million over the next several decades. 
•  AD is after heart disease and cancer the third most expensive disease to treat in the 
USA., costing society close to $100 billion annually. 
•  In Germany actually about 1.000.000 people have AD. This number is expected to 
duplicate within the next decade as a result of an adjustment of the age pyramid. 
 
Besides the financial aspect for the health care, of course there is the dramatic impact of AD 
for the individual families. The patients are helpless and require full-time health care. 
Families, friends and caregivers struggle with great emotional and physical stress to cope with 
the mental and physical changes of the concerned family member.  Introduction    
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For many decades after Alzheimer’s original description, little progress in defining the 
pathogenesis of AD occurred. Only in the past decade the knowledge of its causes and 
mechanisms has grown enormously. Thanks to modern biochemical, genetic, cell biological 
and transgenic modeling studies, today the composition and molecular origin of the amyloid 
plaques and neurofibrillary tangles, the two hallmarks of AD, have been described. 
Nevertheless, the mechanisms leading to neurodegeneration, the formation of plaques and 
tangles is still not completely understood. Despite an intensive search for therapeutic 
intervention, no drug has proven effective in combating this devastating neurodegenerative 
disease. The answers to many questions regarding the understanding of the progression of AD 
pathology are still need missing and imply a big challenge for researchers worldwide. 
 
 
1.2 PATHOLOGICAL CHANGES IN AD BRAIN 
 
1.2.1. Changes in Brain 
 
The clinical appearence of AD is a progressive degeneration of neurons in the cerebral cortex. 
In severe AD stages the brain weight differs notably, compared to non-AD affected same aged 
brains. According to Braak et al. (1994) the pathological changes in the AD brain can be 
divided into the following stages: 
1. Preclinical  stage 
The first brain changes probably start 10 to 20 years before any visible signs or 
symptoms appear. The first brain region affected by plaques and tangles is the 
entorhinal cortex, localized near to the hippocampus. Than it proceeds to the 
hippocampus. Affected regions begin to atrophy. 
2. Mild  Stage 
The cerebral cortex is affected. Symptoms like memory loss, mood or personality 
changes are typical signs for mild AD. 
3. Moderate  Stage 
AD damage has spread to areas of the cerebral cortex that control language, reasoning, 
sensory processing, and conscious thought. The symptoms of this stage include 
increasing memory loss and confusion or difficulty with language. In addition, the 
patients can suffer from hallucinations, delusions, paranoia or from motoric problems. 
 
  7Introduction    
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4. Severe  Stage 
In this stage, plaques and tangles are widespread throughout the brain, and areas of the 
brain have further atrophied. Patients are completely dependent on others for care and 
suffer from weight loss, seizures, infections and lack of bladder and bowel control. 
Since patients ultimately become immobile and suffer from respiratory difficulties, 
most patients die from other illnesses like pneumonia. 
 
The defining neuropathological lesion of AD are extracellular amyloid plaques containing 
beta amyloid peptide (Aß) and intracellular neurofibrillary tangles containing abnormally 
phosphorylated tau protein aggregated into filaments. These histological abnormalities are 
associated with loss of synaptic density and neuronal death.  
 
Figure 1.1. Pathological hallmarks in AD brain: a plaque, mainly consisting of Aß (left). The 
dense amyloid core is surrounded by an amyloid halo. Methamine staining. Neurofibrillary 
tangles (right) are formed by dead neuronal cell bodies due to cytoskeletal changes, for 
instance hyperphosphorylation of tau protein. Gallyas staining  (pictures taken from 
Bogdanovic 2000). 
 
1.2.2 Amyloid plaques 
 
Neuritic amyloid plaques are roughly spherical, extracellular deposits of beta amyloid protein 
(Aß) fibrils intimately surrounded by dystrophic axons and dendrites, activated microglia, and 
reactive astrocytes. Most of the fibrillar Aß found in the neuritic plaques, is the species ending 
at amino acid 42, the slightly longer, more hydrophobic form that is particularly prone to 
aggregation (Jarrett 1993). However, the Aß 40 colocalizes with Aß 42 in the plaque. The 
cross-sectional diameter of neuritic plaques in microscopic brain sections varies widely from 
  8Introduction    
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10 to 120 µm. In addition to Aß, other proteins like ApoE, or lysosomal proteins are found in 
plaques (Atwood 2002). The occurrence of lipids rafts  and cholesterol was also described 
(Burns 2003). 
The fibrillar amyloid plaques are invariably accompanied by many “diffuse” (pre-amyloid) 
plaques in the same brain regions. These do not consist of fibrilla extracellular deposits of Aβ-
immunoreactive granular material that generally lack amyloid fibrils and are associated to 
very few or no dystrophic neurites. In most AD cases, the number of diffuse plaques clearly 
exceeds that of the neuritic plaques. Diffuse plaques appear to represent the earliest light-
microscopically detectable lesion in AD brains. They seem to predate fibrillar neuritic 
plaques, as judged by their occurrence in cognitively normal, late middle-aged and elderly 
healthy individuals (Dickson 1995), as well as by their development in teenagers with Down’s 
syndrome, long before the latter individuals develop the neuritic plaques and neurofibrillary 
tangles typical of AD (Selkoe 2002). 
 
U1.2.3 Neurofibrillary tangles 
 
Neurofibirllary tangles (NFT) correspond to the aggregation of abnormally phosphorylated 
Tau proteins into paired helical filaments. Tau protein, a neuronal microtubule-associated 
protein, is known for its role in the stabilization of microtubules, which is important for the 
generation and maintenance of neurites (Cleveland 1977, Binder 1985). In AD, 
phosphorylated Tau accumulates in neurons, aggregates into paired helical filaments, and 
loses its microtubule-binding and stabilizing function, leading to the degeneration of neurons 
(Garcia  2001).  
 
 
Fig. 1.2. Tau phosphorylation and microtubule polymerization. Polymerization of tubulin into 
microtubules is regulated by the state of phosphorylation of Tau proteins. 
Hypophosphorylated Tau induces tubulin polymerization and microtubule stabilization 
whereas hyperphosphorylated Tau lead to the depolymerization of microtubules into tubulin. 
 Introduction    
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The phosphorylation of Tau is regulated by different kinases and phosphatases, but the exact 
mechanism leading to an enhanced Tau phosphorylation is still not clear. Tau has 
approximately 20 to 30 potential phosphorylation sites, many of which are putative targets of 
proline-directed serine/threonine kinases. Accumulating evidence suggests that two such 
kinases, glycogen synthase kinase-3 (GSK-3ß) and cyclin-dependent kinase-5 (cdk5), are 
major tau kinases (Cruz 2003). Other involved kinases described are p42/44 MAP kinase 
(Mandelkow 1999) and the c-Jun N-terminal kinase (JNK) (Reynolds 1997; Bue´e-Scherrer 
2002). 
 
 
1.3 GENETICS OF ALZHEIMER’S DISEASE 
 
U1.3.1 Causative genes of inherited forms of AD 
 
AD is usually classified according to its age of onset. When the disease occurs before 65 years 
of age it is called early-onset (“presenile”) AD form, while late-onset (“senile”) AD occurs in 
subjects over 65 years of age. About 7 percent of early-onset cases are familial, with an 
autosomal dominant pattern of inheritance and a nearly 100 % penetrance (Campion 1999). 
Thus, familial forms of early-onset Alzheimer’s disease (FAD) are rare (less than 1 % of all 
AD cases); however, their importance extends far beyond their frequency, because they have 
allowed researchers to identify some of the critical pathogenetic pathways of the disease. 
Due to family linkage studies and DNA sequencing, three genes have been identified whose 
mutations cause early-onset FAD. These genes encode for the amyloid precursor protein 
(APP, see 1.4.1) on chromosome 21, the presenilin 1 (PS1, see 1.4.2) on chromosome 14 and 
the presenilin 2 (PS2) localized on chromosome 1 (Goate 1991, St George-Hyslop 1994). 
 
U1.3.2 Apolipoprotein E 
 
In addition to the causative genes of early onset FAD, a genetic "risk factor" for late-onset 
FAD, the apolipoprotein E (Apoε) on chromosome 19, has been identified (Saunders et al., 
1993). Three variants of the gene and the protein are found in human populations and result 
from changes in single amino acids in ApoE (referred to as the Apoε2, ε3 and ε4 alleles). 
Whereas the Apoε3 and Apoε2 alleles have no or even beneficial effects, possession of the 
Apoε4 allele, especially homozygosity for Apoε4, augments the risk for AD. The effects of Introduction    
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Apoε4 allele is “dose-dependent”. The mean age of onset decreases from 84 to 68 years with 
increasing numbers of Apoε4 alleles (Corder 1993).  
Identified Begin of
Chromosome Gene Mutations disease     Penetrance     Phenotype
EO FAD 21 APP 8 45-64 100%                    Aß↑
14 Presenilin 1 >120 28-55 100%                    Aß↑
1 Presenilin 2 8 40-75 100%                    Aß↑
EO AD < 65
LO FAD 19 Apolipo- Poly- 61-65       Riskfactor   Density of
protein E morph. ε 4 Aß plaques↑
ε 2, ε 3, ε 4
LO AD > 65
Genetic Factors for AD 
 
TABLE 1.1. Confirmed genetic factors predisposing to Alzheimer’s disease. To date more 
than 120 different mutations were identified in the PS1 gene leading to early onset (EO) 
FAD. Eight mutations were discovered in APP and PS2 gene  (HTUhttp://molgen-www.uia.ac.be/UTH 
ADMutations). Mutations in these causative genes have a 100% penetrance leading to an 
enhanced Aß production. The Apolipoprotein E polymorphism is a confirmed risk factor for 
the late onset (LO) AD. Other genetic factors which taken alone are not sufficient to develop 
AD are discussed in 1.3.3. 
 
How Apoε4 leads to an enhanced AD risk is still not clear. ApoE is a lipid carrier molecule 
involved in the transport and distribution of cholesterol and lipids from liver to all extra 
hepatic tissues via LDL-receptor mediated mechanism. ApoE is a plasma glycoprotein with a 
molecular mass of 34,2 kDa synthesized mainly by the liver, by both neurons and astrocytes 
in the brain, and also by other cell types including macrophages and monocytes. ApoE 
contains 299 amino acids, the amino terminal domain (residues 1–191) is a stable globular 
structure containing the receptor binding site, while the carboxy-terminal domain (residues 
216–299) is helical, less stable, and contains the lipoprotein binding functions (Mahley 2000). 
In brain, ApoE is not involved in the transport of cholesterol to and from the brain but instead 
is involved in redistribution of cholesterol to different cellular and subcellular sites of neurons Introduction    
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needed for membrane remodelling during regeneration of neurites, axons and synapses 
(Kirsch 2002). ApoE is also involved in many other functions, like nerve regeneration, 
immunoregulation and activation of several lipolytic enzymes (Vancea 2000). Distinct 
binding properties of ApoE isoforms to Aß and Tau protein have suggested ways by which 
ApoE might mediate its action (Myers 2001). In particular, the Apoε4 isoform binds to Aß 
more rapidly than the Apoε3 isoform. Apoε4 associated with Aß forms novel monofibrils that 
precipitate into dense structures. Apoε4 does not bind to Tau protein in vitro, unlike Apoε2 
and Apoε3. It is possible that the interaction between Apoε3 and Tau protein serves as 
protection against Tau phosphorylation and neurofibrillary tangle formation (Strittmatter 
1994). An amyloid-scavenging role of ApoE has been proposed too. ApoE might regulate 
extracellular Aß through ApoΕ receptor-mediated internalisation of Aß via an 
endosomal/lysomal path (Beffert 1996). A role of ApoE during the development, maturation, 
and aging of the CNS was also reported (Nathan 1994), since  ApoE promotes neuritic 
extension in an isoform-dependent manner (Apoε2 > Apoε3 >Apoε4). 
 
 
U1.3.3 Other genetic risk factors 
 
Although age and the inheritance of predisposing genetic factors appear to play a major role, 
recent evidence suggests that the development and progression of AD could be subject to a 
wide variety of both environmental and genetic modifiers (Tanzi 2001). Several other genetic 
factors have been implicated in AD. In the majority of sporadic AD cases genetic factors may 
act as predisposing agents, without the force to induce the disease but able to increase the risk 
of disease above that of the general population. They probably interact with environmental 
factors or with other pathological or physiological conditions to exert their pathogenic effect. 
The typical approach to evaluate genetic contribution to the risk for AD is analysing the 
frequency distribution in cases and controls of the allelic variants at polymorphic sites of the 
candidate genes. Most of these candidate genes identified in case-control association studies 
are proteolytic enzymes, plasma proteins, growth factors or membrane receptors, which may 
exist as different genetic variants. A lot of these genes are involved in APP processing and/or 
in the degradation and clearance of Aß. These genes are potential risk factor for AD, however, 
their significance needs to be confirmed by additional studies. Following candidate genes 
have been described. Introduction    
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•  The gene of α2-Macroglobulin (α2M) on chromosome 12, a serum protease inhibitor 
also expressed in the brain, has been implicated in AD on the basis of its ability to 
mediate the clearance and degradation of Aß. α2M is also a component of senile 
plaques (Blacker 1998). 
•  Low density receptor-related Lipoprotein (LRP) gene is also localized on chromosome 
12. It is the main ApoE receptor expressed in neurons (Rebeck 1995). It is responsible 
for the endocytosis of secreted amyloid precursor protein (Verpillat 2001) and it has 
been detected in senile plaques, dystrophic neurites and reactive astrocytes in AD 
brain (Kounnas 1995). 
•  Angiotensin converting enzyme (ACE) which catalyses the conversion of angiotensin 
I to angiotensin II, by cleaving the two carboxy-terminal amino acids from 
angiotensin. It is widely expressed in the endothelium of cerebral  blood vessels  and 
in neurons, where it contributes to the modulation of pressor response, neuro-humoral 
function, and behaviour (Wright 1992). A polymorphism at intron 16 of the ACE gene 
(chromosome 17), consisting in an insertion/deletion of a 287 base pairs sequence, has 
been found to be associated with AD susceptibility (Kehoe 1999). An increased 
frequency of the insertion allele was reported among patients with late-onset AD 
(Narain 2000). 
•  Insulin degrading enzyme (IDE) gene is located on chromosome 10. It codes for a 110 
kDa extracellular thiol metalloprotease capable of degrading a number of peptides 
including insulin and Aß (Selkoe, 2001). It has been shown that IDE may be the 
protease responsible for the clearance of Aß (Vekrellis 2000, Bertram 2000) and the 
cytoplasmic fragment of APP following liberation of Aß (Edbauer 2002). 
•  Nitric oxide synthase (NOS3, chromosome 7) gene. There is growing evidence 
showing an involvement of nitric oxide (NO) in the AD pathology. The NOS3 
endothelial product (eNOS) has a high concentration in hippocampal pyramidal 
neurons (Doyle 1997). Moreover, NO production by microglial cells, astrocytes and 
brain endothelium is enhanced in AD patients because of a strikingly increased 
expression of eNOS (De la Monte 1997). In addition, Aß has been reported to 
stimulate NO production in neurons harboring Presenilin 1- (Hashimoto 2002) and 
APP mutations (Keil 2004). Finally, there is a growing evidence of an involvement of 
NO in neuronal death in AD. Nitrosative stress caused by increased NO synthesis in 
the brain could be a pathogenic mechanism for AD (Eckert 2003). Dahiyat et al. 
(1999) hypothesized that polymorphic variants in the NOS3  gene might facilitate Introduction    
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degenerative changes. A common structural polymorphism,Glu/Asp, at codon 298 of 
NOS3, has been analysed and the homozygous Glu 298 genotype has been found to be 
significantly over-represented in late-onset AD patients compared with control 
individuals.  
•  c-Jun NH2 terminal kinase interacting protein-1 (JIP-1), which functions as a neuronal 
scaffold protein to allow signalling specificity. JIP-1 interacts with many cellular 
components including the LRP, kinesin and the Alzheimer's amyloid precursor 
protein. JIP-1 colocalized with JNK and phosphorylated tau in neurofibrillary tangles. 
A 499Asp>Glu polymorphism in the 5' regulatory region of the JIP-1 gene was 
decribed by Helbecque (2003) whereby the G allele was proposed to be  a risk factor 
to the onset of AD. 
 
 
1.4 MOLECULAR MECHANISMS OF ALZHEIMER’S DISEASE 
 
U1.4.1 The Amyloid-Precursor-Protein 
       
Studies on amyloid precursor protein (APP) as genetic determinant of AD have begun in the 
middle 1980s with the observation that individuals with Down’s syndrome invariably develop 
the clinical and neuropathological features of AD if they live over 30 years (Mann 1985). 
These data pointed to the involvement of chromosome 21 in AD and supported the theory that 
overexpression of a gene mapping on chromosome 21, present in an extra copy in Down’s 
syndrome, could produce the AD phenotype. Later, the gene encoding for APP was the first 
gene identified as the leading cause of hereditary AD (Tanzi 1987, Goate 1991). 
APP comprises a heterogeneous group of ubiquitously expressed polypeptides with molecular 
weights between 110 and 140 kDa. This heterogeneity arises from alternative splicing 
(yielding 3 major isoforms of 695, 751, and 770 residues) as well as by a variety of 
posttranslational modifications, including the addition of N- and O-linked sugars, sulfation, 
and phosphorylation (Selkoe 1994, Walter 1997). The APP splice forms containing 751 or 
770 amino acids are widely expressed in nonneuronal cells throughout the body and also 
occur in neurons. However, neurons express even higher levels of the 695-residue isoform, 
which occurs at very low abundance in nonneuronal cells (Haass 1994).  
The APP undergoes at least two proteolytic cleavages. One pathway involves the membrane-
associated  α-secretase, which cleaves APP within the Aß domain and secretes the Introduction    
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extracellular N-terminal of APP (soluble APPα, Hooper 1997). This way is not pathogenic 
(Selkoe 1994b). The other cleavage pathway, occurring in the endosomal–lysosomal 
compartment (Haas 1992), involves ß-secretase, which cuts between residues 671 and 672 of 
the APP, and yields the N-terminus of Aß peptide. In addition, APP can be processed by a 
third proteolytic cleavage, the γ-secretase, yielding the C-terminus of Aß peptide (see Fig.1. 
3). The cleavage site of γ-secretase is of critical importance as it may generate peptides of 
different lengths. The 40 amino acid long Aß peptide is the most common form usually 
produced in the endosomal–lysosomal system by a cleavage at residue 712–713. A peptide of 
42 amino acids (Aß42) in length is generated from a cleavage site after residue 714, which is 
thought to be more fibrillogenic and neurotoxic (Lorenzo 1994). 
 
 
Figure 1.3. Schematic diagrams of the amyloid precursor protein (APP). The processing of 
APP by a protease designated as α-secretase leads to the secretion of a large soluble 
ectodomain of APP (APPs) and retention of a 83-residue COOH-terminal fragment in the 
membrane. Alternatively, cleavage of APP by ß-secretase produces a membrane-bound C-
terminal fragment, C99 which is further cleaved by a γ-secretase leading to the release and 
secretion of pathogenic Aß-peptide and a C-terminal fragment designated as AICD (APP 
intracellular domain: C57/C59). Missense mutations in the APP-gene either interfere with α-
secretase or enhance ß- or γ-secretase cleavage, resulting in an increased production of the 
toxic Aß peptide. Introduction    
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The function of APP is still poorly understood. In vitro studies suggest that secreted APPα 
can function as an autocrine factor by stimulating cell proliferation and cell adhesion and 
supporting nerve growth factor-induced neurite outgrowth of PC12 cells (Villa 2001). Other 
studies have implied a role for APP in signal transduction (Nishimoto 1993) or, in association 
with other proteins, e.g. Fe 65, in regulation of transcription (Cao 2001). Recent data indicate 
a pysiological function of APP, as a cargo receptor for the microtubule motor kinesin, in the 
anterograde transport of several transmembrane proteins (Kamal 2001, Verhey 2001). 
 
APP is highly conserved in evolution, but the deletion of the APP gene in mice results in 
neither early mortality nor appreciable morbidity. This lack of vital consequence of APP 
deletion  in vivo may result from expression of the homologous proteins the amyloid 
precursor-like proteins (APLPs) (Slunt 1994). Delineation of the precise functions of APP and 
its homologs in vivo awaits further study. No evidence has emerged that a fundamental 
cellular function of APP is lost in AD patients. Instead, APP mutations seem to act by a toxic 
gain-of-function mechanism.  The APP mutations in the APP gene are clustered near the α-, 
β-, or γ-secretase cleavage sites, having a direct effect on APP processing namely, by 
increasing production of the potentially cytotoxic Aß fragment. For example, transgenic mice 
expressing the Swedish APP double mutation (KM670/671NL) produce numerous Aß 
deposits in the form of classical senile plaques (Bayer 2003) and exhibit an age-dependent 
increase in soluble Aß (1-40) and Aß (1-42) levels  (Christi 2001, Gao 2002). 
 
 
1.4.2 The beta amyloid peptide 
 
As decribed above, the Aß peptide is generated by processing through ß- and γ-secretases.  ß-
secretase was recently identified (Yan 1999, Vassar 1999) as a transmembrane aspartyl 
protease known as BACE1 (b-site APP cleavage enzyme). BACE1 is expressed in all tissues 
with the highest level of expression in the brain. BACE1 shares 55% homology with a second 
enzyme called BACE2. Both enzymes contain the two characteristic D(T/S)G(T/S) motifs of 
aspartyl proteases, which form the catalytic site, and share significant sequence homology 
with other members of the pepsin family of aspartyl proteases. In contrast to all other aspartyl 
proteases of the pepsin family, BACE1 and BACE2 are type I transmembrane proteins with a 
large lumenal domain containing the active center, a single transmembrane domain, and a 
small cytoplasmic tail (Hong 2000). The γ-secretase is described in detail in 1.4.3. Introduction    
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Fig. 1.4 Diagram of BACE. An aspartyl protease active site motifs (DTGS, DSGT) is localized 
in the lumenal/extracellular domain. During translocation and maturation through the 
secretory pathway the lumenal domain of BACE is N-glycosylated at four asparagine 
residues. As indicated by the arrow, during transport through the Golgi, the prodomain is 
endoproteolytically removed by a furin protease to generate the mature enzyme (Haas 
2001).  
 
To explain massive neuronal loss in the brain of AD patients, several models have been 
proposed. The dominant theory in the past decade has been the so-called “amyloid cascade” 
hypothesis,  placing Aß as a principal culprit (Citron 1992; Yankner 1990; Selkoe 2002). The 
dysregulation in APP processing might occur early in the illness, leading to increased 
production of Aß. This in turn leads to a chain of downstream events including development 
of neurofibrillary pathology and cell death. The fact that a macromolecular form of Aß is 
toxic in in vitro studies by itself supports this hypothesis (Hardy 1992; Droet 1999). More 
importantly, as described before, rare dominant mutations causing FAD result in the 
accumulation of Aß.  
The precise mechanisms whereby Aß leads to synaptic dysfunction and cell death in AD are 
not yet known, although there have been recent insights into this process. Possible 
mechanisms of Aβ toxicity include generation of free radicals (described in 1.6) and 
activation of apoptosis (see 1.5). An Aβ -induced perturbation of calcium homeostasis (Suo 
1997, Gibson 2002, Eckert 2001b, Mattson 2003) and an alteration of the APP metabolism by 
cholesterol has also been proposed (Yanakisawa 2002, Mizuno 1999, Kirsch 2002). 
 
Another question that still needs to be answered is: What kind of Aß peptide is responsible for 
neuronal cell loss? Aß42 is a hydrophobic peptide with an ominous tendency to assemble into 
long-lived oligomers and polymers. During the last decade, the extracellular, deposited, and 
fibriller Aß was culprit for the disease, since it is the main consistent of the senile plaques, Introduction    
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and synthetic Aß peptides can aggregate into an array of assembly forms, when added to cell 
culture. The problem thereby is that synthetic Aß peptides used in vitro have generally been 
applied at micromolar concentrations (in contrast to the low nanomolar levels of natural Aß 
found in the brain and cerebrospinal fluid). This aggregated forms may have biophysical and 
toxic properties unlike those found in vivo. Moreover, recent reports suggest that the toxicity 
of Aß lies not in the insoluble fibrils that accumulate but rather in the soluble oligomeric 
intermediates (Hardy 2002, Wilson 2003). Soluble Aß oligomers are also found in human AD 
cerebrospinal fluid, and the soluble Aß content of human brain correlated better with the 
severity of the disease than plaques. (Kuo 1996, Pitschke 1998, Lue 1999, McLean 1999).  
Other experiments argue against the classical amyloid hypothesis which postulates that Aß 
deposition is the primary event triggering the pathological cascades leading to AD 
abnormalities, especially neuronal death. Studies of transgenic mice overproducing 
extracellular Aß have repeatedly observed the lack of neuronal loss in the presence of Aß 
deposition, suggesting that Aß deposition alone is not sufficient to cause neuronal death 
(Irizarry 1997). More recently, it was found that doubly transgenic mice expressing both the 
Swedish APP Mutation and  the M146L-Presenilin 1 mutation show behavioral changes, but a 
lack of neuronal loss in the presence of Aß deposits (Holcomb 1999, Takeda 2004). 
Conversely, neuronal loss by a α-secretase-resistant mutant APP occurs without detectable 
extracellular Aß deposition (Moechars 1996).  
 
The discrepancy between Aß deposition and neuronal loss as well as recent data pointed for 
intracellular Aß as a contributing factor or initiating event towards neuronal death and 
synaptic loss in early AD pathogenesis. Intracellular accumulation of Aß might impair cellular 
functions and may probably represent the primary event within the neurotoxic Aß cascade. 
(Wirths 2001). In cultured neuronal cells expressing APP, natural oligomers of Aß are formed 
soon after generation of the peptide within intracellular vesicels (Walsh 2002). A significant 
increase of intracellular Aß42-positive neurons in isolated cases of AD and in atypical AD 
cases not associated with dense core amyloid depositions was shown (Tabira 2002). In mutant 
PS1 transgenic mice the death of neurons is associated with intraneuronal Aß accumulation,  
but without extracellular Aß deposition (Chui 1999). Finally, it was found that the 
intracellular Aß1–42 mediates apoptosis of cortical neurons infected with adenovirus 
encoding APP (Kienlen-Campard 2002). 
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U1.4.3 Presenilin 
 
The concept that changes in APP processing are central to AD pathology won further support 
after the discovery that mutations in the presenilins interfere with the cleavage of APP, 
leading to an overproduction of Aß peptide. Mutations in the PS1 gene, located on 
chromosome 14, account for 18–50% of the early onset AD cases (Cruts 1998) and  also 
cause the most aggressive forms of AD, in some cases with an onset below the age of 30. The 
majority of the over 120 known PS1 and 8 PS2 mutations are missense substitutions; only a 
couple of deletions and insertions have been reported to date (Tandon 2000). 
PS1 and PS2 are integral proteins sharing 60% amino acid sequence homology and contain 6 
to 8 transmembrane (TM) domains (Doan 1996). On the cytoplasmic side of the membrane 
they contain between TM domains 6 and 7 a large hydrophilic loop. The cytoplasmic loop 
includes the sites where proteolytic cleavages occur (see Fig.1.5). Full-length PS undergoes 
endoproteolysis to form stable N-terminal (NTF, 30 kDa) and C-terminal (CTF, 20 kDA) 
fragments (Thinakaran 1996). In 1999, it was hypothesized that PS1 could be the γ-secretase 
(Wolfe 1999a). This hypothesis was based on studies with inhibitors showing that γ-secretase 
has characteristics of an aspartyl protease (Shearman 2000; Wolfe 1999b). Identification of 
two conserved aspartate residues in TM domains 6 and 7 of PS critical for γ-secretase activity 
(D257 and D385 in PS1) provided the conceptual basis for the theory that PS is the aspartyl 
secretase. When either aspartate residues in PS1 (Wolfe 1999a) or PS2 (Kimberly 2000) are 
mutated, γ-secretase activity is blocked, and Aß levels are significantly reduced in cultured 
cells. The same was also observed in transgenic mice overexpressing D257A mutant PS1 (Xia 
2001).  
 
Despite these reports implicating presenilin as the γ -secretase, it has not been possible to 
increase substrate-cleaving activity by overexpressing PS1 and PS2 alone. This failure 
presumably relates to the observation that the endoproteolysis of presenilin heterodimers 
requires certain limiting cellular factors (Thinakaran 1996). Several factors apparently critical 
for γ-secretase activity have been identified to date. The presenilins are incorporated with 
nicastrin (Yu 2000) PEN-2 (Francis 2002) and Aph-1 (Goutte 2002) into a high molecular-
weight protein complex of 200-250 kDa to form the γ-secretase. Presenilins appear to provide 
the active core of the protease while the other factors are needed for the assembly of the 
complex by stabilizing or proteolysing the Presenilin. Nicastrin is a glycosylated 130 kDa 
integral membrane protein that binds relatively well to both the NTF and the CTF of Introduction    
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Presenilin, while Aph-1 is a 30 kDa multimembrane spanning protein that is needed for the 
correct subcellular transport of Nicastrin to the cell surface. Pen-2 is a small, hairpin-like 
membrane protein of 12 kDa. All individual γ-secretase complex components might 
determine each other’s expression. Taking away a single component disrupts the entire γ-
secretase complex and consequently blocks intramembrane proteolysis (De Stropper 2003). 
 
Fig. 1.5 Intramembrane proteolysis of APP by the γ-secretase complex according to Haass 
and Steiner (2002). After the cleavage of APP  by ß-secretase, the generated C99 enters the 
active site of the γ-secretase residing in PS, which is itself part of a native 200–250-kDa 
complex containing nicastrin, PEN-2 and APH-1. The two crucial aspartates in TMDs 6 and 7 
of PS mediate endoproteolysis, which results in the secretion of Aß and the liberation of 
AICD.  
 
The deletion of the PS1 gene in mice resulted in an embryonic lethal phenotype (Shen 1997) 
because presenilins are also critical for processing of the Notch receptor, a signaling molecule 
crucial for cell-fate determination during embryogenesis (Wong 1997). After translation in the 
ER, Notch is processed by a Furin-like protease, resulting in a heterodimeric receptor that is 
shuttled to the cell surface (Fig. 1.6). Upon interaction with a cognate ligand, the ectodomain 
of Notch is cleaved by a metalloprotease apparently identical to tumor necrosis factor-a 
converting enzyme (TACE) (Mumm 2000). Interestingly, metalloproteases such as TACE and 
ADAM-10 are among the identified α-secretases that shed the APP ectodomain (Buxbaum Introduction    
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1998). The membrane associated C terminus is then cut by γ-secretase within the postulated 
transmembrane domain to release the Notch intracellular domain (NICD), which then 
translocates to the nucleus where it interacts with and activates the CSL family of 
transcription factors (Schroeter 1998). NICD formation is absolutely required for signaling 
from the Notch receptor. Interestingly in this context, the C-terminal fragment (AICD, see 
Fig. 1.3), composed of the last 57-59 amino acids of the C terminus of APP, has been 
demonstrated to cause transcriptional activation after translocalization into the nucleus, 
suggesting a role of AICD in gene regulation (Kinoshita 2002, Kim 2003). 
 
cytosol
Notch
Furin TACE
γ-secretase 
NICD
Translocation to the nucleus and 
activation of transcription factors
extracellular space
 
Figure 1.6. The processing of Notch occurs similar to APP. Notch signaling depends on three 
endoproteolytic cleavages. Notch maturates in the Golgi by furin-mediated cleavage. At the 
cell surface, Notch is cleaved by the metalloprotease TACE. Finally, PS-dependent cleavage 
liberates the NICD, which translocates to the nucleus, thereby regulating the transcription 
target genes by binding to transcription factors of the CSL family. 
 
 
 
1.5 NEURONAL DEGENERATION IN ALZHEIMER’S DISEASE   
 
U1.5.1 Cell death mechanisms in central nervous systemU  
 
Cell death occurs by necrosis or apoptosis. These two mechanisms have distinct histologic 
and biochemical signatures. In necrosis, the stimulus of death is itself often the direct cause 
for the death of the cell. In apoptosis, by contrast, the stimulus of death activates a cascade of 
events that orchestrate the destruction of the cell. Unlike necrosis, which is a pathologic Introduction    
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process, apoptosis is part of normal development (physiologic apoptosis). Its major function is 
to facilitate the survival of the organism by the controlled elimination of damaged or 
superfluous cells. Neuronal cells, for example, undergo extensive apoptotic death during 
development. However, apoptosis also occurs in a variety of diseases. Too less apoptosis is 
the causative factor for the origin of cancer. Too much apoptosis is a characteristic feature of 
many neurodegenerative disease. 
 
 
1.5.1.1 Necrosis 
 
Necrotic cell death in the central nervous system follows acute ischemia or traumatic injury to 
the brain or spinal cord (Linnik 1993). It occurs in areas that are most severely affected by 
abrupt biochemical collapse, which leads to the generation of free radicals and excitotoxins 
(e.g., glutamate, cytotoxic cytokines, and calcium). The histologic features of necrotic cell 
death are mitochondrial and nuclear swelling, dissolution of organelles, and condensation of 
chromatin around the nucleus. These events are followed by the rupture of nuclear and 
cytoplasmic membranes and the degradation of DNA by random enzymatic cuts in the 
molecule (Kanduc 2002, Kerr 1972). 
 
1.5.1.2 Apoptosis 
 
Apoptosis is an actively regulated process of cell death necessary for proper control of tissue 
growth. Apoptosis was originally described by Kerr et al. (1972) as an event characterized by 
plasma membrane blebbing, cell shrinkage, chromatin condensation, and degradation of DNA 
The word ‘apoptosis’ is derived from the Greek and literally means “the falling off of leaves 
from a tree, or the falling off of petals from a flower.” This definition came from early 
morphological observations of cells undergoing apoptosis. The surfaces of apoptotic cells 
have many blebs that look lile petal of flowers. In humans, ~100,000 cells die every second 
by apoptosis and are replaced by new cells of the same number. Apoptotic death is a tightly 
controlled process, and the cellular pathways that regulate apoptosis have been well conserved 
in multicellular organisms from simple to complex animals. 
 
In the nervous system apoptotic cell death, also known as programmed cell death, can be a 
feature of both acute and chronic neurologic diseases (Yuan 2000, Martin 1999). After acute 
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insults, apoptosis occurs in areas that are not severely affected by the injury. For example, 
after ischemia, there is necrotic cell death in the core of the lesion, where hypoxia is most 
severe. Apoptosis occurs in the surrounding tissue. In chronic neurodegenerative diseases like 
Huntington’s, Parkinson’s or Alzheimer’s Disease, apoptosis is the predominant form of cell 
death (La Ferla 1995, Thomas1995).  
 
Apoptotic cell death is characterized by the activation of a biochemical cascade. Proteases 
termed as caspases (see. 1.5.2), destroy molecules that are required for cell survival and 
activate others that mediate a program of cell suicide. During the process, the cytoplasm 
condenses, mitochondria and ribosomes aggregate, the nucleus condenses, and chromatin 
aggregates. Finally, the cell is fragmented  into “apoptotic bodies,” and chromosomal DNA is 
enzymatically cleaved to 180-bp internucleosomal fragments. Other features of apoptosis are 
a reduction in the membrane potential of the mitochondria, intracellular acidification, 
generation of free radicals, and externalisation of phosphatidylserine residues (Kerr 1972,  
Thornberry 1998). 
 
 
1.5.2 Caspases 
 
Caspases (cysteine dependent, aspartate-specific proteases) are the major executioners of the 
apoptotic program. The first caspase initially discovered as a cytokine-processing enzyme was 
designated interleukin 1bconverting enzyme (today also known as caspase 1). The discovery 
of this enzyme resulted from studies with the nematode Caenorhabditis elegans. The gene 
CED (cell death abnormal)-3 was found to be essential for apoptotic cell death in the 
developing worm (Yuan 1993). Database research revealed later the gene encoding for 
interleukin 1bconverting enzyme as the  mammalian homologue. 14 caspases have since been 
identified, 11 of them are present in humans (Mattson 2003). The numbering is in order of 
their discovery.  
 
1.5.2.1 Caspase structure 
 
Caspases are synthesized as zymogens or proenzymes (30–50 kDa) containing an N-terminal 
prodomain together with one large (p20 kDa) and one small (p10 kDa) subunit. Caspase 
activity requires proteolytic cleavage at aspartate residues separating these domains and the 
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association of two large and two small subunits into an active heterotetramer with two active 
sites (see Fig. 1.7). 
Caspases play critical roles in the initiation or execution of apoptosis or, like caspase 1, in 
inflammation (Thornberry 1998). The prodomains of the caspase family fall into three groups. 
Prodomains of the initiator caspases tend to be long and contain protein interaction domains 
such as death effector domains (DED) or caspase recruitment domains (CARD). These 
domains, which share similar structural features, have a regulatory role by serving to couple 
cellular signaling pathways to caspase activation (Bratton 2000). Thus, the initiator caspases 
are usually the first to be activated upon integration of signals that commit the cell to die. 
Activated initiator caspases then cleave and activate effector caspases containing a short 
prodomain. In turn, effector caspases cleave crucial cellular substrates executing the apoptotic 
cell death (see 1.5.3) The prodomains of the inflammatory caspases (see table 1.2) are often 
long and may contain regulatory domains, consistent with the need to control their proteolytic 
activity. 
 
 
 
 
 
Figure 1.7. Mechanisms of Caspase Activation: Upstream initiator caspases are activated 
during the initiation of the cell-death cascade. They contain an prodomain, a large subunit, 
and a small subunit. Activated upstream caspase have autocatalytic activity and activate 
downstream effector caspases, which have a short prodomain as well as a large subunit and 
a short subunit.  
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Caspases are among the most specific proteases known. Each caspase recognizes a  different 
tetrapeptide motif within a substrate and is characterized by almost absolute specificity for 
aspartic acid in the P1 position. Using a synthetic combinatorial tetrapeptide library, 
Thornberry et al. (1998) determined the preferred substrate cleavage site for several 
mammalian caspases (see table 1.2).  
The catalytic mechanisms are similar for all caspases, since caspases hydrolyze peptide bonds 
on the carboxyl side of an aspartate residue (termed the P1 residue). During the cleavage of a 
substrate a tetrahedral intermediate is formed by His/Cys/Gly residues of the enzyme and the 
P1-Asp of the substrate. The specificity of caspases is due to structural feature. Since every 
caspase show considerable variation in both, length and amino acid composition of the active 
site, only the precise substrate is stabilized by hydrogen bonding in the substrate binding 
pocket. In addition to the presence of a consensus caspase site, the conformation of the target 
protein is also an important determinant of sensitivity to caspase cleavage. The structure of 
some caspases have been determined recently by X-ray diffraction. For example the structure 
of caspase 2 comprises two copies of the p20/p10 monomer. The core of the enzyme is 
formed by a 12-stranded ß-sheet, which is surrounded by a total of 14 α-helices (Schweizer 
2003). 
Name  Prodomain length  Regulatory motif  Adapter   Optimal  
   (kDA)     molecule  Tetrapeptide 
Initiator        
Caspase 2  51  CARD  RAIDD/ PACAP  DVAD/ DESD 
Caspase 8  55  DED  FADD  IETD 
Caspase 9  45  CARD  Apaf-1, Cyt C  LEHD 
Caspase 10  55  DED  FADD  ? 
Caspase 12  50    ?  ? 
Effector        
Caspase 3  32    Casp 8, 9,   DEVD 
Caspase 6  34    Casp 3,7  VEID 
Caspase 7  35    Casp 3, 8, 9,   DEVD 
 
Cytokine processors        
Caspase 1,4,5,11,13,14  30 - 50  CARD  Inflammatosome  (W/Y,F)EHD 
        
 
Table 1.2. Characteristics of caspases. Caspases can be divided into initiator caspases and 
effector caspases based on the presence of a large prodomain at their amino-terminal 
region. Initiator caspases containing a long prodomain, like caspase 2, caspase 8, caspase 9 
and caspase 10 generally act in early stages of a proteolytic cascade, while effector 
caspases, like caspase 3, caspase 6 and caspase 7 act downstream, and are involved in the 
cleavage of specific cellular proteins. The third group consist of several caspases involved in 
the maturation of cytokines. Introduction    
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1.5.3 Apoptotic cell signaling 
    
Apoptosis can be triggered by many different stimuli, including involvment of ‘death 
receptors’ (such as tumour necrosis factor and Fas ligand), growth factor insufficiencies, 
toxins, oxidative stress, and impaired calcium homeostasis. Thereby two pathways of caspase 
activation during apoptosis have been described. 
 
1.5.3.1 Extrinsic apoptotic pathway: 
 
In the extrinsic apoptotic pathway, death receptors, including CD95/Fas, DR4 and DR5 (death 
receptors 4 and 5; also called TRAIL-R1 and TRAIL-R2), as well as TNFR1 (tumor necrosis 
factor receptor 1), are activated by their cognate ligands, CD95 ligand, TRAIL (TNF-related 
apoptosis-inducing ligand) and TNF, respectively. Triggering of the receptors with their 
cognate ligands or agonistic antibodies results in receptor trimerization. Each of these 
receptors belongs to the TNF superfamily of receptors, and each activates caspase 8 by first 
recruiting the adapter proteins, FADD (Fas-associated death domain) and/or TRADD (TNF 
receptor-associated death domain). Death receptors possess both cysteine-rich extracellular 
domains and an intracellular cytoplasmic sequence known as the death domain (DD). The 
adapter protein FADD also contains a C-terminal DD, which enables it to bind to  trimerized 
receptors through DD–DD interactions, as well as an N-terminal DED (death effector 
domain), which can associate with similar DEDs located in the prodomain of caspase 8. This 
complex of proteins is referred to as the DISC (death-inducing signalling complex) 
(Barnhardt 2003).  
Following its activation within the complex, processed caspase 8 can in turn activate the 
effector caspase 3, which cleaves critical structural and regulatory proteins, resulting in 
apoptosis. Similarly, trimerized TNFR1 can recruit the adapter protein TRADD, which 
consequently recruits FADD and procaspase 8. TRADD however, also binds to the serine-
threonine kinase RIP (receptor-interacting protein) and in turn, the adapter molecule RAIDD 
through a series DD–DD interactions. Interestingly, the N-terminus of RAIDD shares 
sequence similarity to the prodomains of caspase 2, and it recruits and activates procaspase 2 
(Shearwin 2000).  
Another initiator caspase involved in extrinsic apoptotic pathway is caspase 10. Like caspase 
8, it also contains two DEDs in its N-terminal prodomain. However, it has been shown 
recently that caspase 10 cannot functionally replace caspase 8 in the DISC (Sprick 2002). 
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Thus, caspase-10 may serve as an inititator caspase only in some receptor mediated caspase 
cascades. 
 
                  Fig.1 .8  Extrinsic apoptotic pathway   
 
1.5.3.2 Intrinsic apoptotic pathway   
 
In the second apoptotic pathway, diverse apoptotic signals converge at the mitochondrial 
level, inducing permeabilization of the outer mitochondrial membrane and the release of 
cytochrome C from the mitochondria into the cytosol. Once in the cytosol, cytochrome C 
binds to its cytosolic partner APAF-1 (apoptotic protease activating factor-1), the human 
homologue of Caenorhabditis elegans apoptotic protein CED-4, and induces the 
oligomerization of APAF-1-cytochrome c complex in a dATP/ATP-dependent manner (Green 
1998). This heptameric complex, named “apoptosome,” recruit the initiator caspase, 
procaspase 9, to the complex and induces procaspase 9 autoactivation (Cain 2003). The 
activated caspase 9 is released from the apoptosome and subsequently initiates a caspase 
cascade involving the effector caspases such as caspases 3 and 7 (Thornberry 1998). Two 
other proteins, Smac
 (also called Diablo) and Htr2A/Omi (Yang 2003), are also release from 
mitochondria and increase caspase activity by inactivating endogenous caspase inhibitors 
(IAP) (Verhagen 2000).
  Mitochondria also release apoptosis inducing factor (AIF) and
 
endonuclease G, which appear to induce cell death independently of caspases by migrating to 
the nucleus and inducing chromatin condensation and large-scale DNA fragmentation.
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Therefore, mitochondria are thought to be a central regulatory
  element in stress-induced 
apoptosis (Wang 2002).  
The mitochondrial apoptotic pathway is regulated by proteins of the Bcl-2 superfamily. The 
Bcl-2 superfamily which consists of more than 20 members, are central regulators of 
apoptosis because they integrate diverse survival and death signals that are generated outside 
and inside the cell. The family is subdivided into two classes: anti-apoptotic members such as 
Bcl-2 and Bcl-xL (the Bcl-2-like survival factors) protect cells from apoptosis and generally 
contain four domains of sequence similarity, designated BH1 through BH4. Pro-apoptotic 
members are classified according to whether they contain one homology region (the “BH3-
only” proteins, e.g., Bid, or Bim) or three (the “multidomain” or “BH1-3” proteins, including 
Bax, Bak, and Bok) (Cory 2002). It is still not entirely clear, how the 20 members of the bcl-2 
superfamily regulate mitochondrial apoptotis. Each member of the BH3-only group might be 
activated in response to particular set of stimuli and through a characteristic mechanism. For 
example, Bid is cleaved by caspase 8 following death-receptor engagement, in turn Bim is 
involved in UV-induced apoptosis. Bax and Bak appear to permeabilize the outer 
mitochondrial membrane, allowing efflux of proapoptotic factors. Whereas Bax is 
predominantly a cytosolic monomer in healthy cells, during apoptosis it undergoes 
conformational changes, translocates to the outer mitochondrial membrane, and oligomerizes. 
In contrast, Bcl-2-like proteins prevent mitochondrial permeabilization such that none of the 
pro-apoptotic factors like cytochrome c or Smac are released to the cytosol (Kaufmann 2003). 
 
            Fig.1 .9  Intrinsic apoptotic pathway  
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1.5.4 Caspase-Substrates 
 
Caspases are extraordinarily selective enzymes. During apoptotic cell death, only a small 
fraction of the cellular proteome is cleaved by caspases. Comparative 2-D gel analysis 
revealed about 70 peptides as caspase “victims”. These substrates, containing the sequence 
DX(E)X(V)D for caspase cleavage, are key structural components of the cytoskeleton and 
nucleus, or proteins involved in signaling pathways. The effects of these cleavage events are 
to disable homeostatic and repair processes, inactivate inhibitors of apoptosis, as well as 
mediate structural disassembly and morphological changes.  
In order to mediate these events, caspases can modify the function of their target polypeptides 
in several ways (Earnhaw 1999): 
•  Caspases inactivate the normal biochemical function of their substrates. For example, 
one of the hallmark events of apoptotic cell death is genomic disassembly and 
oligonucleosomal fragmentation. Caspases disable normal DNA repair processes by 
inactivating at least two key proteins involved in the homeostatic maintenance of 
genomic integrity; poly(ADP-ribose) polymerase  (PARP) and DNA-dependent 
serine/threonine kinase (DNA-PK). At the same time, an apoptosis-endonuclease 
(CAD, caspase activated desoxyribonuclease) is activated by caspase-mediated 
cleavage of its cognate inhibitor (ICAD).  
•  Caspases activate substrates by removal of regulatory domains (e.g. BID, PKCs,). 
•   Finally, the structural components of the cytoskeleton and nuclear scaffold require 
disassembly during apoptosis and caspases play a key proteolytic role in these steps as 
well (e.g. lamins, fodrin, gelsolin).  
•  Caspase cleavage normally occurs at a single, discrete site within the target 
polypeptide, although multiple cleavage has also been reported (ICAD). 
 
 
U1.5.5 Apoptosis and Alzheimer’s disease 
 
Apoptosis is of particular interest in the AD pathology. There is growing evidence that 
disturbances in the tight regulation of apoptosis may contribute to the progressive neuronal 
loss in AD brain. Convincing evidence by both, post-mortem examination (Su 1994, La Ferla 
1995) and in vitro experiments (Forloni 1993, Loo 1993) indicate that neuronal cell death 
associated with Aß is apoptotic in nature. Aβ is believed to play a major role in promoting Introduction    
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neuronal degeneration and death by rendering neurons vulnerable to age-related increases in 
levels of oxidative stress and impairments in cellular energy metabolism (Mattson 2002, 
Gibson 2002). The underlying mechanisms of the Aß-induced apoptosis is still not 
understood. One possible mechanism for initiating apoptosis could be the generation of free 
radicals (Butterfield 1994) as discussed in 1.6. More evidences for the implication of 
apoptosis in AD come from experiments investigating AD mutations. Mutation in both, APP 
(Eckert 2001) and Presenilin 1 (Wolozin 1996, Terro 1992, Hashimoto 2002) sensitises cells 
for apoptosis.  
 
As described in section 1.3 AD-causing mutations in Presenilins shift the normal processing 
pattern of APP by secretases toward an enhanced production of Aß peptide. In addition, 
Presenilin 1 is cleaved by caspase 3, generating a C-terminal fragment (PSCas); therefore an 
involvement of PS1 in the regulation of apoptotic proteolytic cascade has been proposed (Kim 
1997). In addition to PS1,  it has been shown that APP and PS2 are substrates of caspases in vitro 
and in cultured cells. (Gervais 1999, Kim 1997).  
 
Despite these findings, it still remains unknown if PS1 have a direct regulatory function in 
apoptosis. Moreover, the function analysis of PS1 has been controversial. Due to pro-
apoptotic reports of PS1, it has been hypothesized that caspase cleavage of presenilins and 
APP creates an apoptotic amplification cycle, accelerating cell death in the neurons of AD 
patients (Loetscher 1997 Kim 1997,). In contrast, persuasive evidences describing an 
antiapoptotic action of PS1 have  also been shown (Roperch 1998; Imafuku 1999; Amson 
2000).  PSCas and ALG-3, a truncated form of PS2, may inhibit Fas induced apoptosis 
(Vezina 1998, Vito).  PS1 assembles with the anti-apoptotic protein Bcl-2 into a 
macromolecular complex (Alberici 1999), and interact with a novel presenilin-associated 
protein (PSAP) (XU 2002). A negative regulation of the stress-activated protein kinase 
(SAPK)/c-Jun N-terminal kinase (JNK) signaling pathway by presenilin 1 was proposed as 
the mechanism by which PS1 regulates apoptosis since overexpressed PS1 suppressed the 
SAPK/JNK activation in oxidative stress induced cell death (Kim 2001). 
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1.6 OXIDATIVE STRESS IN ALZHEIMER’ S DISEASE 
 
1.6.1 Generation of Reactive Oxygen Species 
 
The brain is highly dependent on glucose for ATP generation necessary for many biochemical 
processes, and although the brain represents only 2% of the body mass, it accounts for 20% of 
the body’s glucose consumption (Perry 2003). The key source for ATP is the mitochondrial 
electron transport chain. Electrons from nicotinamide adeninedinucleotide (NADH) and 
flavine adenine dinucleotide (FADH2), produced during the citric acid cycle, are transferred 
to molecular oxygen. At the same time, protons are translocate across the inner mitochondrial 
membrane. The consequence is the generation of a pH gradient across the inner membrane 
membrane that is utilized by ATP synthase for the production of ATP.  
 
The mitochondrial electron transport chain consumes more than 90% of the oxygen taken up 
by the cell. From this about 1–5% are converted into superoxide O2
- during normal 
physiological state (Aliev 2003). O2
- belongs to a group of radical termed as reactive oxygen 
species (ROS), recognized as potentially toxic by-products of cellular metabolism. O2
- is 
converted into hydrogen peroxide (H2O2) by superoxide dismutase (SOD). H2O2 in turn is 
reduced to water by glutathione peroxidase (GPx). If this does not occur, in the presence of 
divalent cations such as iron or copper H2O2 can undergo Fenton reaction and produce 
hydroxyl radicals (OH
-). 
 
The free radical hypothesis of aging, proposed by Harman in 1992, postulated that the age-
related accumulation of ROS results in damage of major components of cells: nucleus, 
mitochondrial DNA, membranes, and cytoplasmic proteins. The imbalance between the 
generation and elimination of ROS may be involved in the pathogenesis of most of the 
neurodegenerative disorders, including AD. Neurons appear to be particularly vulnerable to 
attack by free radicals, because their glutathione content is low (Cooper 1997) and brain 
metabolism requires substantial quantities of oxygen. Since age is the major risk factor for 
AD, and one of the earliest pathological events in AD is oxidative damage in brains of 
affected individuals (Smith 2000, Bayer 2003), free radicals may play a key role in the 
development of the disease.  
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Recent reports show an HB2
BOB2
B induced increase in the concentrations of both intracellular 
(Misonou 2000) and bio-secreted Aß (Olivieri 2001). Simultaneously, Aβ is believed to 
promote neuronal degeneration and death by rendering neurons vulnerable to increases in 
levels of oxidative stress and impairments in cellular energy metabolism (Mattson 2002, 
Gibson 2002).  
 
How genetic factors of AD are related to oxidative is unknown. It is assumable, that some AD 
related genetic factors (see. 1.3) lead to enhanced oxidative stress. In fact, increased oxidative 
stress levels have been found in the temporal inferior cortex from Swedish FAD patients 
(Bogdanovic 2001) and brains of mice transgenic for human presenilin 1 showed reduced 
antioxidative enzyme activity (Leutner 2001). 
 
 
U1.6.1 Stress-activated Protein Kinase and AD 
 
Alterations in gene expression and enzyme activity, induced by extracellular stimuli/stress, 
are mediated through the interplay of multiple signaling pathways. Among these are the 
highly conserved mitogen-activated protein kinase (MAPK) pathways, which are the central 
mediators that propagate signals from the membrane to the nucleus. MAPKs comprise a 
group of serine/threonine kinases that are activated through multiple protein kinases by dual 
phosphorylation at conserved threonine and tyrosine residues All eukaryotic cells possess 
multiple MAPK pathways, each of which is preferentially activated by distinct sets of stimuli, 
thereby allowing the cells to respond coordinately to multiple divergent inputs. MAPK 
pathways play important roles in cellular processes from gene expression, cell cycle control, 
proliferation, differentiation, inflammation and cell death (Grewall 1999). 
 
In neuronal cells, potentially deleterious stimuli, such as deprivation of trophic factors, UV 
irradiation, free radicals, hypoxia, ischemia, heat shock, and cytokines, provoke an 
intracellular stress response that either leads to apoptosis or defensive-protective adaptations. 
Stress-activated protein kinase (SAPK, also know as c-Jun N-terminal kinase; JNK) pathways 
and its downstream effectors are the major cellular factors involved in this response, which 
can lead to neurodegeneration or neuroprotection depending on the cellular and environmental 
conditions, as well as the influence of other signalling pathways (Herdegen 1997). Introduction    
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Since JNK activation plays an important role in oxidative stress signalling as reported recently 
(Zhu 2001, Aoki 2002),  there is increasing interest in understanding the role that JNK may 
play in the pathogenesis of AD. Oxidative stress may cause the activation of c-Jun N-terminal 
kinase  in degenerating neurons in AD (Suzaki 2002). Other models reported the involvement 
of JNK pathway by the induction of Fas ligand in Aß-induced neuronal apoptosis (Morishima 
2001) and in TNF-induced  induced cell death (Dietrich 2003).   
 
JNK is also implicated in the modulation of APP metabolism since JNK induces 
phosphorylation of Thr668 within the carboxy-terminus of APP, a  phosphorylation which is 
believed to regulate the function and metabolism of APP (Standen 2001). Furthermore, the 
findings that JIP1b, the JNK scaffolding protein, strongly binds to the cytoplasmic domain of 
APP (Taru 2002a, Scheinfeld 2002) at the YENPTY-motif, prompt the suggestion that JIP1b 
facilitates JNK accession to, and phosphorylation of, APP. This is supported by the finding 
that JNK associates with AßPP via JIP1b (Matsuda 2001) and that the overexpression of JIP-
1b enhances the JNK dependent threonine phosphorylation of APP ( Taru 2002b). 
 
Since APP is able to trigger intracellular signalling pathways, it is assumable that APP may 
regulate the JNK pathway via JIP-1b as a receptor. JIP-1b my act as a scaffold protein 
between APP and JNK (Inomata 2003) and link APP and kinesin light chain-1 (Matsuda 
20003). JIP-1b interaction with APP stabilizes immature APP and inhibits Aß secretion in 
vitro (Taru 2002b). The kinesin–JIP-1b–APP complex may mediate fast axonal transport of 
vesicles containing APP, presenilin, and BACE (Kamal 2001). JIP-1b could serve as cargo for 
the microtubule motor kinesin to mediate the transportation of several transmembrane 
proteins in which APP is supposed to be a cargo receptor, probably the physiological role of  
APP.  A disruption of the kinesin-JIP-1b-APP complex assembly could be the origin for the 
activation of JNK, leading to phosphorylation of APP and proteolytic cleavage by ß- and γ-
secretase. 
 
Interestingly, JNK is also associated to phosphorylation of Tau. It was shown that JNK can 
phosphorylate Tau in neuronal cells (Bue´e-Scherrer 2002). Additionally, JNK activation 
correlates with increased phosphorylated Tau in the brains of mice (Planel 2001). Thus, JNK 
activation may link both neuropathological hallmarks of AD; Aß production and the Introduction    
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formation of intracellular neurofibrillary tangles containing abnormally phosphorylated tau 
protein aggregated into filaments.  
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1.7 AIM OF THESIS 
 
Massive and progressive neuronal loss is the central abnormality occurring in brains suffering 
from Alzheimer's disease (AD), in addition to senile plaques and neurofibrillary tangles. The 
elucidation of the mechanisms involved in neuronal death in AD is therefore of particular 
importance in order to develop therapeutic targets. Strong evidence indicates that responsible 
for this massive neurodegeneration, affecting probably 20–30 million people worldwide, is a 
small peptide called amyloid beta (Aß). It arises by proteolysis from the amyloid precursor 
protein (APP) through an initial β-secretase cleavage followed by an intramembraneous cut of 
the γ-secretase complex. Aß is generated first intracellulary and then exposed to extracellular 
deposits accumulated principally in a filamentous form in neuritic plaques. The neurotoxicity 
of Aß has been associated with different events such as oxidative stress, altered calcium 
regulation, mitochondrial defects, excitatory toxicity, and deficiency of survival factors.  
 
Although the cause of sporadic AD is yet unknown, certain rare familial AD (FAD) cases are 
caused by mutations in several genes. Missense mutations located within the APP-gene and 
immediately flanking the beta amyloid (Aß) sequence were the first familial AD-gene to be 
identified. The two other genes implicated in the early onset FAD are presenilins (PS) 1 and 
2, causing the most aggressive form of AD known, with onset commonly occurring in the 40s 
and 50s and very rarely as early as 30s. Little is understood of how these mutant genes lead to 
these early onset forms of AD. Interestingly, FAD and sporadic AD have common clinical 
and neuropathological features. Therefore, using transgenic models expressing FAD-
mutations are promising approaches to elucidate the underlying mechanisms of neuronal 
death in AD. On the basis of many studies in cell cultures, transgenic animal models, and 
patients, we know that FAD mutations alter APP processing with respect to an enhanced Aß 
production. 
 
Based on results which indicate that Aß promotes neuronal degeneration and death by 
rendering neurons vulnerable to increase in levels of oxidative stress, the main aim of this 
thesis was to elucidate the neurotoxic biochemical pathways induced by Aß, investigating the 
effect of the APP Swedish double mutation (APPsw, KM670/671NL) on oxidative stress-
induced cell death mechanisms. This mutation results from a three- to sixfold increased Aß 
production compared to wild-type APP (APPwt). As cell models, the neuronal PC12 (rat 
pheochromocytoma) and the HEK (human embryonic kidney 293) cell lines were used, which Introduction    
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has been transfected with human wiltyp APP or the human APP containing the Swedish 
double mutation. The PC12 cell model offers two important advantages. First, compared to 
experiments using high concentrations of Aß at micromolar levels applied extracellularly to 
cells, PC12 APPsw cells secret low Aß within picomolar range reflecting physiological 
production in Ad brain. Thus, this cell model represents a very suitable approach to elucidate 
the AD-specific cell death pathways mimicking pathological conditions. Second, these two 
cell lines (APPwt and APPsw) with different production levels of Aß may additionally allow 
to study dose-dependent effects of Aß. In addition, APP-transfected HEK cells exhibit a 30-
fold increased Aß production as APP-transfected PC12 cell, representing a model of high 
chronic Aß stress, allowing to study further dose-dependent effects of Aß. 
 
Another aim of the present study is based on previous findings showing an anti-apoptotic role 
of Presenilin 1. Presenilin 1 is an aspartyl protease, involved in the γ-secretase mediated 
proteolysis of Aß. Recent studies have suggested an additional role for presenilin proteins in 
apoptotic cell death observed in AD. Since Presenilin 1 is proteolytically cleaved by caspase 
3, it has been proposed that the resulting C-terminal fragment of PS1 (PSCas) could play a 
role in signal transduction during apoptosis. Moreover, it was shown that mutant presenilins 
causing early-onset FAD may render cells vulnerable to apoptosis. The mechanism by which 
PS1 regulates apoptotic cell death is yet not understood. Therefore, it should be investigated if 
Presenilin 1 is involved in the proteolytic apoptotic cascade and whether the cleavage of PS1 
by caspase 3 has an regulatory function. As cell models, PC12 and Jurkat T-cell lymphoma 
cells were transfected with human full lengths Presenilin 1,  the caspase 3 cleaved C-terminal 
fragment of PS1 (PSCas) or full lengths Presenilin 1 with a mutated caspase 3 recognition site 
(D345A/ PSMut), which inhibits cleavage of PS1 by caspase 3. Finally, the effects of these 
transfections with regard to apoptotic vulnerability and apoptotic mechanisms were analyzed. 
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1.8 ZIELE DER ARBEIT 
Massiver und fortschreitender neuronaler Zelltod gehört zu den zentralen Charakteristika der 
Alzheimer Demenz (AD), ebenso wie Senile Plaques und Neurofibrillenbündel. Die 
Aufklärung der Mechanismen die zum neuronalen Zelltod führen sind daher von 
entscheidender Bedeutung bei der Suche nach neuen therapeutischen Ansätzen. 
Verantwortlich für den neuronalen Zelltod ist das Amyloid-Beta Peptid (Aß), das ein 
proteolytisches Spaltprodukt des Amyloid Precursor Proteins (APP) ist. Die Spaltung von Aß 
erfolgt hierbei initial durch die ß-Sekretase und anschließend  intermembranär  durch den γ-
Sekretase Komplex. Aß wird intrazellulär generiert und extrazellulär in aggregierten und 
unlöslichen Plaques angereichert. Die Mechanismen der Aß-Toxizität sind noch nicht genau 
bekannt; assoziiert werden oxidativer Stress, veränderte Kalziumhomöostase, mitochondriale 
Defekte und der Verlust an Überlebensfaktoren. 
 
Obwohl die Ursachen der sporadischen AD nicht bekannt sind zeigen genetische Analysen, 
dass Mutationen im APP-Gen auf Chromosom 21 die familiäre Form der Alzheimer 
Erkrankung (FAD) verursachen. Daneben wurden zwei andere Loci auf Chromosom 14 
(Presenilin 1) und Chromosom 1 (Presenilin 2) mit der early-onset FAD beschrieben. 
Mutationen im Presenilin 1 oder Presenilin 2 Gen führen zu einem frühen Beginn der 
Erkrankung, zum Teil schon  vor dem 40. und 50. Lebensjahr. Wie diese mutierten Gene zur 
early-onset FAD führen, ist fast völlig unbekannt. Interessanterweise weisen FAD- und 
sporadische AD-Fälle die gleichen klinischen und neuropathologischen Eigenschaften auf. 
Daher bieten transgene FAD-Modelle vielversprechende Ansätze um die zugrundeliegenden 
Mechanismen des neuronalen Zelltods bei der AD aufzuklären. Aufgrund von Studien mit 
Zellkulturenmodellen, transgenen Tiermodellen und Patienten, wissen wir, dass FAD 
Mutationen die APP Prozessierung beeinflussen und eine erhöhte Aß Produktion bewirken. 
 
Basierend  auf  Ergebnissen, die darauf hinweisen, dass bei AD eine veränderte Vulnerabilität 
gegenüber den oxidativen Stress induzierten Zelltod vorliegt, sollten im Rahmen dieser Arbeit 
die vom Aß eingeleiteten neurotoxischen biochemischem Signaltransduktionswege aufgeklärt 
werden. Hierfür wurde der Effekt der schwedische APP Doppelmutation (APPsw, 
KM670/671NL) auf den durch oxidativen Stress induzierten Zelltod untersucht. Diese 
Mutation die im Rahmen der FAD vorkommt, verursacht eine drei- bis sechsfach erhöhte Aß 
Produktion im Vergleich zu humanen wild Typ APP (APPwt). Als Zellmodell dienten PC12- 
und HEK-Zellen, die mit Vektoren transfiziert wurden, die einerseits APPwt, und anderseits Introduction    
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APPsw enthalten. Das PC12 Zellmodell bietet hierbei zwei wichtige Vorteile. 1. Verglichen 
mit Experimenten bei denen Aß extrazellulär im mikromolaren Bereich appliziert wird, 
sekretieren PC12 APPsw Zellen, entsprechend der physiologischen Produktion im Gehirn von 
AD Patienten, Aß im pikomolaren Bereich. 2. Beide Zelllinien (APPwt und APPsw) haben 
eine unterschiedliche Aß Produktion, was die Untersuchung von dosisabhängigen Effekten 
ermöglicht. APP-transfizierte HEK Zellen weisen eine 30fach erhöhte Aß Produktion im 
Vergleich zu den APP-transfizierte PC12 Zellen auf, und stellen ein Modell für chronisch 
erhöhte Aß-Spiegel dar. Dies erlaubt weitere dosisabhängige Untersuchungen von Aß. 
 
Ein weiteres Ziel dieser Arbeit basiert auf vorhergehenden Hinweisen, die auf eine anti-
apoptotische Rolle von Presenilin1 (PS1) hindeuten. PS1 ist eine Aspartyl-Protease, involviert 
in der Proteolyse von Aß durch den γ-Sekretase Komplex. Neue Daten lassen auf eine 
zusätzliche Rolle von PS1 im Rahmen des apoptotischen Zelltods bei der AD schließen. Da 
PS1 proteolytisch durch die Caspase 3 gespalten wird, wurde postuliert, dass das resultierende 
C-terminale Fragment von PS1 (PSCas) eine Rolle während der apoptotischen 
Signaltransduktion haben könnte. Zusätzlich wurde gezeigt, dass FAD mutiertes PS1 zu einer 
erhöhten Vulnerabilität von Zellen führt. Wie PS1 den apoptotischen Zelltod reguliert, ist 
unbekannt. Daher wurde im Rahmen dieser Arbeit untersucht, ob PS1 in der proteolytischen 
apoptotischen Kaskade involviert ist, und ob die Spaltung von PS1 durch Caspase 3 eine 
regulatorische Funktion besitzt. Als Zellmodelle wurden PC12 und Jurkat T-cell lymphoma 
Zellen verwendet ,die transfiziert wurden mit: 
1. humanem  PS1 
2.  Caspase 3 gespaltenem C-terminalem Fragment von PS1 (PSCas) 
3.  mit Caspase-3  mutierter Erkennungssequenz (D345A/ PSMut), was die Spaltung von 
PS1 durch Caspase 3 verhindert. 
Schließlich wurden die Effekte der Transfektionen in Hinblick auf die Zellvulnerabilität und 
Apoptosemechanismen untersucht. 
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2. Material and Methods 
The material listed below include the used laboratory equipment and utensils. The used 
buffers, enzymes, chemicals or antibodies are listed under the appropriate methods step. 
2.1 APPARATUS: 
Agitator, type REAX 2000, Heidolph, Merck Eurolab GmbH, Frankfurt 
BiomaxP
TM
P TranScreen-LE, Eastman Kodak, Rochester, New York, USA 
Branson Sonifier, Cell Disruptor B15, Branson Ultrasonics Corp., Danbury 
Centrifuge, model GS-6R, Beckman, München 
Centrifuge,  model J2-with  JA-20 und JA-20.1 rotor, Beckman, München 
COB2
B-incubators Heraeus, Typ BB 6220, Heraeus Instruments GmbH, Hanau 
Combitips 0.5 ml, 2.5 ml, 10 ml, Eppendorf-Netheler-Hinz-GmbH, Hamburg 
Coverslips for haemacytometer (Neubauer chamber), Superior, Merck Eurolab GmbH, Frankfurt 
Cryo-vial, model Cryo-S, 2 ml, Greiner Labortechnik, Frickenhausen 
Culture dishes and flasks, CorningP
®
P 25 cmP
2
P, Polystyren, Dunn Labortechnik, Asbach 
Culture vessels, IWAKI Dunn Labortechnik / Greiner Labortechnik Frickenhausen 
Developer, Replenisher, GBX reagents, Eastman Kodak, Rochester, New York, USA 
Electrophoresis, transfer-chamber Mini-Trans-Blot, BioRad, München 
FACSCalibur™ (E1034), Becton Dickinson, Heidelberg 
Fluorescence microscope, Eclipse E 800, Nikon, Japan 
Fluorescence spectrometer, Victor Multilabel counter, Perkin Elmer, Jügesheim 
Horizontal slab gel electrophoresis apparatus 10 x 15 cm, PeqLab Biotechnologies GmbH, Erlangen 
Incubator for bacteria, Kelvitron kl. Heraeus Instruments GmbH, Hanau 
Inverse microscope, model TMS, type I04, Nikon, Japan 
Laminar flow hood, Heraeus InstrumentsGmbH, Hanau 
Latex examination gloves, Ansell GmbH, München 
Liquid scintilattion counter, Wallac 1409 Berthold, Turku, Finland 
Magnetic agitator, type Poly 15, H + P Labortechnik, Merck Eurolab GmbH, Frankfurt 
Microtiter plates IWAKI, 96 well with flat bottom, Dunn Labortechnik GmbH, Asbach 
Microtiter plate, U-shaped botttom, sterile, Greiner Labortechnik, Frickenhausen 
Microcentrifuge, type GS-6R Centrifuge, Beckman, Krefeld 
MultipetteP
®
P plus 4981, Eppendorf, Merck Eurolab GmbH, Frankfurt 
Neubauer chamber Superior, Merck Eurolab GmbH, Frankfurt 
ParafilmP
®
P M, Merck Eurolab GmbH, D-60487 Frankfurt  
pH-meter, type CG 825, Schott, D-65719 Hofheim 
Photometer for microplate model Digiscan, Firma Asys Hightech, Eugendorf 
PipetusP
®
P-akku, Hirschmann, Merck Eurolab GmbH, Frankfurt 
PlastibrandP
®
P Tip-Rack, 5 – 300 µl, Brand, Merck Eurolab GmbH, Frankfurt  
Pipettes model Pipetman 10, 20, 200, 1000 und 5000 µl, Abimed, Langenfeld 
Pipettes sterile packed 5, 10 and 25 ml, Greiner Labortechnik, Frickenhausen 
PP-tubes 15 ml and 50 ml, CellstarP
®
P, Greiner Labortechnik, Frickenhausen  
PVDF-ImmobilonTM-P-transfermembran, Millipore, Eschborn 
Thermocycler, GeneAMP PCR-9700, Perkin Elmer Bio Systems, USA 
TransferpetteP
®
P-8, 10 - 100 µl, Brand, Merck Eurolab GmbH, Frankfurt 
TransferpetteP
®
P-8, 30 - 300 µl, Brand, Merck Eurolab GmbH, Frankfurt 
UV/VIS-photometer, type U-2000 Spectrophotometer, Hitachi, Düsseldorf 
Vertical slab gel electrophoresis apparatus, Bio-Rad, München 
Water bath, type Thermomix 1441, B.Braun-Melsungen, Düsseldorf 
Water bath, type 1003, GFL, Merck Eurolab GmbH, Frankfurt 
Weighing scale machine, model Ab204 and AT261, Mettler, Gießen 
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2.2 CELLBIOLOGICAL METHODS 
 
U2.2.1 Culture of cell lines 
 
All here described experiments with cell lines were conducted under sterile conditions in a 
laminar flow box. Cells were kept at 37°C, 94% humidity and 5% COB2
B in sterile culture 
vessels. All buffers and solutions were made from commercially available chemicals of 
analytical grade using purified (Millipore MilliQ-Plus) or double distilled water and were 
autoclaved or sterile filtered prior to use. 
Media were heated to 37 °C prior to use. To separate adherend Cells from culture dishes a 
mix of EDTA/Trypsin was used. Cells were routinely passaged and washed with phosphate 
buffered saline (PBS). In regular time intervals cells were checked for Mycoplasma 
contamination by perfoming a Mycoplasma PCR . 
 
PBS  Invitrogen 
EDTA/Trypsin (0,25% EDTA/1 mM Trypsin)  Invitrogen 
Mycoplasma PlusP
TM
PPCR Primer Kit  Stratagene 
 
 
 
U2.2.2 Used cell lines 
 
The following cell lines were used: 
 
PC12 cells (rat pheochromocytoma) ref. (Greene et al. 1976): 
a) untransfected PC12 cells 
The cells were cultured in DMEM supplemented with 10% heat-inactivated fetal calf serum, 5% 
heat-inactivated horse serum, 50 U/ml penicillin and 50 µg/ml streptomycin. 
 
D-MEM complete medium   Invitrogen 
10% FCS (fetal calf serum)  Invitrogen 
-5 % HS (Horse Serum)  Invitrogen 
-50 µg/ml (1%) Penicillin    Invitrogen 
-50 µg/ml (1%) Streptomycin    Invitrogen 
 
 
b) PC12 cells transfected with pCMV-vector containing: 
•  human wildtyp APP (APPwt) 
•  human APP containing the swedish double mutation KM670/671NL (APPsw) Material and Methods    41 
 
•  empty pCMV- vector (control). 
 
PC12 cells were transfected with DNA constructs harbouring human mutant (APPsw, 
KM670/671NL) or wild-type APP (APPwt) gene, inserted downstream of a CMV promotor, 
using FUGENE technique (Roche Diagnostics). The stably transfected clones (APPwt M5, 
N10, U7 and APPsw Q8, Q9) were selected based on their similar expressoon of APP695 and 
the fivefold increased secretion of Aß(1-40) in the APPsw clones. 
The pCMV695-vector contains a neomycin-resistance cassette, allowing to select stably 
transfected cells to be selected using G418. 
 
c) PC12 cells transfected with a pcDNA3-vektor encoding: 
•  human presenilin 1 (PS1) 
•  human presenilin 1 with a mutated caspase 3 cleavage site D-345-A, (PS1mut) 
•  a C-terminal human presenilin 1 fragment processed by caspase 3 cleavage (PS1Casp) 
•  empty pcDNA3-vektor (A3) 
These cells were stably transfected by Lipofectamine 2000 reagent (The procedure is 
described in 2.2.5). Stably transfected cells were selected using G418 on the basis that 
pcDNA3-vector contains a neomycin- resistance cassette. The effective transfection of the 
different contructs were verified by RT-PCR. 
 
Transfected PC 12 cells were cultured in DMEM supplemented with 10% heat-inactivated fetal 
calf serum, 5% heat-inactivated horse serum, 50 U/ml penicillin, 50 µg/ml streptomycin and 400 
µg/ml G418. 
 
D-MEM complete medium   Invitrogen 
10% FCS (Fetal Calf Serum)  Invitrogen 
-5 % HS (Horse Serum)  Invitrogen 
-50 µg/ml (1%) Penicillin    Invitrogen 
-50 µg/ml (1%) Streptomycin    Invitrogen 
400 ug/ml G418          PAA Laboratories 
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HEK cells (human embryonic kidney 293) ref. ( Shigematzu et al. 1971) 
a) untransfected HEK cells 
The cells were cultured in DMEM supplemented with 10% heat-inactivated fetal calf serum, 50 
U/ml penicillin and 50 µg/ml streptomycin. 
 
D-MEM complete medium   Invitrogen 
-5 % HS (Horse Serum)  Invitrogen 
-50 µg/ml (1%) Penicillin    Invitrogen 
-50 µg/ml (1%) Streptomycin    Invitrogen 
 
b) transfected HEK cells with pCMV-vector containing: 
 
•  human wildtyp APP (APPwt) 
•  human APP containing the swedish double mutation KM670/671NL (APPsw) 
 
Transfected HEK cells were cultured in DMEM supplemented with 10% heat-inactivated fetal 
calf serum, 50 U/ml penicillin, 50 µg/ml streptomycin and 400 µg/ml G418. 
 
D-MEM complete medium   Invitrogen 
10% FCS (fetal calf serum)  Invitrogen 
-50 µg/ml (1%) Penicillin    Invitrogen 
-50 µg/ml (1%) Streptomycin    Invitrogen 
400 ug/ml G418          PAA Laboratories 
 
Jurkat T-cell lymphoma cells 
The cell suspension of Jurkat T-cell lymphoma cell line was maintained in RPMI culture 
medium containing 10% FCS and Penicillin/ Steptomycin. 
 
RPMI-culture medium: 
-10% FCS (2 hours heat inactivated at 56°C)  Invitrogen 
- Penicillin/ Streptomycin 1%  Invitrogen 
Æ in RPMI  Invitrogen 
 
Using Lipofectamine 2000 reagent (see 2.2.5), transient transfected Jurkat cells were 
generated by transfection with pcDNA3-vector encoding for: 
•  human presenilin 1 (PS1) 
•  human presenilin 1 with a mutated caspase 3 cleavage site D-345-A, (PS1mut) 
•  a C-terminal human presenilin 1 fragment processed by caspase 3 cleavage (PS1Casp) 
•  empty pcDNA3-vektor (A3) 
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U2.2.3 Cell counting and viability test 
 
To resolve the cell number, cells were resuspended with care and mixed with trypan dye 
solution (10:1). An aliquot of the stained cell suspension was subjected to a Neubauer 
chamber. Trypan dye penetrate into death cells due to a disrupted cell membrane, while vital 
cells are undyed. The arithmetical mean from different counting sections is determined and 
the cell number calculated in respect to the chamber factor and the dilution. 
 
Trypan blue dye  Invitrogen 
 
 
U2.2.4 Cryoconservation of cells 
 
Cells were washed with PBS, collected by centrifugation and all supernatant removed. Cells 
were resuspended in freezing medium, containing DMSO, in order to prevent harm by ice 
crystal formation during storage under freezing conditions. Cells were subjected quickly on 
ice for several minutes and than stored overnight in a freezer (-20°C). The following day, the 
cells were subjected in an -80°C freezer overnight and than stored for in liquid nitrogen. 
To thaw cells, cryotubes containing the desired cells were rapidly subjected from the freezer 
or the nitrogen tank to a prewarmed (37°C) water bath for one or two minutes, until the 
solution is thawed. The cells were immediately diluted in a large amount of prewarmed 
complete culture medium, and washed several times by gentle centrifugation. Finally the cells 
were seeded in a culture vessel. 
 
Freezing medium: 
-50% FCS  Invitrogen 
-10% DMSO (dimethylsulfoxide)  Sigma 
Æ in medium 
 
 
U2.2.5 Transfection of cells 
 
The transfection of PC 12 and Jurkat cells were performed using the Lipofectamine™ 2000 
reagent. The principle of the transfection is the uptake of an endocytotic DNA/cationic lipid 
complex by the cell. The day before transfection, PC 12 cells were counted and plated in a 24 
well plate at 3 X 10P
5
P cells per well so that they were 90% confluent on the day of transfection. Material and Methods    44 
Cells were plated in 0.5 ml of their normal growth medium containing serum without 
antibiotics. 
For each well of cells, 0.8 µg of DNA were deleted in 50 µl of OPTI-MEM Reduced Serum 
Medium without serum. At the same time for each well of cells, 2 µl of Lipofectamin 2000 
were diluted in 50 µl OPTI-MEM I Medium and incubate for 5 min at room temperature. The 
Lipofectamin reagent and the diluted DNA were mixed and incubate for 20 min, to allow the 
formation of DNA-Lipofectamin complex. Finally the DNA-Lipofectamin complexes (100 
µl) were added directly to each well and mix gently. 
 
The cells were incubated at 37°C in a CO2 incubator for 24 hr washed with PBS and splitted 
in a high ratio to allow the identification of individual clones Individual clones were the 
incubate for 7 days in D-MEM containing 10 % FCS, 5 % HS, 1% Penicilin, 1 % 
Streptomycin and a high concentration of G418 (800 µg/ml), to allow the selection of positive 
transfected clones stably expressing the inserted gene.  
 
Lipofectamine  2000           Invitrogen 
Optimem-medium           Invitrogen 
 
Jurkat cells were transfected transiently. The principle of the transfection is the same as for 
the PC12 cells, with the difference that after the addition of the DNA-Lipofectamine 
complexes, cells were incubated at 37°C in a CO2 incubator for 4 hr and the OPTI-MEM 
replaced with the growth medium. After 24 cells were assayed for experiments. 
 
 
 
 
 
2.3 GENETIC ENGINEERING 
   
All the molecular biological work steps were performed under sterile conditions in order to 
avoid digestion of nucleic acids by DNases and RNases as well as the contamination by strange 
DNA. Hence, only sterile disposable plasticware, glass, pipettes and other material were used. 
The used solutions and buffers were autoclaved before use. Furthermore, during all working 
steps one-way gloves were worn. 
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2.3.1 Plasmids 
 
The following plasmids were used: 
a) pCMV,  b) APPwt-pCMV,  c) APPsw-pCMV 
 
 
Figure 2.1. APP-pCMV695 vector. The human APP is under the control of the CMV 
promotor. The vector also contains an ampicillin resistance for selection. 
 
 
    d) pcDNA3  e) pcDNA3-PS1wt, f) pcDNA3-PS1Mut (D345A), g) pcDNA3-PSCas 
Figure 2.2 pcDNA3 vector.  
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Figure 2.3 pcDNA3-PS1 vector. The cloned PS-1 cDNA is under the control of the CMV 
promotor, subsequent to a stop codon there is a polyA site. The vector contains a neomycin 
resistance for selection in eukaryotic cells, and an ampicillin resistance for selection in 
prokaryotes. All other vectors generated here are analogously. PcDNA3-PSCas contains the 
C-terminal PS1 Fragment after the caspase cleavage site. 
 
2.3.2 Gelelektrophoresis  
 
The characterization of DNA and RNA were performed by gelelectrophoresis, which allow 
the separation of charged molecules. Nucleic acids are negatively charged molecules, and are 
moved by electric current through a matrix of agarose towards the anode. The size of the 
fragments is determined using a marker. For the preparation of an 1% agarose gel, 1g  agarose 
was dissolved in  100 ml 1X TAE buffer and heated until the solution becomes clear. 
Ethidium bromide was added to a final concentration of 0.5 µg/ml. The gel solution was 
poured into a prepared gel casting tray and allow to solidify before samples with the 
appropriate loading dye were runned by electrophoresis at 50-150 volts. DNA was visualized 
by the UV-induced fluorescence of ethidium bromide dye intercalated into the nucleic acid. 
The amount of fluorescence is proportional to the amount of nucleic acid present. Dye bound 
to DNA has a much stronger fluorescence in UV light than free dye. UV light at 254 nm is 
absorbed by the DNA and transmitted to the dye and UV at 302 nm and 366 nm is absorbed 
by the dye itself. The energy is re-emitted at 590 nm in the red-orange part of the visible 
spectrum. 
 
50x TAE-buffer: 
-242 g Tris  Sigma 
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-57,1 ml acetic acid  Merck 
-100 ml 0,5 M EDTA (pH 8,0)                Merck 
filled  up with   HB2
BO  to 1l  
 
loading bufferU:U 10x BlueJuice  Invitrogen 
Ethidiumbromid: Invitorgen 
agarose  Merck 
100 bp DNA-ladder  New England Biolabs/Invitrogen 
1 kb DNA-ladder  New England Biolabs/Invitrogen 
 
U2.3.3 Quantification of Nucleic Acid Concentration 
 
The quantification of nucleic acid concentration was done by  optical density measurements. 
The absorbance of UV light at 260 nm wavelength by nucleic acids gives an estimate of 
concentration, assuming firstly that there are no protein or phenol contaminants in the solution 
and secondly, that the concentration of the nucleic acid is greater than 250 ng / ml. The ratio 
of readings taken at 260 nm and 280 nm wavelengths (both in the UV range) gives an 
indication of the purity of the nucleic acid. 
An OD unit corresponds to the amount of nucleic acid in µg in a 1 ml volume using a 1 cm 
path length quartz cuvette that results in an OD260 reading of 1. 
For DNA OD260 1 = 50 µg / ml,  
For RNA OD260 1 = 40 µg / ml, 
For single stranded oligonucleotides OD260 1 ~ 33 mg / ml 
 
 
U2.3.4 RNA-IsolationU  
 
Total RNA from cells was isolated using the TRIZOL Reagent, a mono-phasic solution of 
phenol and guanidine isothiocyanate, based on the single-step RNA isolation method 
developed by Chomczynski and Sacchi (1987). To prevent introduction of RNases, all steps 
were worked under severe sterile conditions. Isolated RNA was dissolved in 
diethylpyrocarbonate (DEPC, 0,01%) treated and autoclaved water. 5X 10P
6
P cell were 
harvested, washed with PBS and lysed in 1 ml Trizol reagent. The homogenized samples were 
incubated for 5 minutes at room temperature to permit the complete dissociation of 
nucleoprotein complexes. After the addition of 0.2 ml of chloroform per tubes were 
vigorously shaked and incubate at room temperatue for 2 to 3 minutes. Samples were Material and Methods    48 
 
centrifuge at 12,000 g for 15 minutes 4°C. After the centrifugation, the mixture is separated 
into a lower red, phenol-chloroform phase, an interphase, and a colorless upper aqueous phase 
containing RNA . The aqueous phase was transferred to a fresh tube and precipated by mixing 
with 0.5 ml isopropylalcohol. After an incubation at room temperature for 10 minutes samples 
were centrifuged at 12,000 ⋅ g for 10 minutes at 4°C. The supernatant was removed and the 
small RNA pellet washed with  1ml 75% ethanol. Following another centrifugation step 
(7,500 ⋅ g for 5 minutes at 4°C), the RNA pellet was briefly dried and dissolved in 50 µl 
DEPC treated water. 
 
TRIZOL Reagent  Invitrogen 
Chloroform Merck 
Isopropylalcohol Merck 
Ethanol  Merck 
Diethylpyrocarbonate (DEPC)  Invitrogen 
 
 
U2.3.5 cDNA- Synthesis 
 
Isolated RNA was used for first-strand cDNA synthesis reaction catalyzed by  SuperScript. II 
Reverse Transcriptase (RT). This enzyme is not inhibited significantly by ribosomal and 
transfer RNA, it may be thus be used effectively to synthesize first- strand cDNA from a total 
RNA preparation. Oligo(dT), which hybridize to 3´ poly(A) tails,  were used as primer. The 
following components were mixture for each individual sample before starting the cDNA 
synthesis reaction: 
2 µg total RNA 
10mM dNTPs mix  1 µl 
Oligo(dT)12-18 (0.5 µg/µl)   1 µl   
 filled up with DEPC-treated water  to   10 µl   
 
The samples were incubate at 65°C for 5 min to destroy secondary structures, and then place 
on ice for at least 1 min.  
The following master mixture was prepared:  
10X RT buffer            2 µl   
25 mM MgClB2
B            4 µl   
0.1 M DTT              2 µl   
RNaseOUT (Recombinant RNase Inhibitor)    1 µl   Material and Methods    49 
 
Both, RNA/primer and master mixture were mixed and incubate at 42°C for 2 min. Finally, 1 
µl (50 units) of SuperScript II RT was added to each tube and incubate at 42°C for 50 min. 
The reaction was terminated by an incubation step at 70°C for 15 min. At the end  1 µl of 
RNase H was added to each tube and incubate for 20 min at 37°C before proceeding to 
amplification of the Target DNA by PCR.  
 
SuperScript First-Strand Synthesis System for RT-PCR  Invitrogen 
MgCl2   Invitrogen 
DTT   Sigma 
 
2.3.6 Reverse Transcriptase PCR (RT-PCR) 
 
Following Target DNAs were amplificated with appropriate primer pairs by PCR for 
quantification: 
 
Target  Primer  Product size  Annealing Temp
forward  5' -GGA TCC TGG GGC CAG GGT ACT GAT-3'  AIF, human 
reverse 5‘ -CTC GGG GAA GAG TTG AAT CAC TTC-3’  550 bp   60 °C 
forward 5’-GAG CTA CGA GCT GCC TGA CG-3’  ß-Actin, human 
reverse  5’-GTA GTT TCG TGG ATG CCA CAG-3’  119 bp   58 °C 
forward 5‘ -ATT ACG GGA CCC AAA TGT CA-3’  GSK3ß, human 
reverse  5‘ -TGC AGA AGC AGC ATT ATT GG-3’  217 bp  55 °C 
forward  5‘ -GCA CAG AAA GGG AGT CAC AAG-3’  PS1, human 
reverse  5‘ -TAA TTG GTC CAT AAA AGG-3’  425 bp   46 °C 
forward  5‘ -GGTAAAGCCTCAGCAACAGC-3’  PS1Cter, human 
reverse  5‘ -AAACAAGCCCAAAGGTGATG-3’  153 bp   59 °C 
forward  5' -AGT GGA AGA CTG GCT GGA GA-3'   AIF, rat 
reverse 5‘ -TCA CTC TCC GAA CGG ATA-3’  217 bp   59 °C 
forward  5' -AGG ATC GAG CAG AGA GGA TG-3'   Bax, rat 
reverse 5‘ -GAG GAC TCC AGC CAC AAA GA-3’  449 bp   59 °C 
forward  5' -CTG GCA TCT TCT CCT TCC AG-3'   Bcl-2, rat 
reverse 5‘ -CTC ACT TGT GGC CCA GGT AT-3’  576 bp   55 °C 
forward  5' -GGCTGCCTTCTCTTGTGA-3'   GAPDH, rat 
reverse 5‘ -CTC GTG GTT CAC ACC CAT-3’  355 bp   57°C 
forward  5' -GGA TCT GCC ATC GAG ACA TT-3'   GSK3ß, rat 
reverse 5‘ -CCA ACT GAT CCA CAC CAC TG-3’  273 bp   58 °C 
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The following mixture was prepared for each individual PCR sample:  
10X Tag buffer with Mg
2+          5 µl   
5X Tag enhancer (heated to 65°C)      10 µl   
dNTPs mix (10 mM each)          2 µl   
Taq polymerase (5U/µl)          0,5 µl   
Primer forward (100 pmol/µl)      0,5 µl  
Primer reverse   (100 pmol/µl)       0,5 µl  
c D N A         2   µ l  
H2O        29,5  µl  
Total volume   50 µl 
 
The PCR was run in a thermal cycler, with following adjusted cycling parameter: 
10 min:  94 °C 
1 min:  94°C 
1 min:  appropriate anneling temperature 
1 min:  72°C 
10 min:  72°C 
chilled to   4°C 
 
The reactions were stopped in  the exponential phase of amplification (After 20 or 25 cycles 
respectively), since at some later cycles the amplification rate drops to near zero (plateaus), 
and little more product is made. As control, actin or GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) standards were used. The PCR products were separated on a 1.5 % agarose 
gel, stained with ethidium bromide, and visualized under UV light. 
 
Primer Ordering  MWG Biotech 
10X Tag buffer (500mM KCL, 100mM Tris-HCL pH 8,3, 15 mM Mg(OAc)2) Epppendorf 
5X Tag enhancer  Eppendorf  
dNTPs  mix  (10  mM  each)                           Eppendorf/Invitrogen 
Taq polymerase                                Eppendorf/Invitrogen
        
 
   
2.3.7 Cloning of PS-Plasmids 
 
Human PS1 in pcDNA3 was a kind gift from C.Haaß (München, Germany) to our laboratory. 
PS-1Cas was amplified from PS-1-pcDNA3 using PfuI polymerase and appropriate primers 
with an annealing temperature of 51°C. The resulting PCR fragments were subcloned into 
Kpn/XbaI restriction sites of pcDNA3 containing a gentamycin resistance gene.  The ligation 
was performed with T4 DNA ligase overningt at 16°C. T4 ligase catalyzes the ligation of 
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double-stranded DNAs between the 3'-hydroxy and the 5'-phosphate termini in the presence 
of ATP: 
 
1 µl pcDNA3-vector (50 ng/µl) (digest with Kpn/XBa 
3 µl PSCas insert (50ng/µl) 
0,5 µl Ligase   
1 µl Ligase-buffer (10x)   
4,5 µl H2O 
10 µl total volume 
 
PSCas-Primer: 
Sense: 5’-CGG GGT ACC CCG ATG CCT CAT CGC TCT-3’   MWG Biotech 
Antisense: 5’-TGC TCT AGA GCA CTA GAT ATA AA AT-3’                       MWG Biotech 
PfuI  polymerase          New  England  Biolabs 
T4  Ligase           New  England  Biolabs 
Ligase  buffer          New  England  Biolabs 
 
 
Human PS1Mut (D345A) was constructed using  theQuickChange
TM mutagenesis kit from 
Stratagene. The vector PS-1-pcDNA3 was replicated with primers containing a single base 
exchange, leading to a directed mutant replication. GAC was exchanged with GCC in the 
sense-, GTC with GGC in the antisense-primer. Therefore, the amplificated vector contains a 
mutant aminoacid at site 345, substituting D (aspartate) with A (alanine). PCR was done with 
PfuI polymerase. Annealing temperature was 54°C, extension time 10 minutes. Parental DNA 
was digested with 10.000U DpnI, in order to remove methylated parental vector DNA and 
amplified DNA subsequently transformed with Top 10 component cells. Base exchange was 
approved by sequencing. 
 
Psmut-Primer 
Sense 5’-CCCAGAGGGCCAGTCATCTAGGG-3’ 
Antisense 5’-CCCTAGATGACTGGCCCTCTGGG-3’ 
  
QuickChange
TM  mutagenesis  kit        Stratagene 
PfuI  polymerase          New  England  Biolabs 
 
 
2.3.8 Transformation in competent Bacteria 
 
For the amplification of plasmide DNA competent bacteria were transformed. The competent 
bacterial cells, pretreated with CaCl2, were stored at –80°C. Therefore, first the competent 
cells (50 µl/tube) were thawed on ice and gently mixed with 10 µl plasmide DNA (10 ng). 
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After an incubation on ice for 30 min, cells were heat shocked (1 min at 42°C). Cells were 
placed on ice for 2 min and 250 µl SOC medium added. It followed a gently shaking at 37°C 
for 60 min and finally cells were plated on LB plus antibiotics plate. Plates were incubated in 
an inverted position in the 37°C incubator overnight. Individual clones were picked and 
cultured in 2 ml or 200 ml SOC-Amp medium for Plasmide DNA minipreparation and 
maxipreparation, respectively.   
 
Top Ten, competent bacteria    Invitrogen 
 
SOC medium: 
20 g LB-powder was dissolved   Invitrogen 
 in 1 l HB2
BO and autoclaved. 
SOC-Amp-medium: 
SOC-medium with 0,1 mg/ml Ampicillin-finalconcentration 
Ampicillin-Stock: 50 mg/ml  Merck 
 
LB plus antibiotic plate: 
1 l autoclaved  SOC-medium and 
15 g Agar  Invitrogen 
were heated to become a clear solution. 
After a chilling 1 ml Ampicillin (0,1 mg/ml finalconcentration)  
was added,  and about 20 ml casted into a dish.  
 
 
2.3.9 Plasmid-Mini/Maxipreparation 
 
The plasmid purification protocols are based on a modified alkaline lysis procedure, followed 
by binding of plasmid DNA to anion-exchange resin under appropriate low salt and pH 
conditions. RNA, proteins, dyes, and low-molecular-weight impurities are removed by a 
medium-salt wash. Plasmid DNA is eluted in a high-salt buffer, and then concentrated and 
desalted by isopropanol precipitation. 
Plasmide DNA was isolated from transformed bacteria suspension by mini preparation; the 
bacterial suspension was centrifuged at 12,000 ⋅ g for 10 minutes at 4°C. The bacterial pellet 
was completely resuspended in 0.3 ml of Buffer P1 containing RNase A. Buffer P2 (0,3 ml) 
was added, mixed gently by inverting the tube 4–6 times. After an incubation at room 
temperature for 5 min 0.3 ml of chilled Buffer P3 was added, mixed immediately and incubate 
on ice for 5 min. The precipitated proteins were separated by a centrifugation step at 18,000 
⋅ g for 10 minutes at 4°C. The clear supernatant was loaded onto  a spin column in a 2 ml Material and Methods    53 
 
collection tube and allow to enter the resin by gravity flow. After a centrifugation step (1 min) 
the spin column was washed twice with 0,75 ml buffer PE by centrifugation. Finally the 
column was placed in a new microfuge tube and the DNA eluated with 50 µl EB buffer. The 
isolation of plasmide DNA by maxi preparation was performed in the same procedure, only 
with differences in the used volumes.  Afterwards DNA was precipitated with 0,7 volumes) of 
room-temperature isopropanol, centrifuged immediately at 12,000 x g for 30 minutes at 4°C 
min and the supernatant carefully decanted. The DNA was washed with 1 ml of  70% ethanol 
to remove precipitated salt, air-dried for 5 min, and redissolve in sterile water. For 
determination of the yield, DNA concentration was measured by UV spectrophotometry. 
 
Resuspensionsbuffer P1: Qiagen 
50 mM Tris-HCl, pH 8,0 
10 mM EDTA, 
100 µg/ml RNase A 
 
Lysisbuffer P2: Qiagen 
200 mM NaOH 
1% SDS 
 
Neutralisationbuffer P3: Qiagen 
3 M Natriumacetat, pH 5,5 
 
Washing buffer PE: Qiagen 
1 M NaCl 
50 mM MOPSD, pH 7,0 
15% Isopropanol 
 
Eluationsbufer EB: Qiagen 
1,25 M NaCl 
50 mM Tris-HCl, pH 8,5 
 
Isopropanol Merck 
Ethanol Merck 
 
 
2.3.10 Analytical Restrictionanalysis 
   
Plasmide DNA was digest with restriction endonucleases for cloning, or to verify the 
successful ligation or transformation, thereby taking into account the optimal reaction buffer, 
incubation temperature or the BSA concentration. A typical preparation was incubated for 2 h 
at  37 °C as followed: 
 
5 µl Plasmid-DNA 
1,5 µl NEB-Puffer 2  New England Biolabs 
0,7 µl Kpn  New England Biolabs 
0,7 µl Xba  New England Biolabs 
1,5 µl BSA (10x)  New England Biolabs 
10,6 µl HB2
BO 
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2.4 ANALYTICAL CELLBIOLOGICAL METHODS 
 
2.4.1 Detection of cell viability 
 
2.4.1.1. Induction of cell death 
 
The detection of cell viabillity was performed by the following described methods. Cell death 
was induced by hydrogen peroxide, staurosporine or Fas-ligand. 
Oxidative stress was induced with hydrogen peroxide (freshly prepared solutions) in PC12  
and HEK cells. The respectives concentrations are stated below for each experiment. In other 
experiment staurosporine was used to induce apoptosis. Stauroporine is an alkaloid produced 
by streptomyces bacteria. The exact mechanism of its apoptosis inducing effect is still not 
known. An inhibition of protein kinase  (Swannie et al. 2002) and  cyclin-dependent kinase 
(Mikolajczyk et al. 2003, Gray N.1999) was reported. The use of staurosporine derivates in 
cancer therapie is discussed (da Rocha et al. 2002). 
Jurkat cells were additionally incubated with Fas-ligand (50 ng/ml) for 24 hr. When 
announced, cells were incubated 1 to 3 hours prior to cell death induction with different cell 
permeable caspase inhibitors or SP600125, a selective anthrapyrazolone inhibitor of JNK. 
The inhibitors were solved in DMSO. 
 
Caspase 2 Inhibitor (Z-VDVAD-FMK)  Calbiochem/Merck Bioscience 
Caspase 3 Inhibitor (AC-DEVD-CMK)  Calbiochem/Merck Bioscience 
Caspase 6 Inhibitor (VEID-CHO)  Calbiochem/Merck Bioscience 
Caspase 8 Inhibitor (IETD-CHO)  Calbiochem/Merck Bioscience 
Caspase 9 Inhibitor (LEHD-CHO)  Calbiochem/Merck Bioscience 
SP600125, anthra (1,9-cd) pyrazo-6-(2H)-one; 1,9pyrazoloanthrone  Calbiochem/Merck Bioscience 
DMSO  Merck Bioscience 
Hydrogen Peroxide  Sigma 
Staurosporine  Merck Bioscience 
Fas-ligand and potentiator kit  Upstate Biotechnology (Biozol) 
 
 
2.4.1.2. Quantification of apoptosis by flow cytometry   
 
Apoptosis was quantified by propidium iodide staining using a fluorescence-activated cell 
sorter (FACS). The principle of flow cytometry is follows: a beam of laser is projected 
through a liquid stream that contains cells, or other particles, which when struck by the 
focused light give out signals, which are picked up by detectors. These signals are then 
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converted for computer storage and data analysis, and can provide information about various 
cellular properties. The term "flow cytometry" derives from the measurement (meter) of 
single cells (cyto) as they flow past a series of detectors. For the measurement of 
biological/biochemical properties, the cells are usually stained with fluorescent dyes which 
bind specifically to cellular constituents. The excitation of dyes by the laser beam leads to  an 
emission of light at longer wavelengths which is pick up by detectors. Three fluorescent 
detectors (FL1, FL2 and FL3) are available in the FACS. All green (e.g. FITC) emissions are 
detected by FL1, all red by FL2 and all far red by FL3. In addition to these fluorescent 
emissions the FACS can also collect information on reflected laser light. There are two 
additional detectors that measure forward and right angle light scatter. Forward light scatter 
(FSC) measures that ability of a cell ( or particle) to deflect light from its path which is a 
parameter for the cell size. Side scatter (SSC) measures the ability of a cell (or particle) to 
redirect light at a 90° angle, which is a parameter for cellular structure. 
As apoptotic fluorescence dye propidium iodide was used, which is an analogous of ethidium 
bromide. It intercalates between the bases in double stranded DNA. When stacked between 
the bases, interactions between the π-electrons of the dye and the DNA bases occur, resulting 
in an altered emission maximum. The emitted fluorescence intensity is dependent on the 
length of the DNA molecule; the more basepairs the molecule consists of, the stronger is the 
fluorescence intensity subsequent to appropriate excitation. According to Nicoletti et al. 
(1991) apoptosis can be detected by lysing the cells in hypotonic buffer and staining of the 
DNA content. Sub-GB0
B-DNA content, indicative for apoptotic nuclei, is determined by flow 
cytometry in FL2. 
 
 
 
Figure 2.4. Molecular structure of propidium iodide. It posses the common planar 
conformation with conjugated bindings as the most DNA intercalating substances. 
Absorbance and emission spectra of propidium iodide.  
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Cells were harvested by centrifugation at various time points after cell death induction, 
washed with PBS and the pellets were resuspended in lysis buffer containing propidium 
iodide. Samples were stored at 4°C overnight before flow cytometry analysis using Cell Quest 
software. As shown in Fig. 2.5 vital cell populations display a very small percentage of 
apoptotic subG0 nuclei (M1) and exhibits a huge G0/G1-peak. A smaller G2-peak is also 
displayed in a histogram plot. Apoptotic cells display a higher percentage of subG0 nuclei. 
The G0/G1-peak represents the cells in the G0-, G1-phase of the cell cycle, respectively. 
Doubled DNA contents owned by cells in the G2-phase are displayed as G2-peak. In between 
those two peaks, there is a population, displaying cells that are in the DNA-synthesis (S) 
phase. 
 
Lysis buffer: 
0.1% sodium citrate  Merck Biosciences 
0.1% Triton X-1000  Sigma 
50 µg/ml propidium iodide  Calbiochem/Merck Biosciences 
 
Fluorescence activated cell sorter (FACS, flow cytometer) FACSCalibur
TM
CellQuest
TM analysis software 
FACSComp
TM software 
SimulTest
TM software                                                                                                                                all Becton Dickinson 
                    
 
A) B) 
Figure 2.5 Representative histogram of PI-stained cells. A) Basal apoptotic levels,  B) 
apoptotic stimulated cells. 
 
 
2.4.1.3 MTT-assay 
In some experiments the cytotoxicity was measured using the MTT assay kit. This assay 
which allow to measure metabolic activity is  based on the cleavage of the yellow tetrazolium 
salt MTT into purple formazan by metabolically active cells. This cellular reduction involves 
the pyridine nucleotide cofactors NADH and NADPH. The MTT formazan crystals are 
 Material and Methods    57 
 
insoluble in aqueous solution, but may be solubilized by adding the solubilization solution 
included in the kit. The solubilized formazan product is than photometrically quantified using 
an ELISA reader. An decrease in the number of living cells results in an decrease of total 
metabolic activity which leads to a weaker color formation. For the respective experiments 
cells were plated the day before at a density of 5 X 10P
4
P cells/well in 96-well tissue culture 
plate. After the indicated periods of time of cell death incubation (total volume 200 µl), MTT 
reagent was added (20 µl, final concentration 1.0 mg/ml) and incubation was continued for 
another 2 hrs. The formazan crystals were solubilized by adding 100 µl of a 20%SDS/50% 
N,N-dimethly-formamide solution (Mosmann, 1983). The absorption of the solubilized 
formazan was measured in triplicates at 570 nm using a microplate reader. MTT reduction 
values are expressed as percentages relative to control cells (= 100%). 
Cytotoxicity Proloferation Kit (MTT-Assay)                   Roche Diagnostic 
 
MTT-Solubilzation solution: 
N,N-Dimethyl-formamide                     90 ml  Sigma  
Solubilization solution  (from kit)          90 ml    
Sodium dodecyl sulfate                         27g  Sigma 
(soluble at 37 °C, stored at 4°C) 
 
 
Figure 2.6. Metabolization of formazan salt by viable cells. 
 
 
 
NADH NADP
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2.4.1.4 Caspase-Assay 
The caspase-assay is a method, which allows to detect early events in apoptosis. While the 
quantification of apoptosis using propidium iodide using flow cytometry only includes cells 
holding a reduced DNA amount (sub GB0
B), the caspase assay detects the activity of caspases in 
cells, in which apoptosis is actually ocurring. The reduced DNA content is a consequence of  
fragmented DNA present in apoptotic vesicles. Caspase activity is needed for the cleavage of 
different substrates, like cytoskeleton or nuclear proteins involved in DNA metabolism and 
repair. 
 
The assay is based on the cleavage of synthetic tetrapeptides tagged with a colorimetric or 
fluorogenic dye, which a used as caspase substrates. Since every caspase is specific to a 
cleavage site sequence, the activity was measured monitoring the release of para-Nitroaniline 
(pNA) from the tetrapeptide ( see fig. 2.4) using  a photometer (λ = 405 nm). 
 
 
 
 
Figure 2.7. Catalytic center of caspase 3 according to Earnshaw et al. (1999). All caspases 
hydrolyze peptide bonds on the carboxyl side of an aspartate residue (termed the P1 
residue).  
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The requirement for aspartate at the P1 position of a substrate and the catalytic residues are 
conserved in all human caspases. This aspartate is buried in a deep pocket, termed the S1 site 
which is lined by Arg179, Gln283, Arg341, and Ser347 of the enzyme. The specificity of 
caspases is due to structural feature. For example, in caspase 1 the S4 subsite is a large, 
shallow hydrophobic depression that easily accommodates bulky hydrophobic side chains. In 
caspase 3, this subsite consists of a rather narrow hydrophilic pocket that can accommodate 
small acidic side chains but excludes bulky side chains because of an occluding Trp. 
 
 
 
Figure 2.8. As shown for caspase 3 the substrate cleavage involves deprotonation of the 
sulfhydryl of Cys285 by the imidazole ring of His237, thereby yielding a thiolate nucleophile 
that attacks the carbonyl carbon of the scissile bond to form a tetrahedral intermediate, which 
is stabilized by hydrogen bonding to the amide nitrogen of Gly238. 
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Cell Extract Preparation: 
For the measurement of the caspase activity cells were plated the day before at a density of 
5x10P
6
P cells/culture dish (∅ 10 cm). After treatment with hydrogen peroxide or staurosporineB 
Bcells were harvested, and after a centrifugation step (5 min, 300 g) the culture medium 
aspirated. The cells containing pellet was washed with PBS and lysed in 100 µl lysis buffer 
(10 mM HEPES, 0.1% Triton X-100, 1 mM PMSF, 0.1 mM EDTA, 1 mM DTT, 1 µg/ml 
pepstatin A, 1 µg/ml leupeptin, 0.1 % CHAPS, pH 7.4) and incubated for 30 min on ice. 
Lysates were centrifuged at 20,000 x g for 10 min at 4°C, and the protein amount of the 
supernatant determined by a Lowry protein test (see 2.4.2.1). For later use, extracts were 
stored at –70°C. 
Cell Lysis -Buffer (pH 7.4) 
10 mM HEPES  Sigma 
1 mM DTT  Sigma 
0,1 mM EDTA  Sigma 
0,1% CHAPS  Sigma 
0,1% Triton X100  Merck 
1 mM PMSF  Sigma 
1 µg/ml Pepstatin  Sigma 
1 µg/ml Leupeptin  Sigma 
 
 
Photometric monitoring: 
Caspase activity of the probes was measured at room temperature and λ = 405 nm. In a total 
volume of 100 µl, 80 µl assay buffer and 10 µl cell extract were mixed and incubated for 10  
min. The reaction was started by adding 10 µl of the colorimetric caspase substrate (Ac-
DEVD-pNA, Ac-VEID-pNA, Ac-VDVAD-pNA, Ac-IETD-pNA Ac-LEHD- p NA for 
caspase 3, caspase 6, caspase 2, caspase 8 and caspase 9, respectively; final concentration of 
200 µM). The absorbance AB405
B was measured for 30 min and the slope of the AB405
B nm vs. 
linear time course plot calculated. As controls, assay mixtures containing the respective 
recombinant enzyme, inhibitor or no cell extract were used. 
 
Assay-buffer (pH 7.4) 
100 mM NaCl  Merck 
50 mM HEPES  Sigma 
10 mM DTT  Sigma 
1 mM EDTA  Sigma 
10 % Glycerol  Merck 
0,1 % CHAPS  Sigma 
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Substrates: 
Caspase-3-substrate (Ac-DEVD-pNA, colorimetric)  Calbiochem 
Caspase-6-substrate (Ac-VEID-pNA, colorimetric)  Calbiochem 
Caspase-2-substrate (Ac-VDVAD-pNA, colorimetric)  Calbiochem 
Caspase-9-substrate (Ac-IETD-pNA, colorimetric)  Calbiochem 
Caspase-9-substrate (Ac-LEHD-pNA, colorimetric)  Calbiochem 
 
 
Sample Activity Calculation 
 
For the calculation of the sample activity the conversion factor was determined. 100 µl of p-
Nitroaniline [50 µM pNA in assay buffer] were pipetted in to three wells and the absorbance 
measured. The calculation of the conversion factor is based on the concentration of p-
Nitroaniline in the calibration standard (50 µM). The extinction coefficient for p-Nitroaniline 
in assay buffer is 10,500 MP
-1
P cmP
-1
P . 
 
Conversion factor   = 50 µM/ Absorption avarage (λ = 405) 
 
The activity of a single probe is calculated using the slope (graph of blot absorbance vs. time 
course) and the assay volume:  
 
activity (pmol/min) = slope (DA/min) x conversion factor x assay vol (100 µl)  
 
 
 
p-Nitroanilin Calbiochem 
 
 
 
 
2.4.1.5 Determination of mitochondrial membrane potential 
 
Cells were plated the day before at a density of 2x105  cells/well in a 24 well plate. In 
respective experiments, cells were pretreated for 1 or 3 hr with JNK- or different caspase 
inhibitors and hydrogen peroxide was added for 6 or 24 h (total volume in well: 500 µl). The 
membrane potential of the inner mitochondrial membrane was measured using the dye 
Rhodamine 123. Rhodamine 123 is widely used as a structural marker for mitochondria and 
as an indicator of mitochondrial activity. The dye was added to the cell culture medium at a 
concentration of 0.4 µM for 15 min. The cells were washed twice with HBSS (500 µl) and the 
fluorescence was determined with a fluorescence reader (filters: λ = 495 nm for absorption, 
and λ = 535 nm for fluorescence). Transmembrane distribution of the dye depends on the 
mitochondrial membrane potential (∆ΨBm
B). 
 
Rhodamine 123, Xanthylium, 3,6-diamino-9-(2-(methoxycarbonyl) phenyl, chloride      Molecular Probes Material and Methods    62 
 
 
Figure 2.9. Molecular structure, and spectra of absorbance and emission of Rhodamine 123.  
 
 
2.4.1.6 Determination of ATP-levels using a bioluminescence assay 
 
ATP levels were determined using a bioluminescence assay (ViaLightTM  HT) kit from 
Cambrex/USA. The bioluminescent method utilises an enzyme, luciferase, which catalyses 
the formation of light from ATP and luciferin according to the following reaction: 
 
        ATP + Luciferin + O2              Oxyluciferin + AMP + PPi + CO2 + LIGHT   (Emission at 565 nm) 
Luciferase 
Mg++ 
 
 
The emitted light is linearly related to the ATP concentration and is measured using a 
luminometer. 
For the assay, HEK cells were plated the day before at a density of 5x104 cells/well in a 96 
well white walled microplate. After 30 min of hydrogen peroxide incubation (total volume of 
100 µl) 100 µl of ATP Monitoring Reagent was added to each well. The concentrations of 
ATP/ 5x104 cells were determined using a concentration dependent ATP standard. 
 
ViaLightTM HT  bioluminescence  assay         Cambrex/USA 
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2.4.2 Proteinchemical methods 
 
2.4.2.1 Determination of protein amount by Lowry protein test 
 
The Lowry procedure is one of the most widely-used protein assays, being first described in 
1951 (Lowry 1951). Under alkaline conditions, copper complexes with protein. When Folin-
phenol reagent (phospho-molybdic-phosphotungstic reagent) is added, the Folin-phenol 
reagent binds to the protein. Bound reagent is slowly reduced and changes color from yellow 
to blue.  
For the measurement, 5 µl of the probes, standart or the corresponding buffer as blank value 
were mixed with 25 µl of Bio-Rad reagent A (alkaline copper tartrate solution). Afterwards 
200 µl of Bio-Rad reagent B (Folin-Ciocalteu's phenol reagent, 2N) was added. As standart a 
dilution series of Bovine Serum Albumin (BSA) were used. After an incubation of 15 min 
under weak agitation the absorbtion of the solution was measured at λ = 620 nm using a 
microplate reader. If  reducing agents or detergents were present in the probes, first 20 µl of 
the Bio-Rad reagent S (surfactant solution) were added to 1 ml reagent A. 
 
Bio-Rad  DC  Protein  reagent  A      BioRad 
Bio-Rad  DC  Protein  reagent  B      BioRad 
Bovine  serum  Albumine       Merck  Biosciences 
 
 
 
 
 
2.4.2.2 Western blotting 
 
PC12 or HEK cells were plated at a density of 5x10P
6
P cells/culture dish (∅ 10 cm) and treated 
with HB2
BOB2
B for the indicated periods of time. Cells were harvested and lysed in 100 µl SDS 
sample buffer: Tris-HCl (62.5 mM, pH6.8); 2 % SDS, 10 % Glycerol, 50 mM DTT, 0.01 % 
bromphenol blue. After sonicating (1 min) and boiling at 95°C (5 min), proteins were 
separated by electrophoresis on a polyacrylamide gel (12-18 %). The separated proteins were 
transferred to a PVDF membrane. These membranes were stained with Ponceau S red 
(reversible stain) to visualize the proteins. Nonspecific sites on the membranes were blocked 
with 5% fat-free milk in Tris-buffered saline, 0.1% Tween-20 (TBST) for 1hr. The incubation 
of the  membranes with Primary Antibody (at the appropriate dilution) was performed in 
primary antibody dilution buffer (1X TBS,0.1%Tween-20 with 5%BSA) with gentle agitation 
overnight at 4°C. Proteins were visualized with the appropriate secondary antibodies (1 hr Material and Methods    64 
incubation at appropriate dilution in 1X TBS, 0.1% Tween-20 with 5% nonfat dry milk at 
room temperature). After thorough washing with TBST, membranes were covered with 
ECL
TM detection reagents and quickly exposed to an autoradiography film. Membranes were 
routinely stripped for actin control. 
Antibodies: 
Caspase 3 (cleaved, Asp 175),  human,  rat, mouse  Cell Signaling Technology 
Caspase 9, rat   Cell Signaling Technology 
Caspase 2, human, rat, mouse   Alexis 
Caspase 8, human, rat, mouse   Biocat, Heidelberg 
Phospho SEK/MKK4 (Thr 261)   Cell Signaling Technology 
Phospho JNK (Thr183/Tyr185)   Cell Signaling Technology 
Phospho-c-Jun (Ser63)  Cell Signaling Technology 
Actin, human, rat, mouse  Santa Cruz-Biotechnology 
 
Secondary Antibodies: 
Anti-Rabbit IgG, Peoxidase Conjugated  Calbiochem 
Anti-Rat IgG, Peroxidase Conjugated   Calbiochem 
Anti-Goat IgG, Peroxidase Conjugated  Calbiochem 
 
ECL-reagent  Amersham 
 
Running buffer:  
25 mM Tris-HCl, pH 8.3 at RT,  
192 mM glycine   
0.1% (w/v) SDS.   all Merck or Sigma 
 
Stacking gel : 
40% acrylamide  Bio-Rad 
2% bis-acrylamide  Bio-Rad 
Tris-HCl, pH 6.8 
10% SDS 
H2O 
TEMED 
APS  all Merck or Sigma 
 
Running gel: 
40% acrylamide  Bio-Rad 
2% bis-acrylamide  Bio-Rad 
Tris-HCl, pH 8.8 
10% SDS 
H2O 
TEMED 
APS  all Merck 
 
Transfer buffer:  
12 mM Tris-HCl, pH 8.3 at RT,  
96 mM glycine,  
20% (v/v) methanol.   all Merck or Sigma 
Chill to 2-8°C prior to use. 
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2.4.2.3  Immunoblotting of cytoplasmic and mitochondrial proteins 
 
To separate proteins in cytoplasmic and mitochondrial fractions a digitonin permeabilization 
according to Gottlieb et al. (2002) was performed. 5 x 10
6 cells were esposured to oxidative 
stress for different periods of time. After washing with ice-cold PBS cells were resuspended 
in permeabilization buffer containing 75 mM NaCl, 1mM NaH2PO4, 8 mM Na2PO4, 250 mM 
Sucorse, 1mM PMSF, additional protease inhibitors and 0,05% digitonin. Following a 
centrifugation step at 800xg at 4°C for 10 min, the supernatant was separated from the pellet 
consisting of mitochondria and cellular debris. The supernatant containing cytoplasmic 
proteins was purified by centrifugation at 13,000 x g at 4°C for 10 min. The pellet consisting 
the mitochondrial fractions was lysed in a Triton lysis buffer (0,1% Triton in PBS). After 30 
min on ice and a centrifugation step at 12.000 x g and 4°C for 5 min, the supernatant was used 
for immunoblotting. Equal amounts of protein (10 µg) of cytoplasmic and mitochondrial 
fraction were loaded on an arcylamid gel, separated by SDS-PAGE and blotted as described 
in 2.4.2.2. 
 
2.4.2.4 Western Blot Stripping 
To facilitate a 2
nd round reprobing, membranes were kept sealed and moist at 4°C after the 
first ECL development. Membranes were incubated in stripping buffer at 50°C for 30 
minutes. Afterwards membranes were washed thoroughly for multiple times with TBST. The 
washed membranes were than blocked and blotted as normal. 
 
Stripping buffer:  
62,5 mM Tris, pH 6,7 
2 % SDS 
100 mM Mercaptoethanol (freshly added)   all Merck or Sigma 
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2.4.3. Genomic DNA electrophoresis (DNA ladder) 
 
Apoptotic cell death was induced by reduction of trophic support at the indicated period of 
times. 5 x 10
6 cells were centrifuged at 300 x g, the pellet washed with PBS and incubated at 
55°C overnight in 300 µl lysis buffer (10 mM Tris-HCl pH 8.0, 100 mM EDTA, 100 mM 
NaCl, 1 % SDS, 100 µg/ml Proteinase K). After adding RNase (10 µg/ml) the lysates were 
further incubated for 2 h at 37°C. DNA was extracted with Phenol/Chloroform, precipated 
with isopropanol, washed with ethanol and dissolved in Tris-EDTA buffer. Electrophoresis 
was carried out on 3% agarose gel containing ethidium bromid for visualization under UV 
light. 
 
Lysis buffer for DNA-ladder: 
10 mM TRIS (pH 8,0) 
100 mM NaCl 
100 mM EDTA 
1% SDS 
100 µg/ml proteinase K  all Merck 
 
RNase A  Sigma 
phenol (equilibrated with TRIS buffer pH 7.4)  Sigma 
chloroform   
ethanol 
agarose  all Merck 
ethidium bromide solution (10 mg/ml)  Sigma 
 
 
 
 
 
2.5. STATISTICAL EVALUATION OF THE DATA 
 
 
The statistical calculations were performed using Prism 3®-Software (GraphPad Software, Inc, 
San Diego, USA). Data are given as mean + SEM. For statistical comparison, paired t-test, 
student’s t-test or one-way ANOVA followed by Tukey’s posthoc test or two-way ANOVA were 
used. P values less than 0.05 were considered statistically significant. 
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3. Results   
 
3.1 CELL DEATH CASCADES IN A CELL MODELL EXPRESSING  MUTANT APP 
REFELECTING LOW Aß LOAD  
 
3.1.1 Characterization of PC12 cell lines overexpressing APPwt and APPsw 
 
To investigate the effects of APP overexpression in oxidative stress-induced apoptosis several 
clones of PC12 cells were stably transfected with APP cDNAs. Similar expression of human 
APP in the investigated cell lines was confirmed by western blotting by Astrid Bonert from 
our lab. The human-specific antibody does not recognize any APP species in vector-
transfected PC12 cells, while equal expression levels of human APP were detected in clones 
of APPwt cells and in clones of cells containing the Swedish mutation. Culture supernatants 
of the APP transfected cells were also analysed for Aß(1-40) production revealing four- to 
fivefold elevated Aß(1-40) levels in clones of APPsw cells compared to clones of APPwt cells 
(Fig. 3.1). 
 
Figure 3.1 (A) Expression of human APP in transfected cell lines: Representative western 
blot: neo, PC12 vector transfected cell line; wtM5, wtN10, wtU7, PC12 clones stably 
transfected with pCMV695wt; swQ8, swO9, PC12 clones stably transfected with 
pCMV695sw. The higher molecular weight band differs from the posttranslational 
modification of APP. Human APP expression was similar in APPsw and APPwt clones. Results    
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  (B) Analysed conditioned media for Aß production: The clones expressing the Swedish 
mutant APPsw showed a four- to fivefold increase in the Aß(1– 40) production when 
compared to the APPwt clones (ANOVA: ***p<0.001, **p<0.01 vs. swO9 and swQ8, 
+++p<0.001 vs. swQ8, ++p<0.01 vs. swO9 posthoc Tukey‘s). The increase in the production 
of Aß(1– 40) was confirmed in three independent experiments for each clone. PC12 cells 
bearing human APPwt showed only a two- to threefold increase in Aß production compared 
to vector-transfected PC12 cells (ANOVA: * P < 0.05, * P < 0.05 vs. wtM5,  wtN10 and wtU7, 
posthoc Tukey‘s). 
 
 
3.1.2 APPsw mutation leads to an enhanced vulnerability to oxidative stress induced 
apoptosis 
 
Apoptosis was induced in transfected PC12 cells using the oxidative stressor hydrogen 
peroxide. Nuclear DNA fragmentation was quantitatively detected by propidium iodide 
staining and flow cytometry. No differences in apoptotic cell levels have been detected in 
basal apoptosis between APPsw-, APPw-, or vector-transfected clones (Eckert 2001). 
 
 
Figure 3.2 (A)  Basal levels of apoptotic cells were not different between APPsw clones 
(swQ7, swQ8, swO9), APPwt clones (wtM5, wtN10, wtU7) and empty vector-transfected 
(NEO1, NEO3), PC12 cells. Data are means 6 SEM from 8–12 cultures in four to six 
independent experiments per clone. (B) Increase in apoptotic cells after treatment with 
increasing concentrations of H2O2. APPswPC12 cells showed enhanced sensitivity to 
oxidative stress-induced death compared to APPwt and vector cells (ANOVA, P , 0.01). 
Values are means 6 SEM from three or four independent experiments. 
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Importantly, clones bearing the APPsw mutation are sensitised to an exposure to oxidative 
stress for 24 hr in a concentration dependent manner with a maximum increase of apoptotic 
cells at a concentration of 500 µM hydrogen peroxide (Eckert 2001). Treatment with 
hydrogen peroxide led to a significantly enhanced maximum increase of apoptotic cells in 
APPsw-bearing PC12 cells (51,4% + 5,3%) compared to APPwt-bearing cells (28,4% + 
4,7%) and vector control cells (21,3% + 4,3%). Different clones with the same transfectant 
behave similarly in their sensitivity to H2O2-induced cell death (Fig. 3.2). 
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Figure 3.2 (C) Increase in apoptotic cells after treatment with H2O2 in different clones from 
each cell line. Apoptotic cell death was assessed by propidium iodide staining and flow 
cytometry. APPsw PC12 cells showed enhanced sensitivity to oxidative stress-induced death 
compared to APPwt and vector cells (ANOVA, P < 0.001). Different  from pCMV695sw PC12 
cells: posthoc Tukey‘s, ***p<0.001, **p<0.01 vs swO9 and swQ8, ++p<0.01, +p<0.05 vs. 
swQ8,  #p<0.05 vs swO9. Values are means + SEM from four to six independent 
experiments. 
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.2 CASPASE-ACTIVATION IN OXIDATIVE STRESSINDUCED CELL DEATH 
ll following experiments were performed with APPsw clone Q8 and APPwt clone M5. 
.2.1 Oxidative stress induces activation of caspase 2 in PC12 cells
3
 
A
 
3  
xidative stress in the human brain has been implicated as one major cause of neuronal cell 
 metals like zinc, copper or iron with high-affinity, resulting in production of 
 
ig. 3.3 Time course of caspase 2 activity in protein extracts from PC12 cells after treatment 
 
O
loss in AD patients. However, the exact mechanism still remains unknown. Aß appears to 
bind red 
ox-active
hydrogen peroxide and auto-oxidation of the metalopeptide complex (Rottkamp 2001, Tabner 
2002). The signalling cascades activated following the oxidative stress have not been widely 
studied. Therefore, the implication of caspase 2 was studied by measuring the activity and by 
western blotting. Cleavage of the photometric substrate Ac-VDVAD-p-nitroanilide by 
cytosolic protein extracts indicates the presence of caspase 2 protease activity in the cultures 
after exposure to hydrogen peroxide. The activity was already early induced in APPsw cells 
within two hours of induction (Fig. 3.3). Caspase 2 activity was continuously elevated over 
time compared to APPwt and vector-transfected cells. Maximum caspase 2 activity was 
measured after 2 hr, with a fourfold higher activity in APPsw cells than in APPwt and vector 
PC12 cells, respectively (Fig. 3.4). 
F
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way-ANOVA revealed significant differences between cell lines (P< 0.001) and time course 
(P< 0.001). Data are means + SEM from 4-6 independent experiments.  
 
 
Fig. 3.4 The caspase 2 activity was early induced in APPsw cells within two hours of 
oxidative stress induction and fourfold higher compared to APPwt and vector controls (**P< 
0.01 vs. APPwt and vector, ANOVA). Data are means + SEM from 4-6 independent 
experiments.  
 
The mechanism of activation of caspases occurs by a sequential cleavage of the zymogen to 
release the large and the small cleavage products. In accordance to the findings from the 
determination of activity, western blotting confirmed cleavage of caspase 2 within two hours 
of hydrogen peroxide induction. Again, the activation of caspase 2 was noticeable higher in 
APPsw cells compared to vector transfected  controls. 
 
 
 
Fig. 3.5 Western blot analysis of caspase 2 activation in cell lysates of H2O2-treated PC12 
cells. Increased expression of cleaved caspase 2 in APPsw cells is already detectable after 2 
hr treatment. Representative Western blotting is shown from at least three independent 
observations. 
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3.2.2 Activation of caspase 8 in response to oxidative stress 
 
Apoptosis associated with the Fas/Tumour Necrosis Factor Receptor (Fas/TNFR) family of 
death receptors requires caspase 8 activity and adaptor proteins such as FADD. The 
involvement of caspase 8 in processing of APP during apoptosis by caspase 8 has been 
reported, recently (Pellegrini 1999). The blocking of neuronal death by caspase 8 inhibitor 
IETD-fmk in Aß-induced cell death was also demonstrated (Ivins 1999). Hence, the activation 
of caspase 8 was anyalyzed in  transfected PC 12 cell lines overexpressing intracellular high 
levels of Aß in order to ascertain the involvement of this initiator caspase in oxidative stress. 
Ac-IETD-pNA was utilized to measure caspase 8 activity in lysates of treated cells. In parallel 
to the early activation of caspase 2, caspase 8 activity increased about threefold after 2 hr of 
stress induction in PC12 cells expressing the Swedish double mutation and was significantly 
enhanced in a time-dependent manner compared to vector transfected controls (Fig. 3.6).  
 
Fig. 3.6 Time course of caspase 8 activity in protein extracts from PC12 cells after treatment 
with H2O2. Data are means + SEM from 4-6 independent experiments. 
 
Fig. 3.7 The maximal caspase 8 activity was measured after 2 hr induction. APPsw bearing 
cells exhibit a significantly enhanced activity compared to vector controls (* P<0.05 vs. 
vector, ANOVA). Data are means + SEM from 4-6 independent experiments. Results    
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Activation of caspase 8 involves a two-step proteolysis; the cleavage of the procaspase 8 to 
generate a 43 and a 12 kDa fragment which is further processed to 10 kDa. The large 
fragment is then cleaved to yield p26. Here, we used an antibody recognizing the 26 kDa 
large fragment of caspase 8. Western blot analysis showed a notable expression of active 
caspase 8 even in the untreated APPsw PC12 cells. The caspase 8 expression in APPsw cells 
was continuously higher compared to vector control during the induction of 250 µM hydrogen 
peroxide. (Fig. 3.8). 
 
 
 
Fig. 3.8 Over the whole time period, the protein expression in APPsw cells was continuously 
higher compared to vector control as detected by an antibody recognizing the 26 kDa large 
cleaved fragment of caspase 8. Representative Western blotting is shown from three 
independent observations. 
 
3.2.3 Involvement of caspase 9 
 
Mitochondria play a prominent role in the intrinsic apoptosis pathway. During mitochondrial 
dysfunction, several essential players of apoptosis, including procaspases, cytochrome C, and 
apoptosis-inducing factor (AIF) are released into the cytosol. The multimeric complex 
formation of cytochrome C, APAF-1 (apoptotic protease-activating factor-1) and caspase 9 
activates downstream caspases leading to apoptotic cell death. Therefore, it was examined 
whether oxidative stress in PC12 cells activates caspase 9 by using a polyclonal antibody 
specific for the inactive full length pro-caspase 9 and for the cleaved fragments of the protein. 
A time-dependent increase was detected in cleaved fragments of caspase 9 after treatment of 
the cells with hydrogen peroxide (Fig. 3.9). APPsw PC12 cells showed an elevated expression 
of the active cleaved fragments of caspase 9 compared to vector-transfected cells. A time-
dependent cytochrome C increase in the cytosol has also been  detected by western blot using 
a specific antibody (Marques 2003). The highest cytochrome C amount  in the cytosolic 
fraction was detected after 4 hr oxidative stress induction.  Results    
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Fig. 3.9 Western blot analysis of caspase 9 activation in cell lysates of H2O2-treated PC12 
cells. Representative Western blotting is shown from at least three independent 
observations. 
 
In addition, caspase 9 activities were measured colorimetrically using Ac-LEHD-pNA as 
substrate in lysates of hydrogen peroxide-treated cells (Fig. 3.9). An early induced activation 
of caspase 9 after 2 hr was found, while the activity was increased in the APP-transfected 
cells compared to vector-transfected controls, but with no difference between APPsw and 
APPwt cells (Fig. 3.10).  
 
 
Fig. 3.10 Enhanced caspase 9 activity in cell lysates from APP-transfected cells compared to 
vector transfected controls (*P < 0.05 vs. vector after 2 hr induction; 
+P < 0.05 vs. vector and 
wt under basal conditions). Data are means + SEM from 5-7 independent experiments. 
 
 
3.2.4 Increased caspase 3 activity of APPsw PC12 cells in response to oxidative stress 
 
Furthermore, extracts from hydrogen peroxide-treated PC12 cells were prepared and 
measured for their ability to cleave the colorimetric substrate to Ac-DEVD-pNA, which is 
specifically cleaved by caspase 3. Cellular extracts from untreated control cultures showed 
very low Ac-DEVD-pNA cleavage in all cell lines (Fig. 3.11). Under these baseline Results    
 
75
 
conditions, no significant differences could be detected between vector-, APPwt-, and 
APPsw-transfected PC12 cells. After exposure to oxidative stress, caspase 3 activity increased 
gradually and reached a maximum activity after 6 hr incubation, demonstrating a delayed 
increase as compared to the initiator caspases 2 and 8. APPsw and APPwt PC12 cells showed 
a significantly enhanced caspase 3 activity compared to vector-transfected clones with the 
strongest increase in the APPsw cells (Fig. 3.11). 
 
Fig. 3.11 Time course of caspase 3 activity in cytosolic protein extracts from H2O2-treated 
PC12 cells. Maximal caspase 3 activity was reached after 6 hr determined by DEVD 
cleavage. APPsw cells showed enhanced caspase 3 activity after oxidative stress-induced 
death compared to APPwt and vector cells. Maximal caspase 3 activity was reached after 6 
hr of exposure to H2O2 (
++P < 0.01 vs. APPwt; ***P < 0.001 vs. vector, ANOVA). Data are 
means + SEM from 5-6 independent experiments. 
 
By western blotting, we also found a significantly increased protein expression of the active 
caspase 3 in APPsw PC12 cells compared to control cells. The highest protein expression was 
evidenced after 6 hr H2O2 exposure by densitometric immunoblot analysis (Fig. 3.12). 
        
Fig. 3.12 Time course of western blot analysis of active caspase 3 (Two-way ANOVA Results    
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for cell line P < 0.001 and time course, P < 0.001). The highest protein concentration 
was detected after 6 hr H2O2 exposure by densitometric immunoblot analysis. (*P < 
0.05, **P<0.01, vs. corresponding control). Data are means + SEM from 3 independent 
experiments. 
 
3.3 EFFECTS OF CASPASE INHIBITORS ON OXIDATIVE STRESS INDUCED CELL 
DEATH  
  
3.3.1 Prevention of apoptosis by caspase inhibitors 
 
Due to the enhanced activation of several caspases in response to oxidative stress the potential 
of several caspase inhibitors in protecting PC12 cells against oxidative stress-induced 
apoptosis was examined. In a pre-experiment, the caspase 3 inhibitor AC-DEVD-CMK was 
added in a concentration-dependent manner to APPsw transfected PC12 cells 3 hr or 1 hr 
prior to the exposure to 250 µM hydrogen peroxide for 24 hr.  An experiment adding the 
caspase 3 inhibitor and hydrogen peroxide at the same time was also performed. As shown in 
Fig 3.13, best protection was provided adding caspases inhibitor at a concentration of 10 µM 
3 hr prior hydrogen peroxide treatment. 
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Fig. 3.13 Apoptotic cell death after treatment with AC-DEVD-CMK and H2O2 in APPsw 
transfected PC12 cells. Apoptotic cell death was assessed by propidium iodide staining and 
flow cytometry. AC-DEVD-CMK was added to cells in a concentration dependent manner 3 
hr (A) or 1 hr (B) prior H2O2, or at the same time as H2O2 (C). Best protection was measured, 
adding the caspase 3 inhibitor at a concentration of 10 µM 3 hr prior H2O2. Values are means 
+ SEM from 2-3 independent experiments. 
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Next, several PC12 cells were pre-treated with caspase inhibitors at a concentration of 10 µM 
3 hr prior exposure to hydrogen peroxide to test their potential to inhibit oxidative stress-
induced apoptosis. In addition a caspase inhibitor mix containing caspase 3, caspase 8 and 
caspase 9 (10 µM each) was also tested. As shown in Figure 3.14, only the inhibitor of the 
effector caspase 3, was able to reduce apoptotic rates in APPsw cells significantly. The pre-
treatment of the cells with inhibitors of initiator caspase 8 and caspase 9 or the caspase 
inhibitor mix revealed only a tendency in preventing cells from apoptosis after a 24 hr 
hydrogen peroxide [250 µM] incubation. In a later experimental setting when the caspase 2 
and caspase 6 inhibitor becomes available, they were also tested in preventing apoptosis. Here 
again, apoptosis could not be significantly avoided. 
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Fig. 3.14 Apoptotic cell death of APPsw transfected PC12 cells. Apoptotic cell death was 
assessed by propidium iodide staining and flow cytometry. Caspase inhibitors were added to 
cells  3 hr prior H2O2 exposure. The caspase 3 inhibitor strongly reduced apoptotic cell death 
in APPsw cells (**P < 0.01 student t-test). Values are means + SEM from 6-8 independent 
experiments. 
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Fig. 3.15 Apoptotic cell death of APPwt transfected PC12 cells, pre -treated with caspase 
inhibitors (*P < 0.05 student’s t-test). Values are means + SEM from 4-7 independent 
experiments. Results    
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The obtained results using caspase inhibitors were similar for APPwt transfected PC 12 cells 
as APPsw. Significant protection was measured by a pre-treatment of the APPwt cells with 10 
µM caspase 3 inhibitor 3 hr prior the addition of hydrogen peroxide. Here in particular, the 
caspase 9 inhibitor shows a pronounced tendency to prevent apoptosis in oxidative stress 
induced cell death. In vector transfected cells no significant protection could be observed 
using caspase inhibitors. 
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Fig. 3.16 Apoptotic cell death of empty vector transfected PC12 cells, pre-treated with 
caspase inhibitors. Values are means + SEM from 4-6 independent experiments. 
 
3.3.2 Reduction of caspase activity 
 
The experiments using caspase inhibitors show that only the caspase 3 inhibitor was able to 
significantly reduce oxidative stress-induced apoptosis in APPsw and APPwt cells below the 
level of control cells. The inhibition of caspase 8, caspase 9, caspase 2 or caspase 6 was less 
effective in preventing apoptosis. Therefore, another control experiments was performed, 
measuring the caspase activities of cells pre-treated with caspase inhibitors prior to the      .
Fig. 3.17 (A) Caspase 9 activity after 2 hr H2O2 incubation in cell lysates from APPsw-
transfected PC12 cells without and with pre-treatment of 10 µM caspase 9 inhibitor. (B) 
Caspase 8 activity in cell lysates from APP-transfected cells after 2 hr of H2O2 induction (*P < 
0.05, student’s t-test). Data are means + SEM from 3-7 independent experiments. Results    
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treatment with hydrogen peroxide. As controls, caspase 8 and caspase 9 were measured, and 
in fact, reduced activities were detected. This means that although the treatment of PC12 cells 
with hydrogen peroxide leads to activation of these initiator caspases, their inhibition is not 
sufficient enough to avoid apoptosis. The lack of efficacy of the initial caspase inhibitors to 
abolish apoptotic cell death could be attributed to the further consisting compensatory 
pathway. In another experiment, caspase 3 activity was measured in lysates of cells pre-
treated with caspase 8, caspase 9 or caspase 2 inhibitor. Here, a reduced caspase 3 activity 
could be detected  in caspase 8 -and caspase 9 inhibitor pre-treated cells.
 
Fig. 3.18 (A) Caspase 3 activity after 6 hr H2O2 incubation in cell lysates from APPsw-
transfected cells.  Pre-treatment of cells with 10 µM caspase 8, caspase 9 or caspase 2 
inhibitor reduce caspase 3 activity significantly (*P < 0.05, paired t-test). Data are means + 
SEM from 3-6 independent experiments. 
 
3.3.2 Necrotic cell death 
 
The incubation of PC12 cells with increasing concentrations of hydrogen peroxide for 24 hr 
results in increasing apoptotic levels concentration-dependent manner, with the highest 
apoptotic levels using a concentration of 500 µM hydrogen peroxide (Eckert 2001, Fig. 3.19). 
Higher concentrations results in a decrease of apoptotic cells. Therefore, experiments were 
performed using trypan blue dye, which penetrates into dead cells due to a disturbed cell 
membrane, while vital cells are undyed. Since plasma membrane leakage is also a feature of 
necrotic cell death, both apoptotic and necrotic cells are dyed and can be distinguish from 
vital cells. Using increasing concentrations of hydrogen peroxide, the number of death cells 
increases in a concentration-dependent manner reaching approximately 100% at a 
concentration of 1000 µM hydrogen peroxide. This shows that concentrations higher than 250 Results    
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µM hydrogen peroxide results in an increase in the number of necrotic cells, which may 
explain the decrease of apoptotic levels upper 500 µM hydrogen peroxide. 
 
 
Fig. 3.19 (A) Increase of apoptotic cells after treatment with increasing concentrations of 
H2O2. (B) Increase of trypan blue dyed cells after 24 hr incubation of increasing 
concentrations of H2O2. Values are means + SEM from 3-4 independent experiments per 
treatment. 
 
In addition, cell death of 500 µM hydrogen peroxide incubated cells pre-treated with caspase 
inhibitors were determinated using trypan blue. Here, no caspase inhibitor was able to reduce 
absolute cell death significantly, neither in APPsw, APPwt nor empty vector transfected PC12 
cells.  
 
 
Fig. 3.20 Cell death levels of APPsw transfected PC12 cells. (A) APPwt transfected PC12 
cells (B) and vector transfected cells (C). Cell death was assessed by trypan blue dye. 
Caspase inhibitors were added to cells in 3 hr prior H2O2 exposure. Values are means + SEM 
from 6-9 independent experiments. 
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3.3.3 Protection of metabolic activity by caspase inhibitors 
 
In addition to propidium iodide and trypan blue staining, the  MTT assay was performed to 
test, whether caspase inhibitors show protective effects on metabolic activity in oxidative 
stress- induced cell death. In a pre-experiment the conversion of the MTT reagent by 
mitochondrial oxidation-reduction reaction to formazan crystals were measured in APPsw, 
APPwt and empty vector transfected PC12 cells. Noticeable was the reduced metabolic 
activity in APPsw PC12 cells compared to APPwt and to vector transfected cells under basal 
culture conditions (Fig. 3.21A). An incubation for 24 hr with increasing concentrations of 
hydrogen peroxide reduces metabolic activity as shown in Fig. 3.21B. 
 
Fig. 3.21 (A) Metabolic activity of PC12 cells (***P < 0.001, ++P < 0,01, student t-test vs. 
vector, **P < 0,01, vs. Wt). (B) H2O2-induced decrease of metabolic activity in a 
concentration dependent manner. Values are means + SEM from 3 independent 
experiments. 
 
 
Caspase inhibitors (10 µM) were added 3 hr before the incubation of PC12 cells with different 
concentrations of hydrogen peroxide. Only using 100 µM hydrogen peroxide, a protective 
effects was measured using caspase 3 inhibitor in vector transfected cells (Fig. 3.22C). 
Fig. 3.22 (A) Metabolic activity of PC12 cells incubated for 24 hr with 100 µM H2O2. (A) Results    
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APPsw, (B) APPwt and (C) vector (**P < 0.01, studend’s t-test vs. H2O2). Values are means 
+ SEM from 3 independent experiments. 
 
Incubating PC12 cells with 150 µM hydrogen peroxide, a protective effect was found for 
caspase 3 and caspase 8 inhibitor, again only in vector transfected cells (Fig. 3.23C). 
 
 
 
Fig. 3.23 (A) Metabolic activity of PC12 cells incubated for 24 hr with 150 µM H2O2. (A) 
APPsw, (B) APPwt and (C) vector (*P < 0.01, student t-test vs. H2O2). Values are means + 
SEM from 3 independent experiments. 
 
At a concentration of 250 µM hydrogen peroxide, a significant protection could be detected 
with all used caspase inhibitors (caspase 3, caspase 8, caspase 9, caspase inhibitor mix) for 
APPsw and APPwt as well as for vector transfected cells. Thus, caspase inhibitors show best 
protection inducing oxidative stress with 250 µM hydrogen peroxide, in which also the 
highest caspase activities have been measured (Eckert 2001). The different results for 
protective effects of caspase inhibitors measuring apoptosis with propidium iodide staining, 
membrane, membrane leakage with trypan blue dye and metabolic activity with the MTT 
assay may not be surprising. The inhibition of caspases may finally result in a maintain of  
several metabolic pathways. Nevertheless, cells die by apoptosis or necrosis, because the 
metabolic activity is still not sufficient (about 25 % of basal controls) for survival. 
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Fig. 3.24 (A) Metabolic activity of PC12 cells incubated for 24 hr with 250 µM H2O2. (A) 
APPsw, (B) APPwt and (C) vector (***P < 0.001, **P < 0.01,  **P < 0.05 student t-test vs. 
H2O2). Values are means + SEM from 3 independent experiments. 
 
 
3.3.4 Protection of mitochondrial membrane potential by caspase inhibitors 
 
Interestingly, recent data describe caspase 2 to be localized in several intracellular 
compartments, including the mitochondria, Golgi, cytosol, and nucleus  ( Mancini 2000, 
Lassus 2002, Paroni 2002). Cytotoxic stress causes activation of caspase 2, which is required 
for the permeabilization of mitochondria (Lassus 2002) and induces the release of cytochrome 
C (Robertson 2002).  
Since mitochondria play a vital role in energy metabolism, and mitochondrial dysfunction has 
been identified in a large proportion of neurodegenerative disease including AD (Eckert 2003) 
it was investigated, whether the pre-treatment of PC12 cells with caspase 2 inhibitor prior to 
the induction of oxidative stress protects mitochondrial functions.  Therefore, oxidative stress 
was induced for 6 or 24 hr, and the mitochondrial membrane potential measured using the   
structural marker for mitochondria and the indicator of mitochondrial membrane potential 
Rhodamine 123. Caspase 2 inhibitor was added at 4 µM and 10 µM before the exposure of 
cells to 250 µM or 500 µM hydrogen peroxide.  
Here, the results varied depending on time points of oxidative stress induction or caspase 2 
inhibitor concentration. After an induction for 24 hr with 250 µM hydrogen peroxide a 
significant protection was observed with 4 µM caspase 2 inhibitor in APPsw PC12 cells, 
while in APPwt PC12 cells only a using  4 µM caspase 2 inhibitor was measured. In vector 
controls protection was detected using 10 µM caspase 2 inhibitor. 
Fig. 3.25 Mitochondrial membrane potential analysis: An incubation with 250 µM H2O2 for 24 
hr leads to a decrease in the mitochondrial membrane potential (∆Ψm) in PC12 cells. (A) 
APPsw, the pre-treatment with 4 µM caspase 2 inhibitor protects the mitochondria against 
oxidative damage. (B) APPwt. (C) In vector transfected PC12 cells the pre-treatment with 10 
A) B) C) Results    
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µM caspase 2 inhibitor protects mitochondria.  (P
*
PP <0.01 vs. corresponding H2O2-treated 
cells, paired t-test). Values are means + SEM from 6-10 independent experiments. 
 
Using 500 µM hydrogen peroxide a significant protection was measured after an incubation 
of 6 hr and pre-incubating APPsw PC12 cells with 10 µM caspase 2 inhibitor (Fig 3.26).  
Here neither in APPwt nor in vector controls significant protection of caspase 2 inhibitor 
could be detected, confirming the substantial role of caspase 2 in cell death of APPsw cells. 
 
Fig. 3.26 Mitochondrial membrane potential of PC12 cells after an incubation with 500 µM 
H2O2 for 6 hr. (A) APPsw, the pre-treatment with 10 µM caspase 2 inhibitor protects the 
mitochondria against oxidative damage. (B) APPwt. (C) vector.  (P
*
PP <0.01 vs. corresponding 
H2O2-treated cells, paired t-test). Values are means + SEM from 6-10 independent 
experiments. 
 
 
 
 
 
 
 
3.4 ACTIVATION OF JNK DURING OXIDATIVE STRESS IN PC 12 CELLS 
  
3.4.1 Aß doses effect of APP on JNK activation 
 
The mobilization of the stress-activated protein kinase (JNK) plays an important role in 
apoptosis induced by several types of environmental stress, like UV, γ-radiation, 
inflammatory cytokines, and DNA damage (Sanchez 1994, Mesner 1995, Ghahremani 2002). 
In oxidative stress-induced cell death, the activation of mitochondrial apoptosis machinery by 
JNK in adult cardiac myocytes has been observed (Aoki 2002).  
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Hence, the question whether oxidative stress-mediated activation of JNK pathway is affected by 
overexpression of APP was addressed. Western blotting of immunocomplexes to detect activation 
of JNK and c-Jun was performed. Hydrogen peroxide treatment of APPsw PC12 cells induced 
JNK phosphorylation within 2 hr (Fig. 3.27A). The highest expression was detected after 4 hr 
with an elevated expression in APPsw cells compared to APPwt cells and vector controls. When 
activated, JNK translocates to the nucleus to regulate transcription through its effects on c-Jun and 
other transcription factors. As for JNK we observed a strong impact of the Swedish APP 
transfection on the activation of c-Jun (Fig. 3.27B). In these experiments, the kinetics of activation 
of c-Jun correlated with the phosphorylation of JNK with the highest detection of phoshorylated 
c-Jun after 6 hr of H2O2 treatment. The expression of phosphorylated c-Jun was markedly 
elevated in APPsw compared to treated APPwt or vector transfected controls after 4 and 6 hr 
hydrogen peroxide treatment.  
 
Fig. 3.27 Activation of JNK and c-Jun in oxidative stress-induced cell death in APPsw, APPwt  
and vector-transfected cells analysed by Western blotting using anti-active p-JNK and p-c-
Jun antibodies for the analysis of SAPK/JNK  and c-Jun phosphorylation/activity. (A) APPsw 
cells exhibit significantly enhanced protein expression levels of JNK activation in PC12 cells 
compared to APPwt and vector transfected cells. Maximal activated p-JNK was detected 
after 4 hr exposure to oxidative stress. (C) The expression of phosphorylated c-Jun was 
markedly elevated in APPsw cells compared to H2O2-treated APPwt and vector controls after Results    
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hydrogen peroxide treatment. Maximal amount of p-c-Jun was detected after 6 hr H2O2 
treatment. (C) The blots were reprobed with an anti-actin antibody to confirm the equal 
loadings of the protein amounts.Data are from a representative experiment repeated at least 
three times with similar findings. 
 
 
 
 
 
 
 
 
 
3.5 EFFECTS OF JNK INHIBITOR SP600125 ON OXIDATIVE STRESS   
INDUCED CELL DEATH   
 
3.5.1 Effects on caspase activity 
  
As detected by western blotting, the transfection of the Swedish FAD mutation in PC 12 cells 
leads to an enhanced activation of the JNK pathway under oxidative stress. Therefore, the 
effect of SP600125, a selective anthrapyrazolone inhibitor of JNK (Bennet 2001), was 
investigated. The activity of different caspases was measured in PC12 cells pre-treated with 
JNK inhibitor to attribute the JNK involvement in oxidative stress-induced apoptosis. A 
highly significant reduction of caspase 9 activity (Two-way ANOVA P < 0.001) and caspase 
3 activity (Two-way ANOVA P = 0.0384) in cell lysates of APPsw cells pretreated with 200 
nM JNK inhibitor was found, whereas the activities of caspase 2 and caspase 8 were not 
significantly altered (Fig. 3.28).  
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Fig. 3.28 Reduction of caspase activities by JNK-inhibitor SP60125: Cells were pretreated 
with 200 nM SP 600125 and incubated with H2O2 in a time dependent manner. Caspase 
activities were measured in cytosolic protein extracts. Caspase 9 activity in cell lysates of 
APPsw cells pretreated with JNK inhibitor was significantly reduced compared to APPsw 
cells without pretreatment with the inhibitor (two-way ANOVA: p< 0.001 for pretreatment). 
The maximal reduction of caspase 9 activity by pretreatment of the cells with JNK inhibitor 
was measured after 2 hr exposure to oxidative stress (**P < 0.01 vs. corresponding 
pretreated cells, *P < 0.05 vs. corresponding pretreated cells after 4hr H2O2 induction). 
Caspase 3 was also reduced by the JNK inhibitor (Two-way ANOVA: P < 0.01 for time 
course and pretreatment) with maximal reduction of caspase 3 activity after 2 hr exposure to 
oxidative stress (*P < 0.05 vs. corresponding pretreated cells). The activity of caspase 2 and 
caspase 8  were not significantly altered. Values are means + SEM from 4-6 independent 
experiments. 
 
 
3.5.2 Protection of mitochondria 
 
Since a reduction of caspase 9 was observed using SP600125 (see. 3.5.1), we measured if the 
mitochondria are protected from the collapse of the membrane potential, which normally 
occurs when oxidative stress is induced (Keil 2004). Corresponding to the reduction of Results    
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caspase 9 activity, we were able to detect a protection against a decrease in the mitochondrial 
membrane potential by SP600125 (Fig. 3.29) after the induction of oxidative stress for 6 hr, 
indicating an involvement of JNK upstream of mitochondria in oxidative stress signalling. 
 
. 
Fig. 3.29 Mitochondrial membrane potential analysis: oxidative stress leads to a decrease in 
the mitochondrial membrane potential (∆Ψm) in PC12 cells. The strongest reduction of the 
mitochondrial membrane potential occurs in APPsw cells (P
$$
PP <0.01 vs. corresponding H2O2-
treated vector cells, t-test). The pre-treatment of cells with SP600125 before exposure to 
H2O2 significantly protects the mitochondria against oxidative damage and decrease in  ∆Ψm 
in all three cell lines (**P <0.01 vs. corresponding H2O2-treated cells, paired t-test). 
3.5.3 JNK activation in mitochondrial fraction 
 
Since JNK inhibition shows protective effects on mitochondrial membrane potential when 
oxidative tress is induced, mitochondrial fractions were isolated from PC12 cells, and 
examined whether JNK translocates into mitochondria during oxidative stress. While nearly 
no activated JNK was found in untreated PC12 cells, after 2 hr of incubation with 250 µM 
hydrogen peroxide, slight JNK activation could be detected. Of note, in PC12 cells containing 
the Swedish APP mutation, activated JNK was also found in mitochondrial fraction after 4 
and 6 hr induction. 
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Fig. 3.30 mitochondrial translocation of JNK during oxidative stress in PC12 cells. Data are 
from a representative experiment repeated at least three times with similar findings. 
 
 
 
3.5.4 JNK inhibitor studies on apoptosis 
 
As shown in 3.52 the JNK inhibitor SP600125 protects mitochondria against a decrease in the 
mitochondrial membrane potential which occurs when oxidative stress is induced. Also a 
reduction in the caspase 9 and caspase 3 activity in cell lysates of APPsw cells pre-treated 
with 200 nM JNK inhibitor was observed. In addition, it was investigated whether the JNK 
inhibitor reduces apoptotic levels of APPsw PC12 cells after 24 hr of hydrogen peroxide (250 
µM)  incubation. The treatment with hydrogen peroxide led to a significant increase of 
apoptotic cells in APPsw-bearing PC12 cells (42.21% +3.71%) compared to vector cell line 
(30.87% + 5.97%), APPsw cells pre-treated with the 200 nM JNK inhibitor (33.77 % + 
4.06%) exhibited similar apoptotic cell levels as the corresponding vector cells (Fig 3.31A). 
Higher concentrations of JNK inhibitor were less protective in preventing oxidative stress 
induced apoptosis, because at high concentration the JNK-inhibitor is toxic itself (Fig. 3.31B). 
In PC12 cells cultured under basal conditions, without other stimulation, it was found that 
10,000 nM JNK inhibitor enhanced apoptotic levels significantly. 
 
Fig. 3.31 Apoptotic cell death after treatment with H2O2 in PC12 cells. (A) APPsw PC12 cells 
showed enhanced sensitivity to oxidative stress-induced death compared to vector cells ( 
+P 
< 0.05, student’s t-test). In parallel experiments cells were pretreated for 3 hours with 
different concentrations of the JNK inhibitor SP600125) and then exposed to H2O2 for 24 hr. 
Pre-treatment of APPsw cells with JNK inhibitor at a concentration of 200 µM reduced Results    
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apoptotic cell death to levels corresponding  to that of vector cells. Values are means + SEM 
from 6-8 independent experiments. (B) High concentrations of JNK inhibitor (10 000 nM) 
enhance basal apoptotic levels of APPsw PC12 cells ( 
***P < 0.001, student’s t-test, vs. 
APPsw control). Values are means + SEM from 5-6 independent experiments. 
 
 
3.6 MESSENGER RNA EXPRESSION OF APOPTOTIC FACTORS DURING  
     OXIDATIVE STRESS IN PC12 CELLS OVEREXPRESSING APP   
 
 
3.6.1 Members of the Bcl-2 family 
 
Since the mitochondrial apoptotic pathway is regulated by proteins of the Bcl-2 superfamily, 
the expression of the pro-apoptotic Bax- and the antiapoptotic Bcl-2 proteins were 
investigated in oxidative stress induced cell death in PC12 cells. After an incubation of the 
indicated periods of time with 250 µM hydrogen peroxide, total RNA was isolated, transcript 
into a cDNA bank, and a PCR using appropriated designed primer  (see. 2.3.6) was run. For 
Bax, nearly no increase in the mRNA was found after induction of hydrogen peroxide induced 
cell death in PC12 cells. Here the expression was also not altered between APPsw-, APPwt- 
or vector transfected PC12 cells. Similar results were detected by western blotting concerning 
the protein expression by Astrid Bonert from our group in parallel experiments (Keil 2004). 
 
 
Fig. 3.32. Expression of Bax mRNA during oxidative stress in PC12 cells Data are from a 
representative experiment repeated at least three times with similar findings. 
 
 
Analysing the expression results of Bcl-2 in PC12 cells was surprising, because no Bcl-2 
mRNA expression could be detected using appropriate and verified primer for rat Bcl-2. After 
checking the literature, in fact, a publication was found, showing also no Bcl-2 protein Results    
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expression in PC 12 cells (Maroto 1997). This was confirmed by Astrid Bonert from our lab, 
perfoming western blotting. 
 
Fig. 3.33. PC12 cells show no BCL-2 mRNA expression, Data are from a representative 
experiment repeated at least three times with similar findings. 
 
 
 
3.6.2 Apoptosis inducing factor 
 
AIF is a recently discovered flavoprotein that resides in the mitochondria and identified as a 
cell death molecule (Susin 1999). Upon death stimuli, AIF translocates from the mitochondria 
to the nuclei and induces large-scale DNA fragmentation ( > 50 kbp) and cell death in a 
caspase-independent manner (Daugas 2000). Here, the RT-PCR analysis show an oxidative 
stress induced increase in the expression of mRNA in PC12 cells, whereas the expression was 
higher in both, APPsw and APPwt cells compared to vector controls after 1 hr hydrogen 
peroxide induction. An enhanced AIF protein expression was also found by Astrid Bonert in 
mitochondrial fractions of PC12 cells. 
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Fig. 3.34. Expression of AIF mRNA increases during oxidative stress in PC12 cells. Data are 
from a representative experiment repeated at least three times with similar findings. 
 
 
 
3.6.3 Glycogen synthesis kinase 3ß 
 
Glycogen synthase kinase 3ß (GSK3ß) was initially described as a key enzyme involved in 
glycogen metabolism, phosphorylating and inactivated glycogen synthase the final enzyme in 
glycogen biosynthesis. However it is known to regulate many cell functions. GSK3ß is a 
component of the WNT signalling pathway with a role in cell proliferation, differentiation, 
adhesion, microtubule dynamics, apoptosis, and fast axonal transport (Frame 2001, Morfini 
2002). GSK3ß, a serine/threonine kinase, is highly expressed in brain tissue (Mandelkow 
1999) and has been linked to primary abnormalities associated with Alzheimer’s disease. 
These include participation of GSK-3 in phosphorylating the microtubule binding protein tau 
that may contribute to the formation of neurofibrillary tangles (Mandelkow 1999, Sang 2000) 
and interactions of GSK-3ß with presenilin (Kirschenbaum, Morfini 2002b) or AICD (Kim 
2003).   
A very recent online published report shows that the c-terminal fragment of APP (AICD) 
exert neurotoxicity on PC 12 cells and rat primary cortical neurons by inducing the expression 
of GSK3ß, and the Swedish mutant form of APP770 induced the up-regulation of GSK3ß at 
both the mRNA and the protein levels (Kim 2003). In another recent publication a elevated 
endogenous GSK3ß kinase activity in HEK cells expressing the Swedish APP751 mutation 
has been described (Ryder 2004). Therefore the mRNA levels in APP-transfected PC12 cells 
were analysed using appropriate primers. Results    
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Fig. 3.35 Expression of GSK3ß mRNA  is unaltered between APPsw, APPwt and vector-
transfected PC12 cells. Data are from a representative experiment. 
 
 
In contrast to Kim et al (2003), concerning to the GSK3 mRNA expression no effects of the 
Swedish mutation were detected in PC12 cells. Also no differences in mRNA expression of 
GSK3ß were found in vector-transfected control cells. Since GSK3ß is regulated by inhibition 
through phosphorylation of Ser9 by protein kinase B/Akt (Frame 2001b) the activation of 
GSK3ß may be rather trough down regulation of the protein kinase B than through altered 
mRNA expression. 
 
 
3.6.4 GAPDH 
 
As control, RT-PCR from the housekeeping gene GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) was performed from the same cDNA bank. As shown in Fig. 3.31 the 
GAPDH mRNA expression was unaltered. 
 
 
Fig. 3.36. GAPDH mRNA expression in PC12 cells. Data are from a representative 
experiment repeated at least three times with similar findings. 
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3.7 REDUCTION OF TROPHIC SUPPORT ENHANCE APOPTOSIS 
IN APPSW EXPRESSING PC12 CELLS 
 
3.7.1 DNA ladder 
 
Cells require serum to maintain growth in vitro. Serum provides growth and survival factors 
and its removal causes cellular stress. In parallel experiments APP- transfected PC12 cells has 
also been analysed by Dr. Steffen Leutz for their susceptibility to cell death induced by the 
reduction of trophic support or by additional treatment with staurosporine (Leutz 2002). The 
expression of APPsw markedly enhanced the level of apoptotic PC12 cells induced by serum 
reduction. Likewise, the expression of APPsw rendered PC12 cells more vulnerable to 
staurosporine but only under serum-reduced conditions. One feature of apoptosis is that 
chromosomal DNA is enzymatically cleaved to 180-bp internucleosomal fragments. 
Therefore, to confirm the apoptotic nature of cell death after trophic factor withdrawal, 
genomic DNA was isolated and DNA laddering was assessed in APP-expressing PC12 cells 
grown under serum-reduced conditions as shown in Fig. 3.37. While APP-expressing PC12 
cells grown in regular culture medium with 15% serum have a complete genomic DNA, the 
APP-expressing PC12 cells grown for 24 hr in serum free medium contain fragmented 
genomic DNA. 
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Fig. 3.37. Reduction of serum concentration induces apoptosis as indicated by typical DNA 
laddering. APPwt- and APPsw-expressing Pc12 cells exhibit ladder-like DNA fragmentation 
after withdrawal of trophic factors for 24 hr. No DNA laddering is detected when cells were 
grown in regular culture medium (15%). Results    
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3.8 A CELL MODEL REFLECTING HIGH Aß LOAD 
 
3.8.1 Characterization of HEK cell lines overexpressing APPwt and APPsw 
 
As an additional cell system to PC12 cells, HEK (human embryonic kidney 293) cells were 
also stably transfected with APPwt or APPsw cDNA. HEK cells are non neuronal cells but 
are often used in transfection experiments in laboratories because of the high transfections 
rates. The characterisation of HEK cells overexpressing APPwt or APPsw has been performed 
by Astrid Bonert from our lab showing similar results concerning the APP expression. The 
Aß(1-40) production of HEK cells transfected with APPwt or APPsw is shown in Fig. 3.38. 
Culture supernatants of the APPsw transfected HEK cells showed elevated Aß(1-40) levels 
compared to HEK cells overexpressing APPwt, whereas the differences in the Aß production 
were more pronounced as in PC12 cells (Fig. 3.1).  HEK APPsw cells showed a tenfold 
increase in the Aß(1-40) production compared to HEK APPwt cells. Of note, HEK cells 
bearing the APPsw mutation exhibit a 30-fold increased Aß production compared to APPsw 
bearing PC12 cells (Fig. 3.1). 
 
 
 
Figure 3.38 Conditioned media analysed for Aß in HEK cells: HEK cells expressing the 
Swedish mutant APPsw showed a tenfold increase in the Aß(1– 40) production when 
compared to the HEK APPwt cells (ANOVA ***P<0.001: 
+++P< 0.01 vs. APPwt, ***P<0.001vs. 
control, posthoc Tukey‘s). The increase in the production of Aß(1– 40) was confirmed in 
three independent experiments. HEK cells bearing human APPwt showed a nine fold 
increase in Aß production compared to controls  (***P<0.001 vs. control, posthoc Tukey‘s). 
Values are means + SEM from three independent experiments 
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3.8.2 Basal apoptosis is  already increased in APPsw HEK cells 
 
Apoptosis in HEK cell populations was measured by propidium iodide staining and flow 
cytometry anaylsis. In contrast to APPsw PC12 cells, which show no increased basal 
apoptosis (Eckert 2001),  the APPsw-transfection of HEK cells leads to increased levels of 
apoptotic cells under basal conditions. Thus, APPsw PC12 cells seems to be able to 
compensate the consequences of the increased Aß levels, while the 30 fold higher Aß levels in 
APPsw HEK cells compared to APPsw PC12 cells, lead directly to increased levels of 
apoptotic cells even under basel conditions (Fig. 3.39). Additionally, treatment of PC12 cells 
extracellularly with Aß1-42 (100 nM) results also in increased apoptotic cell death (Keil 2004). 
Thus, under basal conditions APPsw PC12 cells are able to compensate the consequences of 
the increased Aß production. In contrast, APPsw HEK cells expressing high amounts of Aß, 
show already increased level of apoptotic cells under baseline conditions. 
 
 
 
Figure 3.39 Increase basal apoptotic levels in HEK cells overexpressing APPsw mutation 
compared to controls cells (ANOVA ***p<0.001: ***p<0.001 vs. control, posthoc Tukey‘s). 
Also HEKwt cells have enhanced basal apoptotic levels vs. controls (*p< 0,05, posthoc 
Tukey’s). Apoptotic cell death was assessed by propidium iodide staining and flow cytometry. 
Values are means + SEM from eight independent experiments 
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3.8.3 Oxidative stress induced cell death in HEK cells 
 
Similar to PC12 cells, apoptosis was induced in HEK cells using the oxidative stressor 
hydrogen peroxide and the nuclear DNA fragmentation was quantitatively detected by 
propidium iodide staining and flow cytometry. Here, after an induction of 24 hr with 250 µM 
hydrogen peroxide, more apoptotic cells were detected in HEK APPsw as well as HEK 
APPwt cell populations compared to untransfected controls (Fig 3.40). 
 
 
 
 
Figure 3.40 Increase in apoptotic cells after treatment with H2O2 in HEK cells transfected with 
APPwt or APPsw compared to controls. Apoptotic cell death was assessed by propidium 
iodide staining and flow cytometry. (ANOVA ***p<0.001: 
***p< 0.01 vs. control, posthoc 
Tukey‘s). Values are means + SEM from 6-8 independent experiments. 
 
 
3.8.4 Effects of caspase inhibition in oxidative-stress induced cell death in HEK cells
 
Since HEK APPsw cells show increased apoptotic levels under normal culture contidions, 
caspase inhibitors were tested in their potential to inhibit the enhanced basal apoptosis of 
HEK APPsw cells, which produce high Aß levels. Therefore, cells were cultured for 24 hr in 
the presence of caspase inhibitors at a final concentration of 10 µM.  As shown in Fig. 3.41 
only the caspase 2 inhibitor was effective in reducing basal apoptotic levels of HEK APPsw 
cells. All other tested caspase inhibitors (caspase 3, caspase 8 and caspase 9) showed no 
protective effects. Thus, high Aß levels in HEK cells containing the Swedish APP mutation 
may lead to enhanced apoptosis through enhanced caspase 2 activation. In APPwt or 
untransfected HEK cells, no protective effect of caspase inhibitors could be detected. Results    
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Figure 3.41 Protective effects of caspase 2 inhibitor in basal apoptosis of APPsw transfected 
HEK cells (*p<0.05 vs. HEK APPsw co,student’s t-test). No protection could be detected by 
caspase 3-, caspase 8- and caspase 9 inhibitor in basal apoptosis of HEK cells. Values are 
means + SEM from 6-8  independent experiments. 
 
Caspase inhibitors were also tested in their potential to inhibit oxidative stress-induced 
apoptosis in HEK cells. As shown in Fig. 3.42 the pre-treatment of HEK cells with caspase 2 
and caspase 3 inhibitors 3 hr prior the incubation with 250 µM hydrogen peroxide for 24 hr  
reduce significantly apoptotic levels in APPsw and APPwt cells, whereas no significant 
protection could be measured in untransfected controls. 
 
 
Figure 3.42 Caspase 2 and Caspase 3 inhibitor attenuates apoptosis significantly in APPSw 
transfected HEK cells (A) and in APPwt HEK cells (B). No protection could be detected by 
caspase 3-, caspase 8-, caspase 9 or caspase 2 inhibitor in oxidative stress induced 
apoptosis of untransfected HEK controls. Values are means + SEM from 6-8  independent 
experiments. 
 
3.8.5 JNK activation in HEK cells 
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Activation of JNK during oxidative stress induced cell death was also analyzed using an 
appropriate antibody recognizing only phoshorlyated JNK. As shown in Fig. 3.43, the 
incubation of HEK cells with hydrogen peroxide [250 µM] lead to a time dependent 
activation of JNK in the cytosolic fractions, whereas in both, APPwt and APPsw, JNK was 
found to be more activated compared to untransfected controls. 
 
Figure 3.43 Activation of JNK during oxidative stress in cytosolic fraction of HEK cells 
Representative Western blotting is shown from three independent observations. 
 
 
Analyzing the mitochondrial fractions, enhanced translocated  phoshorylated JNK was found 
after 2 hr of oxidative stress induction, whereas both APP transfected HEK cell lines show 
more activated JNK in comparison to HEK controls. In particular, after 4 hr induction JNK 
activation is more pronounced in APPsw HEK. 
 
Figure 3.44 Translocation of JNK into mitochondrial fraction in HEK cells during oxidative 
stress. Representative Western blotting is shown from three independent observations. 
 
 
 
3.8.6 Mitochondrial membrane potential 
 
Since Mitochondrial membrane potential is a very important marker for the function of 
mitochondria and a decrease in mitochondrial membrane potential has been related to cell 
death in different cell types (Green 1998) the mitochondrial membrane potential of HEK was 
investigated. Interestingly, APPsw HEK cells showed a significantly decreased mitochondrial 
membrane potential in comparison to untransfected HEK cells and APPwt HEK cells (fig. 
4xx). In comparison, APPsw bearing PC12 cells showed a slight hyperpolarised Results    
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mitochondrial membrane potential compared to vector cells and APPwt PC12 cells (Keil 
2004). Treating PC12 cells with extracellular Aß1-42 results also in a significant depolarisation 
of mitochondrial membrane potential but to a lesser degree compared to APPsw HEK cells 
(Keil 2004). Thus, it is necessary to distinguish on the one hand between acute and chronic 
Aß effects and on the other hand between dose-dependent effects of Aß on mitochondrial 
function. 
 
Figure 3.45 Mitochondrial membrane potential is reduced in HEK cells containing the 
Swedish APP mutation compared to HEK APPwt or controls.  (ANOVA ***p<0.001: 
***p< 
0.001 vs. control, *p < 0.05 vs. APPwt, posthoc Tukey‘s). Values are means + SEM from 6 
independent experiments. 
 
The effect of hydrogen peroxide on mitochondrial membrane potential of HEK cells was also 
investigated (Fig 3.46). A hydrogen peroxide incubation for 6 hr strongly reduces the 
mitochondrial membrane potential in a concentration dependent manner, showing that 
oxidative stress leads to mitochondrial damage in HEK cells. 
 
 
Figure 3.46 H2O2 reduce membrane potential in HEK cells in a concentration dependent 
manner. Values are means + SEM from six independent experiments. 
3.8.7 Effects of caspase 2 - and JNK inhibition on mitochondrial membrane potential in HEK 
cells Results    
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Similar as for PC12 cells, HEK cells were pre-treated with 200 nM JNK inhibitor SP600125 
or 10 µM caspase 2 inhibitor before inducing oxidative stress. In contrast to PC12, neither 
JNK inhibitor nor caspase 2 inhibitor show protective effects in stabilizing mitochondrial 
membrane potential when oxidative stress is induced using 250 µM hydrogen peroxide. This 
difference to PC12 cells could be a result of the different cell types, leading to different 
mechanism in the mode of action of caspase 2. Unfortunately, due to a matter of time, the 
involvement of caspase 2 was not characterized more precisely in HEK cells.  
 
Since JNK activation and translocation into mitochondria was observed in HEK cells (see 
3.8.5), it would be assumable that JNK inhibitor may lead to protection of mitochondrial 
membrane potential, however, this could not be measured.  
 
 
 
 
 
Figure 3.47 H2O2 reduced membrane potential in HEK cells. In contrast to PC12 cells, no 
protection of JNK- or caspase 2 inhibitor could be detected. Values are means + SEM from 
3-6 independent experiments. 
 
 
 
 
 
 
 
 
3.8.8 ATP levels of APP transfected HEK cells 
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Since an intact membrane potential of mitochondria is needed to produce ATP in the 
mitochondrial respiratory chain, ATP levels were measured with an bioluminescence assay in 
addition to membrane potential. In accordance to the membrane potential, ATP levels were 
reduced in APPsw transfected HEK cells in comparison to APPwt and controls. Similar 
results have been obtained for APP transfected PC12 cells, but with lesser differences (Keil 
2004), which leads the assumption that Aß has a dose-dependent effect on ATP levels. 
Extracellular Aß treated PC12 cells showed also reduced ATP levels (Keil 2004), but the ATP 
reduction was stronger under physiological conditions using APPsw PC12 cells compared to 
acute treatment with extracellular Aß (37% vs. 13%). Interestingly both, mitochondrial 
membrane potential and ATP levels in dissociated neurons of APP transgenic mice were also 
found to be reduced compared to littermate non-transgenic control mice (Keil 2004). 
 
 
Figure 3.48 ATP levels are reduced in HEK cells containing the Swedish APP mutation 
compared to HEK APPwt or controls, while (ANOVA ***p<0.001: 
**p< 0.01 vs. control, 
*p<0.001vs. APPwt, *p < 0.05 vs. control, posthoc Tukey‘s). Values are means + SEM from 6 
independent experiments. 
 
 
ATP levels of HEK cells were also measured after inducing oxidative stress. As shown in Fig. 
3.49 ATP levels drop down already after a 30 min in a concentration dependent manner to 
hydrogen peroxide incubation. Results    
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Figure 3.49 After 30 min incubation with hydrogen peroxide ATP levels were strongly 
reduced in a concentration dependent manner. Two way ANOVA ***p <0,001 for H2O2- 
concentration dependent treatment and cell line,***p < 0,001,**p < 0,01 ,*p < 0,05 vs. control, 
$$p < 0,01 vs. APPwt, posthoc Tukey’s. Values are means + SEM from 3-6 independent 
experiments. 
 
3.8.9 Messenger-RNA expression of apoptotic factors  
 
To further elucidate the involvement of other apoptotic factors in HEK cells, RT-PCR 
analysis was performed for AIF, GSK3ß and Presenilin 1. As shown in Fig. 3.50, and similar 
to PC12 cells, the induction of oxidative stress leads to an enhanced expression of mRNA of 
AIF, whereas in particular, HEK cells containing the Swedish APP mutation show a clearly 
upregulation of AIF mRNA expression. In addition, a clearly enhanced AIF protein 
expression was also found after 6 hr exposure to hydrogen peroxide in mitochondrial fractions 
of APPsw transfected HEK cells by Astrid Bonert from our group. 
 
Fig. 3.50. Expression of AIF mRNA increases during oxidative stress in HEK cells, whereas 
cells containing the Swedish APP mutation show clearly enhanced mRNA expression in Results    
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comparison to APPwt or controls after 30 min H2O2 (250 µM) incubation. Data are from a 
representative experiment repeated at least three times with similar findings. 
 
Interestingly, the release of AIF into the cytosol was only observed after an 24 hr hydrogen 
peroxide incubation, pointing for a role of AIF in a delayed apoptotic mechanism. As control, 
RT-PCR from the housekeeping gene ß-actin was performed from the same cDNA bank. 
Here, no alteration in the mRNA expression was detected. 
 
 
 
Fig. 3.51. ß-Actin mRNA expression in HEK cells. Data are from a representative experiment 
repeated at least three times with similar findings. 
 
 
As already mentioned in 3.6.3 a very recent report by Ryder et al. (2004) hypothesized that 
Akt/GSK3ß mediated signalling may contribute to underlying AD pathogenesis induced by  
FAD mutations in APP and Presenilins. They found a down-regulated Akt/ PKB kinase 
activity and elevated endogenous GSK3ß kinase activity in HEK cells expressing the Swedish 
APP751. As shown in Fig. 3.52, the Swedish APP overexpression in HEK cells does not alter 
the mRNA expression of GSK3ß in HEK cells.  Thus, rather postranslational  modification or 
activation of GSK3ß may contribute to neurotoxicity than an upregulation in the mRNA 
levels of GSK3ß by the Swedish APP mutation. Nevertheless, enhanced mRNA expression of 
GSK3ß was found when oxidative stress was induced in HEK cells compared to untreated 
controls.  
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Fig. 3.52 Expression of GSK3ß mRNA in HEK cells increases during the induction of 
oxidative stress. Data are from a representative experiment repeated at least three times 
with similar findings. 
 
 
Recently, Tamagno et al. (2002) showed that oxidative stress activates the expression and 
activity of BACE (see. 1.4.2), an aspartyl protease responsible for the beta-secretase cleavage 
of APP.  It was also shown that APP containing the Swedish double mutation seems to be a 
significantly better substrate for β-secretase than wild-type APP (Citron 1992).  
Presenilin 1 is an essential aspartly protease in the γ-secretase complex for the cleavage of 
APP (see. 1.4.3), and Aß production is enhanced by the Swedish mutation in HEK cells. 
Therefore, the mRNA expression of Presenilin1 in HEK cells was analysed, since primers for 
human Presenilin1 have been designed for the characterization of Presenilin transfected PC12 
cells (see. 3.9.1) and were available in the lab.  
 
 
 
Fig. 3.52 The transfection of APP does not affect the Presenilin 1 mRNA expression in HEK 
cells. Data are from a representative experiment repeated at least three times with similar 
findings. 
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As shown in Fig. 3.52, the mRNA expression of Presenilin 1 in HEK cells is not altered by 
the APP overexpression, indicating that the enhanced Aß production in HEK APPsw cells 
may be rather through an enhanced activation of BACE (Kinoshota 2003) as a result of 
upregulated Presenilin 1. Nevertheless, the measurement of the γ-secretase activity or 
experiments using specific γ-secretase inhibitors, would further elucidate, whether altered γ-
secretase contributes to the enhanced Aß production induced by the Swedish APP mutation. 
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3.9.1 APOPTOSIS IN CELL MODELLS OVEREXPRESSING PRESENILIN 1 
 
Presenilin 1 (PS1) is an aspartyl protease, involved in the γ-secretase-mediated proteolysis of 
Aß. Recent studies have suggested an additional role of presenilin proteins in apoptotic cell 
death observed in AD. Since PS1 is proteolytically cleaved by caspase 3, it has been proposed 
that the resulting C-terminal fragment of PS1 (PSCas) could play a role in signal transduction 
during apoptosis. Moreover, it was shown that mutant presenilins causing early-onset of 
familial Alzheimer's disease (FAD) may render cells vulnerable to apoptosis. Recent 
experiments performed from Katharina Schindowski from our lab have revealed reduced 
apoptotic levels in CD4P
+
P T- lymphocytes of PS1wt transgenic mice compared to the littermate 
controls. In contrast, CD4P
+
P T- lymphocytes from mice bearing a FAD PS1 M146L mutation 
show increased vulnerability to cell death (Schindowski 2003).  
The mechanism by which PS1 regulates apoptotic cell death is not yet understood. Therefore, 
one aim of this work was to clarify the involvement of PS1 in the proteolytic cascade of 
apoptosis and if the cleavage of PS1 by caspase 3 has a regulatory function. 
 
U3.9.1 Neuronal cell model 
  
3.9.1.1 Characterization of PC12 cells expressing Presenilin 
 
Starting from a pCDNA3 plasmid containing full length human PS1, two other plasmids, 
pCDNA3-PSCas and pCDNA3-PS1mut (D345A) were generated using appropriate 
oligonucleotides for PCR or mutagenesis (see.2.37). PC12 cells were transfected with 
respective pCDNA3-PS1, pCDNA3-PS1mut, pCDNA3-PSCas or empty pCDNA3 plasmids, 
and stably transfected cells were selected using G418 on the basis that pcDNA3-vector 
contains a neomycin- resistance cassette. The effective transfection of the different constructs 
were verified by RT-PCR (see. 2.3.6). One Primer pair was designed  to amplify a 425 bp 
fragment of human PS1 from cDNA libraries of transfected PC12 cells, whereas the left 
primer starts at sequence size 956 while the complementary right primer recognizes PS1 
starting at  sequence size 1380.  Since the constructed pcDNA3-PSCas contains only the C-
terminal fragment of PS1 starting at the position 1048, another primer pair was designed to 
detect caspase 3 cleaved C-terminal fragment of PS1 from cDNA libraries of transfected 
PC12 cells. Here the left primer recognizes PS1 at sequence size 1180 while the 
complementary right primer starts at sequence size 1333, thus a 153 bp fragments is amplified Results    
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by this primer pair.  As shown in Fig 3.53 an amplified fragment (sequence size 956 – 1380) 
was detected in Presenilin 1 (PS1) and mutated Presenilin (D345A, PSMut) transfected PC12 
cells, while it was not detected in PC12 cells transfected with the caspase 3 cleaved C-
terminal fragment of PS 1 (PSCas) or in empty vector transfected PC12 cells (control). 
 
 
Fig: 3.53 RT-PCR analysis of human Presenilin 1 in transfected PC12 cells.  
 
Using the second primer pair, which amplifies a fragment (sequence size 1180-1333) located 
near to the C-terminus of PS1, in all three human PS1 related cell lines (PS1, PSMut and 
PSCas) this 153 bp fragment was detected, showing that the respective transfected PC12 cells 
express human PS1 mRNA, while empty vector transfected cells show no mRNA expression 
of human PS1. 
 
 
Fig: 3.53 RT-PCR analysis of human C-terminal Presenilin 1 in transfected PC12 cells. 
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3.9.1.2 Antiapoptotic effects of Presenilin during oxidative stress 
 
Since PS1 is cleaved by caspase 3, generating a C-terminal fragment (PSCas), an involvement 
of PS1 in the regulation of apoptotic proteolytic cascade has been proposed (Kim 1997). The 
caspase-mediated cleavage of PS1 occurs between aspartate 345 and serine 346 (Grünberg et 
al, 1998). 
Recent findings indicate that the expression of mutant PS1 (Hashimoto, 2002) or mutant APP 
(Eckert 2001) sensitises cultured cells to apoptosis. In addition to PS1, it has been shown that 
APP and PS2 are substrates of caspases in vitro and in cultured cells. (Gervais 1999, Kim 
1997).  
Despite these findings, it still remains unknown if PS1 has a direct regulatory function in 
apoptosis. Moreover, the function analyses of PS1 have been controversial. Due to pro-
apoptotic reports of PS1, it has been hypothesized that caspase cleavage of presenilins and 
APP creates an apoptotic amplification cycle, accelerating cell death in the neurons of AD 
patients (Loetscher 1997; Kim 1997; Gervais 1999). In contrast, persuasive evidences 
describing an antiapoptotic action of PS1 have also been shown (Roperch 1998; Imafuku 
1999; Amson 2000). PSCas and ALG-3, a truncated form of PS2, may inhibit Fas induced 
apoptosis (Vezina 1998; Vito 1997). PS1 assembles with the anti-apoptotic protein Bcl-2 into 
a macromolecular complex (Alberici 1999), and interacts with a novel presenilin-associated 
protein (PSAP) (XU 2002). 
 
A negative regulation of the stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase 
(JNK) signalling pathway by PS1 was proposed as the mechanism by which PS1 regulates 
apoptosis, since overexpressed PS1 suppressed the UV-stimulated SAPK/JNK activation in 
mouse embryonic fibroblast (MEF) from PS(+/+) mice. 
 
To investigate the apoptotic effects of the overexpression of full length PS1, full lengths PS1 
containing the mutated caspase 3 cleavage sequence site (PSmut, D345A) and the caspase 3 
cleaved C-terminal fragment of Presenilin 1 (PSCas), transfected PC12 cells were incubated 
with 250 µM hydrogen peroxide for 24 hr, and apoptosis was measured by propidium iodide 
staining and flow cytometry. As shown in Fig. 3.54, the overexpression of full length PS1 as 
well as the caspase 3 cleaved C-terminal fragment of PS1 reduced apoptotic level when 
oxidative stress was induced in PC12 cell. However, the mutation at the caspase 3 recognition Results    
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site (D345A/ PSmut), which inhibits cleavage of PS1 by caspase 3, showed similar results as 
PS1 or PSCas towards oxidative stress stimuli in PC12 cells, showing also reduced apoptotic 
levels compared to empty vector transfected PC12 cells. This suggests that proteolysis of PS1 
by caspase 3 may not be a determinant, but only a secondary effect during apoptosis.
 
 
Fig: 3.54 Oxidative-stress induced cell death in transfected PC12 cells. PS 1, PS1-Mut and 
PSCas transfected PC12 cells showed reduced sensitivity to oxidative stress-induced cell 
death compared to vector control cells (ANOVA, P < 0.01). Different  from pCDNA3 vector 
control  PC12 cells: posthoc Tukey‘s,  **P<0.01 vs control, *P<0.05 vs control values are 
means + SEM from 7 independent experiments. 
 
 
3.9.1.3 Presenilin and JNK activation 
 
Since the overexpression of PS1, PSMut and PSCas reduce the sensitivity of PC12 cells to 
oxidative stress, it was investigated if the inhibition of the JNK pathway by PS1 might be a 
possible mechanism for its antiapoptotic action. A negative regulation of JNK signalling 
pathway has been observed recently by Kim et al. (2001). Exposure of HEK cells to UV light 
resulted in UV-stimulated SAPK/JNK activation, whereas this effect was reduced in 
transiently transfected HEK cells overexpressing PS1. In addition, mouse embryonic 
fibroblast (MEF) cells from PS1-null mice were more sensitive to hydrogen peroxide-induced 
apoptosis than in MEF cells from PS(+/+) mice (Kim 2001). 
 
In order to investigate, whether the observed antiapoptotic effects of PS1, PSMut or PSCas in 
oxidative stress induced apoptosis in PC12 cells may be due to a negative regulation of JNK, 
western blotting of cell lysates from hydrogen peroxide treated PC12 cells was performed to 
detect activation of JNK. As shown in Fig. 3.55, the incubation of transfected  PC12 cells Results    
 
112
 
with hydrogen peroxide (6 hr, 250 µM) leads to activation of JNK, however, no reduction of 
the JNK activation could be observed, neither by the overexpression of PS1 and PSMut, nor 
by the overexpression of PSCas. Thus, in oxidative stress induced apoptosis in PC12 cells, the 
observed antiapoptotic mechanism may not be mediated through a negative regulation of 
JNK. 
 
 
Fig: 3.55 Activation of JNK and c-Jun in oxidative stress-induced cell death in PS1, PSMut, 
PSCas and vector control transfected PC12 cells analyzed by Western blotting using anti-
active p-JNK antibody. No reduction in the JNK activation was observed by the 
overexpression of PS1, PSMut or PSCas. Data are from a representative experiment 
repeated at least three times with similar findings. 
 
 
 
3.9.1.4 Presenilin 1 overexpression does not effect mitochondrial membrane potential 
 
As described in 1.5.3 apoptosis is
  inhibited by the antiapoptotic Bcl-2
  involved in the 
regulation of apoptosis. Bcl-2 and
  its related proteins contribute to the formation of 
mitochondrial
 permeability transition pores. They regulate the release of
 calcium stores and 
control the release of mitochondrial factors from mitochondria to the cytosol. Using two-
hybrid
 interaction system, and co-immunoprecipitation
 assays, Alberici et al. (1999) reported 
an interaction between PS1 and Bcl-2, and postulated that PS1 could have a role in apoptosis 
by providing a part of
 Bcl-2 protein in a macromolecular complex, and by liberating Bcl-2 
from the
  complex in response to an apoptotic signal. It was hypothesized that PS1 may 
influence mitochondrial-dependent apoptotic activities, such
 as cytochrome c release and Bax-
mediated apoptosis.  
Before mitochondrial factors are released during apoptosis into the cytosol, a rapid reduction 
of the mitochondrial membrane occurs (Zamsami 1995).  In the present study it was 
investigated whether the overexpression of PS1, PSMut or PSCas influences mitochondrial 
membrane potential. As shown in Fig. 3.56, no alteration in the basal mitochondrial Results    
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membrane potential in PS1, PSMut or PSCas transfected PC12 cells compared to vector 
transfected controls were observed. In addition, the incubation with hydrogen peroxide for 6 
hr reduced membrane potential down to similar levels. Thus, no protection in stabilizing 
mitochodrial membrane potential by the overexpression of PS1, PSMut or PSCas could be 
detected.  
 
 
Fig: 3.56 mitochondrial membrane potential in  PS1, PSMut, PS Cas and vector transfected 
PC12 cells. Values are means + SEM from 6 independent experiments. 
 
 
3.9.1.5 Presenilin and Bcl-xl expression 
 
Bcl-xl is another anti-apoptotic
  member of the Bcl-2 family. Its expression is reduced in 
cytosolic fraction of APPwt and APPsw transfected PC12 cell (Keil 2004). Recently, it was 
shown by the yeast two-hybrid system that Bcl-xl interacts with the carboxyl-terminal
 
fragments of PS1 and PS2 (Passer 1999). Interestingly, interaction analysis revealed that both 
PS2 and its naturally
 occurring carboxyl-terminal products, PS2short and PS2Cas, associated
 
with Bcl-XL, whereas the caspase-3-generated amino-terminal PS2NCas
 fragment did not. 
The authors proposed a role for Presenilins in modulating cell death by affecting Bcl-XL
 
activity. 
 
Here, the bcl-xl expression was investigated, and as revealed by western blotting, no 
alteration in Bcl-xl expression was found by PS1 or PSCas in the cytosol of transfected PC12 
cells compared to vector transfected controls. In addition, Bcl-xl expression was unchanged 
after incubation with peroxide incubation (250 µM, 24 hr), confirming results of Astrid 
Bonert from our group. Results    
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Fig: 3.57 Bcl-xl expression is unaltered by Presenilin 1 overexpression in PC12 cells 
 
Since none of the examined apoptotic factors (JNK, mitochondrial membrane potential and 
Bcl xl expression) seem to be involved in the antiapoptotic action of PS1, other factors need 
to be considered. 
Recent work indicates that PS1 interacts with glycogen synthase kinase 3beta (GSK3beta). In 
vivo, GSK3beta phosphorylates kinesin light chains (KLC) and causes the release of kinesin-I 
from membrane-bound organelles (MBOs), leading to a reduction in kinesin-I driven motility 
(Morfini 2002b). These findings suggest that mutations in PS1 may compromise neuronal 
function by affecting GSK-3 activity and kinesin-I-based motility.  
Thus, it is possible that in PC12 cells transfected with human PS1, the interaction of 
overexpressed PS1 with GSK3ß could lead to reduced GSK3beta activation, since it has been 
shown that GSK3beta activity were increased in fibroblast cultures cells of embyronic 
knockout PS1 (PS1-/-) mice (Pigino 2003). Therefore, analysis of the GSK3ß activation are 
currently under investigation. 
 
 
3.9.1.6 Vulnerability against Staurosporine-induced apoptotis 
 
In addition to hydrogen peroxide, a second apoptotic stimulation was used to analyse the role 
of PS1 in apoptosis. Staurosporine is an alkaloid produced by Streptomyces bacteria. It is 
known to be a broad-spectrum kinase inhibitor with greate potency and is described as a 
Protein Kinase C (PKC) inhibitor (Tamaoki 1986). The exact mechanism of its action is still 
unclear, an activation of several caspases has been observed (Massieu 2004). Nevertheless, 
staurosporine may also induce apoptosis in a caspase-independent pathway (Zhang 2004) 
Additionally, staurosporine-induced neuronal death is associated with increased production of 
reactive oxygen species (Krohn 1998). Recently, Steffen Leutz from our lab ascertained that a Results    
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reduction of trophic support enhance apoptosis in APPsw transfected PC12 cells (Leutz 
2002). Here it was investigated, whether the overexpression of PS1, PSMut or PSCas also 
leads to reduced apoptotic levels in staurosporine-induced cell death compared to vector 
transfected controls. Therefore, PC12 cells were incubated with 500 nM staurosporine for 24 
hr, and apoptosis measured by propidium iodide staining and flow cytometry. 
In contrast to oxidative stress-induced apoptosis, PC12 cells containing human PS1, PS1Mut 
or PSCas show no significant reduction in apoptotic levels compared to empty vector 
transfected controls. Only a tendency in reducing apoptosis could be detected. This difference 
to oxidative stress induced cell death could be a result of the different apoptotic mechanism of 
oxidative stress and staurosporine. Since Zhang et al. (2004) observed a caspase independent 
apoptosis and late apoptotic execution of apoptosis induced by staurosporine, other apoptotic 
factors may rather contribute to apoptosis, that could not be affected by Presenilins.  
 
 
Fig: 3.58 Apoptotic cell death in  PC12 cells induced by 500 nM staurosporine. Values are 
means + SEM from 5  independent experiments. 
 
Interestingly in this context is that the Swedish APP mutation sensitises PC12 cells to 
staurosporine-induced cell death only when at the same time the trophic support was reduced. 
If  PS1 overexpression has antiapoptotic effects in PC12 cells under these conditions still 
needs to be verified. 
 
3.9.2 Peripheral cell model 
 
The use of peripheral Alzheimer cells is a common application to study mechanisms involved 
in the disease. Lymphocyte cell lines, transfected with mutant PS1 (Wolozin 1998), and Results    
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lymphocytes from FAD patients bearing PS1 mutations (Parshad 1996) show similar results 
to primary neurons from FAD mutant mice (Guo 1999) with regard to an increased 
vulnerability to apoptosis. Recently, it was shown that CD4+ T-lymphocytes affected by both, 
sporadic or genetic APP and PS1 AD risk factors share an increased vulnerability to cell death  
(Schindowski 2003). In lymphocytes from PS1wt-transgenic mice, it was observed that 
spontaneous apoptosis is significantly reduced in CD4
+ T-cells from PS1wt-transgenic mice 
compared to non-transgenic littermate controls.  Thus, lymphocytes may serve as a cellular 
system in which to study risk factors of sporadic, as well as genetic AD in vivo.  
 
3.9.2.1 Fas induced apoptosis in Jurkat cells 
 
In previous experiments made by in our lab several constructs encoding full-length PS2, 
ALG-3 (a truncated C-terminal fragment of PS2) were made and transfected into Jurkat T-cell 
lymphoma cells. The results indicate a clearly reduced Fas-ligand-induced  apoptosis by  the 
C-terminal fragment of PS2. 
In order to investigate a possible functional role of PS1 in the proteolytic cascade of 
apoptosis, similar experiments were performed transfecting Jurkat cells transiently with PS1, 
PSMut and PSCas and inducing apoptosis with 50 ng/ml Fas-ligand for 24 hr. Here,  Fas-
ligand induced apoptosis was reduced by PS1, PSMut or PSCas in transiently transfected 
Jurkat cells. 
  
 
Fig: 3.59 Apoptotic cell death induced by 50 ng/ml Fas ligand in transiently transfected Jurkat 
cells. Apoptosis was measured after 24 hr by PI-staining and FACS anaylsis. (ANOVA, P < 
0.05). Different  from pCDNA3 vector control  transfected Jurkat cells: posthoc Tukey‘s,   
*p<0.05 vs control. Values are means + SEM from 5  independent experiments. 
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3.9.2.2 Staurosporine induced apoptosis in Jurkat cells   
 
In addition to the induction of apoptosis by Fas ligand, apoptotic levels of transiently 
transfected Jurkat cells were also measured in staurosporine-induced cell death. Here no 
antiapoptotic effect could be ascertained as a result of the overexpression of PS1, PSMut or 
PSCas. Thus, the antiapoptotic effect may be dependent on the apoptotic stimulus. 
 
 
Fig: 3.60 Apoptotic cell death in  PC12 cells induced by 500 nM Staurosporine  in transiently 
transfected Jurkat cells. Values are means + SEM from four to six  independent experiments 
 
 
 Discussion    
 
118
 
4. Discussion 
 
4.1 APPSW MUTATION LEADS TO AN ENHANCED VULNERABILITY TO 
OXIDATIVE STRESS-INDUCED APOPTOSIS IN PC12 CELLS 
   
The present thesis demonstrates that the overexpression of the familial Alzheimer’s disease- 
related Swedish APP mutation, which is located near the N-terminus of the Aß region, can 
increase the vulnerability to oxidative stress induced cell death in PC12 cells.  This death 
mechanism is probably initiated by intracellulary produced Aß. 
 
Though Aß-induced cell death has been a topic of research in many studies, the relevance of 
these in vitro findings with regard to in vivo processes is not clear. In most studies, synthetic 
Aß peptides have been applied at micromolar levels that are in contrast to the low nanomolar 
levels of natural Aß found in the brain and cerebrospinal fluid of AD patients. Therefore, 
studies of Aß-induced neurotoxic effects under more likely physiological conditions 
mimicking the situation in AD brains are needed (Selkoe 2002). Moreover, Aß is produced 
intracellulary and can accumulate within cells (Wirths 2001; Hartmann 1997; Hartmann 1999) 
before its deposition in senile plaques. Intracellular accumulation of Aß might impair cellular 
functions and may probably represent the primary event within the neurotoxic Aß cascade.   
 
In order to mimic the situation in vivo, PC12 cells were transfected with human APP and the 
FAD-related Swedish APP-Mutation. APPsw and APPwt PC12 cells showed a moderate 
expression of human APP leading to low levels of Aß(1-40) production (APPsw: 90 pg/ml; 
APPwt 20 pg/ml) similar to the situation in vivo. These two cell lines with different 
production levels of Aß may additionally allow to study dose-dependent effects of Aß.  
 
Interestingly, in the absence of additional apoptosis-inducing treatments, no evidence has 
been found for increased apoptosis in APPsw transfected PC12 cells compared to APPwt cells 
or control cells (Eckert 2001). This is consistent with findings in differentiated neuroblastoma 
B103 cells bearing mutant APP V717I (Xu 1999) or in other cell lines, e.g., PC12 cells (Guo 
1997; Keller 1998) or neuroblastoma cells (Tanii 2000), both with PS-1 mutations, indicating 
that the expression of moderate levels of the mutant variant does not trigger enhanced 
apoptosis per se.  Discussion    
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Therefore, it seems rather likely that increased production of Aß at physiological levels 
primes APPsw cells to undergo death, leading to increased cell death only after a secondary 
insult, e.g., oxidative stress. This scenario which has been suggested to occur in AD brain 
might explain the early onset form of Alzheimer’s disease in the rare familial cases, in which 
mutations in the APP gene lead to an enhanced Aß production  and a 100 % penetrance of the 
disease. This hypothesis is supported by the fact that the brain has a high metabolic rate and is 
exposed to gradually rising levels of oxidative stress during life and that in Swedish FAD 
patients the levels of oxidative stress are increased in the temporal inferior cortex 
(Bogdanovic 2001). 
 
This study using a cell model mimicking the in vivo situation in AD brains indicates that 
probably both, increased Aß production and the gradual rise of oxidative stress throughout 
life, lead to an increased vulnerability of neurons to apoptotic cell death in FAD patients. 
 
 
4.2 CASPASE ACTIVATION IN RESPONSE TO OXIDATIVE STRESS-INDUCED CELL 
DEATH 
 
The caspase family of enzymes is a large group of proteases, whose members have defined 
roles in apoptotic cell death (Thornberry 1998). These enzymes can be subdivided according 
to the feature of their prodomains into two groups: initiator caspases, which are usually  the 
first to be activated in the proteolytic cascade of apoptosis and effector caspases, which are 
activated by initiator caspases, and in turn execute apoptotic cell death by cleaving crucial 
cellular substrates (see. 1.5.3).  
Since caspases play a central role in the regulation of apoptotic signalling, the involvement of 
several caspases in oxidative stress-induced apoptosis was investigated to elucidate the 
mechanism leading to enhanced vulnerability of PC12 cells containing the Swedish APP 
mutation.   
 
4.2.1 The Swedish APP mutation induces activation of caspase 2 in PC12 cells 
  
Caspase 2 was initially described as a neuronally expressed caspase that was down regulated 
during the course of brain development (Kumar 1994) and although caspase 2 was the second 
mammalian caspase described (Kumar 1994), it has not generated the sustained interest that Discussion    
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has been focused on other members of the caspase family such as caspase 3, -8 and -9. Only 
in the last years this changed because of studies that have shown a role of caspase 2 in 
permeabilizing mitochondria (Lassus 2002; Paroni 2002; Robertsen 2002).  
 
Using western blot analysis and a kinetic colorimetric assay measuring the enzyme activity, it 
was observed that in PC12 cells an activation of caspase 2 in oxidative stress signalling 
occured.  In APPsw cells, the maximal caspase 2 activity was fourfold higher compared to 
APPwt and vector PC12 cells, respectively.  
 
How does caspase 2 activation occur in response to oxidative stress in PC12 cells? 
 
Today it is still not clear which mechanism leads to activation of caspase 2. A study reporting 
the identification of an adaptor protein for caspase 2, RAIDD, suggested that caspase 2 can be 
activated in TNFR-mediated cell death (Duan 1997). These report showed that RAIDD 
interacts with RIP, then with TNFR1 via TRADD, and presumably recruits caspase 2 to this 
complex to carry out TNFR1-mediated cell death. However, it is not clear that RAIDD is 
always required for the activation of caspase 2. While the overexpression of RAIDD can lead 
to cell death, blocking RAIDD or caspase 2 with dominant-negative forms did not abrogate 
TNF-mediated cell death, thus the relevance of RAIDD and/or caspase 2 in receptor-induced 
death is unknown.  
 
Interestingly, the analysis of the primary sequence of caspase 2 revealed that the prodomain of 
caspase 2 is more closely related in structure to that of caspase 9 than of caspase 8, which is 
activated through interaction of its death effector domain with FADD in extrinsic apoptotic 
pathway (see.1.5.3.1). Both, caspase 9 and caspase 2 contain CARD (caspase recruitment 
domain) domains (Lamkafi 2002). Caspase 9 it is known to be activated by apoptosome 
formation. Thus, it was proposed that caspase 2 may also be activated in an apoptosome. A 
novel reported PACAP protein (proapoptotic caspase adaptor protein) that interacts with 
caspase 2 and  9, might be responsible for the formation of a caspase 2 apoptosome (Bonfoco 
2001). More recently, it was reported that caspase 2 is recruited to a large protein complex of 
over 670 kDa independent of cytochrome c and Apaf-1 and that this recruitment is sufficient 
for caspase 2 activation (Read 2002), whereas this activation occurs before cytochrome c is 
release into the cytosol. 
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Since only little it is known about the mode of caspase 2 activation, it is also difficult to 
address, if the caspase 2 activation in oxidative stress-induced apoptosis in PC12 cells may be 
due to an large protein complex formation and/or through receptor induced death and RAIDD 
interaction. It is also possible that RAIDD could be a component of this large protein complex 
which activates caspase 2. The elucidation of this large protein complex structure and the 
identification of its components will help to delineate the molecular mechanism of caspase 2 
activation. 
 
More evidence for caspase 2 activation by RAIDD interaction comes from a very recent 
report (Jabado 2004) showing that rat RAIDD, cloned from PC12 cells, interacts with caspase 
2 CARD, whereas overexpression of RAIDD induced caspase 2- and caspase 9-dependent 
apoptosis of PC12 cells. In experiments using trophic deprivation, RAIDD overexpression 
increased cell death and formation of RAIDD aggregates. Thus in PC12 cells, an enhanced 
formation of RAIDD aggregates in oxidative stress, similar to trophic factor withdrawal-
induced apoptosis, is possible. 
  
Enhanced caspase 2 activation in APPsw transfected PC12 cells 
 
In addition to the mode of activation, only little is known about the function of caspase 2 in 
death pathways. Caspase 2 has been found to mediate trophic factor deprivation death in 
several different cell types, including PC12 cells (Troy 1997) and primary cultures of 
sympathetic neurons (Troy 2002), whereas caspase 2 seems to act independent of caspase 3 
activation.  
 
Recent reports indicate procaspase 2 localized in mitochondria (Susin 1999) and that 
mitochondria contain oxidative stress induced caspase 2 activity (Takahashi 2004). 
Depending on experimental conditions, in our study a caspase 2 inhibitor was able to protect 
PC12 cells from the collapse of the mitochondrial membrane potential (see.3.25). The 
relationship between caspase 2 activation and oxidative stress-induced alterations in 
mitochondria is not clear at present. A connection could exist in alteration of the pH gradient 
in mitochondria. According to Mitchel (1996), during mitochondrial respiration, protons are 
pumped outwards across the innermitochondrial membrane, generating a proton-motive force 
(∆p), across this membrane. This electrochemical gradient consists of the inner mitochondrial Discussion    
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membrane potential (∆ψm, negative inside) and a pH gradient (∆ pHm, alkaline inside). At 
physiological temperature the following equation is asserted: 
∆p = ∆ψm - 60∆pHm. 
 The regulation of ∆ψm and ∆pHm is tightly coupled and the efficiency of ATP synthesis and 
other mitochondrial physiology (e.g. Na+/Ca2+ exchange, K+/H+ antiport) is very sensitive 
to the mitochondrial pH gradient. 
New findings of Takahashi et al (2004) show that oxidative stress induces a decrease of the 
alkaline mitochondrial pH, whereas the antiapoptotic Bcl-2 may exert its protective activity 
via modulation of mitochondrial pH. In addition, Guo et al. (2002) observed that Bcl-2 and 
Bcl-xL canP
 
Pblock caspase 2-induced cell death. Further experiments analysing the effects of 
caspase 2 inhibitor on mitochondrial pH gradient will elucidate, whether caspase 2 inhibitors 
exert their protective effect on mitochondrial membrane potential through stabilization of the 
mitochondrial pH gradient. Also it will be helpful to analyse, whether an increased Bcl-2 or 
Bcl-xl expression has similar effects. In this context it is interestingly that APPsw transfected 
PC12 cells have reduced expression of Bcl-xl under basal conditions and after exposure to 
hydrogen peroxide (Bonert 2004). 
 
In addition to mitochondria, caspase 2 was found to be localized in several other intracellular 
compartments, including Golgi, cytosol, and nucleus (Mancini 2001; Paroni 2002; 
Zhivotovsky 1999). Cytotoxic stress causes activation of caspase 2, which is required for the 
permeabilization of mitochondria (Lassus 2002), and induces the release of cytochrome c 
(Paroni 2002, Robertson 2002, Guo 2002).  
It is assumable that the enhanced Aß production in the APPsw transfected cells occurs 
through an increased expression and activity of BACE (Tamagno 2002). The elevated 
intracellular levels of Aß in the mutant cells may therefore lead to an enhanced activation of 
caspase 2, which in turn implements the activation of the intrinsic apoptotic pathway by 
permeabilizing mitochondria and reducing mitochondrial pH. Since caspase 2 activation 
occurs early in our cell model and neurons from caspase 2 null mice are resistant to ß-
amyloid-induced death (Troy 2000) this caspase seems to play a critical role in ß-amyloid 
toxicity. 
This assumption is supported by experiments measuring the membrane potential of PC12 
cells pre-treated with caspase 2 inhibitor VDVAD-FMK. Under certain experimental 
conditions a protective effect of caspase 2 inhibitor on mitochondrial membrane potential was 
observed in oxidative stress induced apoptosis. This effect was specifically enhanced in PC12 Discussion    
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cells transfected with the Swedish APP mutation (see. 3.3.4). Moreover, in APPsw transfected 
HEK cells, which exhibit a 30-fold increased Aß production compared to APPsw bearing 
PC12 cells, the enhanced basal apoptotic levels were reduced by the caspase 2 inhibitor. Since 
it has also been reported that caspase 2 induces a caspase 3 independent apoptotic pathway 
(Troy 2000), other effects of caspase 2 need to be considered. It is still unknown, whether 
caspase 2 also induces the release of AIF to cytosol, or if a nonmitochondrial apoptotic 
pathway is induced by ß-amyloid through enhanced caspase 2 activation. 
 
 
4.2.2 Enhanced caspase 8 activation by the Swedish APP mutation during oxidative stress
 
As described in 1.5.3.1 apoptosis can be triggered by different apoptotic stimuli, and two 
different apoptotic pathways have been described. During the intrinsic apoptotic pathway 
diverse apoptotic signals converge at mitochondrial level, pointing a pivotal role of 
mitochondria in regulating this apoptotic pathway. The other well described pathway is 
termed the extrinsic apoptotic pathway. Here, various death receptors have been described, 
which belong to the TNF superfamily of receptors and trigger external signals into the cell by 
binding specific ligands. These death receptors, including CD95/Fas, DR4 and DR5 (death 
receptors 4 and 5; also called TRAIL-R1 and TRAIL-R2), as well as TNFR1 and are activated 
by their cognate ligands, CD95 ligand, TRAIL (TNF-related apoptosis-inducing ligand) and 
TNF, respectively.  
Each of these receptors have in common that they activate caspase 8 by first recruiting the 
adapter proteins, FADD (Fas-associated death domain) and/or TRADD (TNF receptor-
associated death domain). In particular, the complex of CD95 with FADD and caspase 8 is 
referred as the DISC or death-inducing signalling complex. Following its activation within the 
complex, processed caspase 8 can in turn activate the effector caspase 3, which cleaves 
critical structural and regulatory proteins, resulting in apoptosis.  
 
Since PC12 cells transfected with the Swedish APP mutation showed enhanced vulnerability 
in response to oxidative stress induced apoptosis, it was examined whether the initiator 
caspase 8 is involved. Therefore, the expression pf activated caspase 8 and caspase 8 activity 
were measured The results show clearly that after oxidative stress the caspase 8 activity 
increased in PC12 cells with the highest activities measured for APPsw transfected cells after 
2 hr hydrogen peroxide incubation. This was not implicitly expected, since it has been Discussion    
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described that oxidative stress induces intrinsic the apoptotic pathway (Halliwell 1994; Lotem 
1996; Pias 2002).  In vector transfected control cells, in fact the caspase 8 activity increased 
only slightly. Compared to the basal activity, the maximal caspase 8 activity in vector 
transfected PC12 cells did not even duplicated, while the maximal caspase 8 activity in 
APPsw transfected PC12 cells was about fourfold higher as the basal activity. In addition, the 
caspase 8 activity was higher in APPsw cells compared to APPwt cells.  
 
How is caspase 8 involved in oxidative stress induced apoptosis in APP harbouring PC12 
cells? 
 
The obtained results show that the additional caspase 8 activation could specifically 
contribute to the enhanced vulnerability in APPsw transfected PC12 cells, as measured by 
propidium iodide staining and FACS analysis. However, an important question that needs to 
be addressed, is how the Swedish APP mutation leads to the enhanced caspase 8 activation? 
Since PC12 cells harbouring the Swedish APP mutation produce more Aß, it is attempting to 
assume that the enhanced Aß levels might be responsible for this caspase 8 activation. In 
addition to the data obtained in this thesis, there is further evidence pointing caspase 8 to be 
involved in AD pathology. A very interesting recent report shows that soluble Aß might 
interact with APP leading to an APP-dimer complex formation (Lu 2003). This generated 
APP complex may induce toxicity similar to other known physiological pathways, such as Fas 
ligand induced cell death. Similar to TNF receptor, the multimerization of APP by Aß recruits 
caspase 8 to the APP complex, leading to activation of caspase 8. Thus, it is possible that 
enhanced Aß production in PC12 cells could lead to enhanced caspase 8 activation by this 
mechanism. This effect might be enhanced by an additional oxidative stress insult. 
That APP itself could act as death receptor is also suggested by experiments adding an 
antibody to the extracellular region of APP which results in apoptosis. This effect was 
possibly mediated by cross-linking APP, because the effect was seen with bivalent but not 
monovalent antibody (Rohn 2000; Sudo 2000). Interestingly, in a other recent report the 
dimerizated APP induces apoptosis via its cytoplasmic domain by activating JNK (Hashimoto 
2003), an effect, that was also observed by the Swedish APP mutation. 
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Furthermore, it has also been shown that caspase 8 is not only activated by Aß, but is also 
implicated in an alternative processing of APP during apoptosis (Pelligrini 1999). Since APP 
contains a caspase cleavage site with the essential aspartate at position 664, a resulting C31 
APP fragment was generated by in vitro cleavage assays from APP, while caspase 8 inhibitor 
and mutagenesis of APP aborted the formation of C31. In addition to caspase 8, it was also 
proposed that APP is cleaved by caspase 6 (Gervais 1999), whereas the Swedish mutated APP 
may present a better caspase 6 cleavage sequence (VNLD, with the aspartate at position 672) 
as wildtyp APP (VKMD). However, experiments measuring caspase 6 activity in PC12 cells 
revealed no induction of caspase 6 by the Swedish APP mutation (Marques 2001, diploma 
thesis).   
It was also reported that the caspase 8 cleaved APP fragment C31 may have toxic properties 
(Lu 2000; Nishimura 2002) contributing to neuronal cell death. The recent findings that in 
addition to APP-dimer complex formation, Aß also induces the C31 generation by caspase 8 
cleavage of APP in the C-terminus (Lu 2003b) suggest that Aß-mediated toxicity initiates a 
cascade that includes caspase activation and APP cleavage.  
 
Taken together, our findings and the results obtained by other groups, it can be hypothesized 
that the overproduction of Aß in APPsw PC12 cells leads to APP cleavage and APP-dimer 
complex formation. The enhanced vulnerability of APPsw transfected PC12 cells could be a 
result of the recruitment of caspase 8 by the APP complex and an additional toxic effect of 
C31. Nevertheless, this hypothesis needs to be confirmed by experiments, for example using a 
C-terminal antibody against APP that is also able to recognize C31 in PC12 cells undergoing 
apoptosis, or trying to co-immunoprecipitate caspase 8 with APP.  Since it has also been 
shown that oxidative stress induce the increase of intracellular Aß (Misonou 2000), the 
additional hydrogen peroxide incubation could lead to increased Aß production, emphazing 
the caspase 8 activation. Other death receptors recruit adapter proteins like FADD to bind the 
death effector domain of caspase 8. Therefore, it should also be examined, whether the APP 
complex recruit FADD or other adapter proteins, or if the caspase 8 is direct associated to 
APP. 
 
Another possibility has also to be considered to explain the enhanced caspase 8 activity in 
APPsw PC12 cells. The involvement of other death receptors in Aß toxicity needs to be 
assumed as proposed recently by Cantarella et al. (2003), describing the implication of TNF-
related apoptosis-inducing ligand (TRAIL) in Aß-mediated neurotoxicity in human SH-SY5Y Discussion    
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neuronal cells. The mRNA and protein expression of TRAIL was found to be increased when 
cells were treated with Aß. TRAIL was released into the culture medium and found to have 
neurotoxic properties by inducing caspase 8 activation, whereas the overexpression dominant 
negative FADD and caspase 8 inhibitor rescued cells.  
Very recently, a neuronal response of Aß occuring through a TNF receptor signalling cascade 
and a caspase-dependent death pathway has been proposed (Li 2004). Neurons in both AD 
brain and Aß-treated cultures exhibited Fas-ligand upregulation and changes in 
immunoreactivity for Fas receptor (Su 2003). In this context it is interesting that hydrogen 
peroxide upregulates Fas and Fas-ligand expression in PC12 cells (Facchinetti 2002). Using 
concentrations of 250 µM and 400 µM hydrogen peroxide, Fas and FasL mRNA levels 
increased rapidly. Hence it will be interesting to analyse whether the enhanced caspase 8 
activity in APPsw cells could be a result of upregulated Fas, TNF or Trail expression. 
 
 
4.2.3 Oxidative stress induced mitochondrial dysfunction leading to caspase 9 activation 
 
The investigation of the caspase 9 involvement revealed that the induction of oxidative stress 
led to an increased caspase 9 activity in APPwt PC12 cells as well as in APPsw PC12 cells 
compared to vector transfected control cells. At the same time an enhanced cytochrome c 
release has been detected in both, APPsw and APPwt compared to vector control (Marques 
2003). For the interpretation of these results, the understanding of the pivotal role of 
mitochondria in regulating cell death and energy metabolism is very important, since it is not 
known, how AD-related genetic factors are linked to oxidative stress. 
 
Mitochondrial damage induced by overexpression of APP 
 
The respiratory chain reaction in mitochondria inevitably generates reactive oxygen species 
(ROS) including oxygen radicals and hydrogen peroxide. When the ROS production 
dominates cellular ROS-reducing functions, oxidative stress develops (see 1.6.1), ultimately 
leading to apoptosis. At the same time, mitochondria serve as the reservoir of death signals 
originating from physiological stresses, controlling the release of several apoptotic factors like 
cytochrome c (see 1.5.3.2). Before cytochrome c is released from the intermembrane space 
into the cytosol, mitochondria need to disrupt the inner membrane potential (Green 1998). 
The adenine nucleotide translocator (Vieira 2000; Belzacq 2001) and the voltage-dependent Discussion    
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anion channel (VDAC) (Shimizu 1999; Madesh 2001) are thought to accomplish the 
cytochrome  c  translocation under the control of Bcl-2 family proteins (Belzacq 2003). 
However, it has also been reported that pro-apoptotic ‘BH3-only’ molecules, tBID, and Bik, 
can release cytochrome c by outer membrane pore formation in cooperation with the ‘BH1-3’ 
members represented by Bax and Bak (Wei 2001). 
Thus, analyzing the pivotal role of mitochondria in oxidative stress induced apoptosis has 
been one main topic of research in our lab. The obtained results show that the expression of 
APPsw leads to a reduction of the cytochrome c oxidase activity (complex IV of the 
mitochondrial respiratory chain) as well as an impairment of complex II, III and V (Keil 
2004). In this connection it has been observed that basal ATP levels of APPsw PC12 cells 
were significantly reduced compared to vector transfected control cells. APPwt PC12 cells 
show also reduced ATP levels in comparison to vector trasnfected PC12 cells but to a lesser 
extent than APPsw.  
 
How to explain the effects of the Swedish APP mutation on mitochondria in PC12 cells? 
 
Recently, it has been shown that in addition to the localization in the plasma membrane and 
endoplasmatic reticulum (Anandatheerthavarada 2003), APP may be targeted to 
mitochondria. The accumulation of APP in the mitochondrial compartment caused 
mitochondrial dysfunction and impaired energy metabolism in cortical neuronal cells. Thus, it 
is possible that due to the overexpression of APP, more APP is also localized in mitochondria 
of APP transfected PC12 cells, leading to the observed impairment energy metabolism. In 
fact, accumulation of APP in mitochondrial fraction could be detected by western blotting in 
both APPwt and APPsw PC12 cells (Keil 2004). The results are reduced ATP levels and 
reduced metabolic activity as detected by the MTT assay (see. 3.3.3) in APPsw and APPwt 
compared to vector control cells. The accumulation of overexpressed APP in mitochondria 
might explain the differences in ATP levels and metabolic activity between APPsw and 
APPwt, since enhanced expression of human APP has been found in mitochondria of APPsw 
transfected PC12 cells (Bonert 2004). 
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Relevance of  nitric oxide (NO) and mitochondrial failure in beta amyloid-induced cell death? 
 
In addition to our results, several studies have also observed activity changes in mitochondrial 
enzymes in AD brain including pyruvate dehydrogenase and α-ketoglutarate dehydrogenase 
(Gibson 1998). An impaired cytochrome c oxidase activity has further been found in the CNS 
and tissues including platelets of AD patients (Maurer 2000; Cardoso 2004). Moreover, 
accumulating evidence suggests that in addition to oxidative stress, also nitrosative stress is an 
early events in the pathogenesis of AD (De la Monte 2003; Law 2002; Jang 2004). Nitric 
oxide (NO) and its derivates (RNS) are known to inhibit the mitochondrial respiration (Brown 
2002). NO itself causes a selective and reversible inhibition of cytochrome c oxidase, whereas 
RNS inactivate multiple respiratory chain complexes (I, II , III, IV) and ATP synthase (Radi 
2002).  
Experiments from Uta Keil revealed that overexpression of APPsw increased the NO levels in 
PC12 cells and HEK cells. In addition, the treatment of PC12 cells with extracellular AßB1-42
B 
also leads to an increase of NO levels but to a lesser extent than in APPsw PC12 cells. Thus, it 
can be hypothesized that the enhanced intracellular Aß production in APPwt and APPsw cells 
is responsible for the Aß-dose dependent NO increase (Keil 2004). Hence, it is probable that 
the mitochondrial dysfunction is induced by the enhanced NO levels, or by a direct effect of 
Aß  on mitochondrial function, inhibiting key metabolic enzymes and contributing to the 
deficiency of energy metabolism seen in AD.  
 
Impact of the beta-amyloid- induced mitochondrial dysfunction 
 
The consequences of Aß-induced mitochondrial dysfunction are obvious. Under basal 
conditions, the chronic low-levels of intracellular Aß (picomolar range) in APPsw PC12 cells 
leads to reduced ATP levels and reduced metabolic activity. Nevertheless, the cells seems to 
be adapted to this energy deficiency, since no enhanced basal apoptotic levels has been 
measured. If this adaptation occurs through a upregulation of glycolysis needs to be 
determinated e.g. by measuring the activation of the energy charge-sensitive AMP-activated 
protein kinase or the 6-phosphofructo-1-kinase, the master regulator of glycolysis.  
In addition, proteins of the Bcl-2 family, which are important regulators of apoptosis are also 
affected, because the Bcl-xl/Bax ratio is reduced in APPsw cells (Keil 2004). This shift in the 
Bcl-xl/Bax ratio towards the proapoptotic Bax, and the energy deficiency conduct APPsw cell Discussion    
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to be more vulnerable to mitochondrial membrane potential changes and ATP reduction after 
oxidative stress. The consequence is an activation of the intrinsic apoptotic pathway, releasing 
cytochrome c into the cytosol, resulting in an activation of the apoptotic protease-activating
 
factor-1/caspase 9 apoptosome complex. 
 
Since we determined no differences in cytochrome C release and caspase 9 activation between 
APPsw and APPwt cells other effects of the altered Bcl-xl/Bax ratio and energy deficiency 
need to be considered. Interestingly, experiments performed investigating AIF, which induced 
apoptosis independent of caspases, show that  AIF protein  expression is enhanced in 
mitochondria when oxidative stress is induced. This enhanced AIF expression was gene-dosis 
dependent in following order: APPsw > APPwt > vector control. In addition, another 
mitochondrial apoptotic factor, the Smac protein was analyzed by Astrid Bonert. The release 
was enhanced under basal conditions and after oxidative stress in APPsw and APPwt cells 
compared to vector transfected control cells which is in agreement with this obtained caspase 
9 results.  
 
Our results were confirmed by a very recent publication (Katoh 2004). Using U937 cells, 
hydrogen peroxide caused a subtle decrease in the inner membrane potential with cytochrome 
c release and caspase 9 activation, whereas Bcl-2 overexpression cause render cells resistant 
to oxidative stress. 
 
 
4.3 THE IMPLICATION OF THE JNK ACTIVATION IN NEUROTOXIC MECHANISM 
INDUCED BY THE SWEDISH APP MUTATION  
 
Mitogen-activated protein (MAP) kinase signaling pathways relay, amplify and integrate 
signals from a diverse range of extracellular stimuli, thereby controlling the genomic and 
physiological response of a cell to changes in the environment. These responses include 
cellular proliferation, differentiation, development, the inflammatory response and apoptosis. 
In neuronal cells, potentially deleterious stimuli, such as deprivation of trophic factors, UV 
irradiation, free radicals, hypoxia, ischemia, heat shock, and cytokines, provoke an 
intracellular stress response that either leads to apoptosis or defensive-protective adaptations. 
The central mediator thereby is SAPK (stress activated protein kinase) also designated as c-
Jun NH2-terminal kinase (JNK). The other described stress-activated MAP kinase is the 38 Discussion    
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kDa protein kinase p38, which is activated by bacterial endotoxins, inflammatory cytokines 
and osmotic stress (Mielke 2000). 
 
JNK is a serine/threonine kinase and activated through multiple protein kinases by dual 
phosphorylation at conserved threonine and tyrosine residues,  whereas the phoshorylation of  
Thr183 and Tyr185 is essential for the kinase activity. Activated JNK in turn is known to 
phosphorylate and activate several transcription factors like c-Jun at Ser63/73. Due to 
alternative splicing, ten JNK isoforms exist yielding  proteins of 46 and 55 kDa. 
 
An activation of the JNK pathway in cortical neurons exposed to Aß was reported recently by 
Morishima et al. (2002). The phosphorylation and activation of the c-Jun transcription factor 
by JNK was shown to stimulate the transcription of several key target genes, including the 
death inducer Fas ligand. The binding of Fas ligand to its receptor Fas then induces a cascade 
of events that lead to caspase activation and ultimately cell death. In addition,  in other reports 
the activation of JNK associated with amyloid deposition was observed in mice transgenic for 
human APPsw mutation (Savage 2002).  
A direct link between oxidative stress and JNK has been shown by the demonstration that 
JNK is activated by 4-hydroxynonenal (HNE), a major aldehydic end product of lipid 
peroxidation (Parola 1998; Uschida 1999). 
 
Given the important role that JNK pathway plays in cellular stress signalling, we investigated 
the relationship between activated JNK, apoptosis and the Swedish APP mutation. We 
demonstrated that oxidative stress leads to an activation of JNK. JNK phosphorylates specific 
sites in the N-terminal region of c-Jun, thereby enhancing its transcriptional activity. Very 
importantly, we were able to demonstrate that in PC12 cells bearing mutant APPsw the 
activation of JNK and c-Jun was significantly enhanced compared to APPwt cells. At the 
same time activation of JNK and c-Jun is increased in APPwt compared to vector cells. 
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Swedish APP mutation  induced  activation of JNK 
 
The obtained results show that in oxidative stress induced cell death the Swedish APP 
mutation led to an enhanced activation of JNK in PC12 cells. This suggests that the different 
Aß levels in the PC12 cell lines induce a dose-dependent activation of JNK pathway.  At this 
point several questions are arise: How is JNK activated in oxidative-stress induced cell death? 
And why is the JNK activation enhanced by the Swedish APP mutation?  
 
As described above, the energy status of the cell, and here especially the ATP concentration, 
plays a crucial role in cell survival. Prolonged ATP depletion leads to cell death. Small 
changes in ATP levels do not necessarily result in cell death but are sensed by cells. A fall in 
ATP with a subsequent rise in AMP activate the AMPactivated protein kinase (AMPK). 
AMPK acts as a metabolic master switch by inactivating key enzymes of anabolic processes 
that consume ATP. It also favours fattyacid oxidation and, in certain cells, it stimulates 
glycolysis by increasing glucose transport and by activating 6-phosphofructo-2 kinase thereby 
favouring ATP production. ATP conservation is therefore the net result of AMPK activation, 
which contributes to liver cell survival in the short term (Hue 2003). However, consequences 
of prolonged stress and of a sustained AMPK activation triggers cells to apoptosis by the 
activation of JNK as it has been shown recently (Kefas 2003; Larsen 2002). Measurements by 
Uta Keil indicate that after a 30 min hydrogen peroxide incubation ATP levels in PC12 cells 
falls down strongly. In addition, the recovery of the ATP levels is delayed and weaker in 
APPsw PC12 cells. Thus, it is probably that the JNK activation in oxidative stress is catalysed 
by the AMPK. 
 
In addition to AMPK, there is accumulating evidence that JNK activation is associated with 
TNF- and Trail receptor-mediated apoptosis (Arch 1998; Vivo 2003; Reveneau 2003; Deng 
2003; Schwabe 2004). Thereby JNK is activated by ASK1 (Apoptosis signal-regulating 
kinase 1), which is known to bind a death receptor associated  adapter proteins TRAF2 
through direct protein-protein interaction. ASK1 itself is a mitogen-activated protein kinase 
kinase kinase (MAPKKK) family member upstream of JNK. Very recently an activation of 
JNK by hydrogen peroxide has also been reported to occur via TNF receptor (Pantano 2003). 
In fibroblasts from TNF-receptor-deficient mice the ability of hydrogen peroxide to activate 
JNK was inhibited compared with fibroblasts from
  control mice. Simultaneously, Discussion    
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immunoprecipitation of TNF-R1 revealed that in response to hydrogen peroxideP
 
Pthe adapter 
protein, TRADD and JNK were recruitedP
 
Pto the receptor. However, these observed activation 
of JNK in TNF- or Trail receptor apoptosis has never been observed in neuronal cells, and the 
implication of these death receptors for the role of JNK in Aß toxicity needs to be further 
classified. 
 
In addition to the report implicating an APP-dimer complex formation  for the activation of 
caspase 8. Recently, Hashimoto et al. (2003) reported a complex formation of dimerized APP 
with ASK1 and JNK via the scaffold protein JIP-1b (JNK interacting protein). JIP family 
proteins are scaffold proteins that organize specific members of the JNK/MAPK cascade to 
facilitate signalling. Fusion constructs of the epidermal growth factor (EGF) receptor with 
cytoplasmic domain of APP were expressed in neurohybrid cells, and here the addition of 
EGF enhanced neuronal cell death in a caspase 3 dependent manner. Apoptosis was inhibited 
by a dominant-negative ASK1 and SP600125. JIP-1b and ASK1 co-immunoprecipitated  with 
APP, but not with APP lacking the YENPTY-motif. Thus, it was proposed that APP/JIP-
1b/ASK1 form a ternary complex. Indeed, immunoprecipitation were only obtained when 
each molecule was overexpressed. Whether endogenous proteins are also able to form such a 
ternary complex needs to be verified. 
 
Very interestingly are reports proposing that the JIP1b scaffold protein could serve as cargo 
for the microtubule motor kinesin to mediate the transportation of several transmembrane 
proteins (Taru 2002b)  in which APP is supposed to be a cargo receptor (Kamal 2001). In 
addition, JNK has been implicated in the modulation of the APP metabolism, since it   
phosphorylates APP within the carboxy-terminus of APP at Thr 668. This phosphorylation is 
suggested to play an important role in controlling the metabolism and physiological 
functioning of APP (Sisodia 2002). Since cellular stress (inhibition of protein synthesis by 
anisomycin or UV radiation) leads to a phosphorylation of APP by JNK (Taru 2004), and the 
Aß production is significantly reduced when phosphorylation of T668 is abolished by 
mutation (Lee 2003, it is further assumable that phosphorylation of APP may increase Aß 
generation. 
 
Our data clearly indicate that the altered processing of APPsw might play a crucial role in 
activation of stress kinase pathway. If this occurs by a redistribution of JIP scaffold proteins 
or by altering APP metabolism has to be clarified in the future. Discussion    
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4.3.1 JNK inhibitor protects mitochondrial membrane potential and reduces caspase 9 and 3 
activity 
 
Interestingly, using the selective JNK-inhibitor SP600125, a reduction of caspase 9 activity 
was observed whereas activities of caspase 2 and caspase 8 were unaltered. Furthermore, JNK 
translocates to mitochondria, and the JNK inhibitor compensated the mitochondrial 
abnormality when oxidative stress was induced. Due to the fact that members of the anti-
apoptotic Bcl-2 f protein family are inactivated through phosphorylation by JNK (Inoshita 
2002; Maundrell 1997) our results support evidence that JNK alters mitochondrial function. 
Furthermore, the Western blots of the mitochondrial fraction show that JNK translocates to 
mitochondria during oxidative stress.   
 
Our results have been confirmed by other recent reports: JNK was found to be strongly 
activated in APP transgenic mice with extensive oxidative damage, but not in APP transgenic 
mice with little oxidative damage (Zhu 2001; Hwang 2004). In Jurkat cells JNK was activated 
by ROS and caspase 2 and -9 processing as well as cytochrome c release inhibited by 
SP600125 (Dirsch 2004). Furthermore, SP600125 delayed the mitochondrial permeability 
transition, inhibited cytochrome c release and prevented Bid degradation in TNF-alpha 
induced apoptotsis in mouse hepatocytes (Schwabe 2004). Investigations by Isabel Scherping 
from our lab revealed a protective effect of SP600125 on mitochondrial membrane potential 
of dissociated mice neurons incubated with Aß, also suggesting that JNK-regulated 
proapoptotic factors act upstream of the mitochondria. 
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Fig. 4.1 Possible mechanisms for activation of JNK in PC12 cells. Since both, APPsw and 
APPwt transfected PC12 cells have APP overexpression, an enhanced activation of JNK by 
the formation of an APPdimer,JIP1b, ASK1 and JNK-complex is assumable. Due to reduced 
ATP levels in APPsw cells the activation of AMPK could result in the phosphorylation and 
activation of JNK. 
 
 
 
4.4 EFFECTS OF CASPASE INHIBITORS ON OXIDATIVE STRESS INDUCED CELL 
DEATH IN PC12 CELLS 
 
In addition to determination of caspase expression and activity, the importance of caspases were 
investigated using specific caspase inhibitors. The protective effects of caspase inhibitors were 
analysed using different  methods. Apoptotic cell death was measured using the DNA dye 
propidium iodide and FACS analysis, plasma membrane leakage was detected with trypan blue 
dye and metabolic activity was examined by the reduction of cellular 3-(4,5-dimethlythiazol-2yl)-
2,5-diphenyltetrazolium to formazan. Measuring apoptotic cell death the results were surprising, 
since only the caspase 3 inhibitor was able to reduce oxidative stress-induced apoptosis Discussion    
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significantly in APPsw and APPwt transfected PC12 cells. The inhibition of caspase 2, caspase 
8 and caspase 9 was less effective in preventing apoptosis, although the inhibitors show 
efficiency in reducing the respective activities in lysates of treated cells. The lack of efficacy 
of the initial caspase inhibitors to abolish apoptotic cell death could be completely attributed 
to the further consisting compensatory cell death pathway. Although the treatment of PC12 
cells with hydrogen peroxide leads to activation of these initiator caspases, their inhibition is 
not enough to avoid apoptosis, because different caspase pathways co-exist (Fig. 3.2). Such a 
compensation of caspase pathway was ascertained in sympathetic neurons from caspase 2 null 
animals. A lack in caspase 2 expression was compensated by an increased expression of both 
mRNA and protein for caspase 9 and DIABLO/Smac in trophic factor deprivation-mediated 
death (Troy 2001). 
 
The failure of the caspase inhibitor mix (containing caspase 3, caspase 8 and caspase 9, 10 
µM each) in preventing oxidative stress induced apoptosis in PC12 cells could be a result of 
the toxic effects of caspase inhibitors at high concentrations. As determined by pre-
experiments, the addition of 50 µM caspase 3 inhibitor enhanced apopototic rates of PC12 
cells compared to controls. Protective effects were only measured using 1µM or 10 µM 
caspase 3 inhibitor. Here the mix containing a total concentration of 30 µM may also be toxic. 
Thus, experiments mixing caspase inhibitors at lower concentrations could result in a better 
protective effects, which however needs to be tested. 
As detected with trypan blue staining, the incubation with increasing concentrations of 
hydrogen peroxide leads to increased rates of PC12 cells showing membrane leakage, 
whereas at high concentrations (up 500 µM) a shift from apoptosis towards necrotic cell death 
occurs, because the rate of membrane leakaged cells (which occurs in both apoptosis and 
necrosis) increased, while the apoptotic rate declined. As determined by trypan blue staining, 
no significant reduction of caspase inhibitors in preventing absolute cell death could be 
ascertained. 
 
APPsw PC12 cells show reduced metabolic activity 
 
 The MTT assay is a widespread used assay to measure cytotoxic effects in cell culture. It 
allows to measure the metabolic activity, quantifying the reduction of -(4,5-dimethlythiazol-
2yl)-2,5-diphenyltetrazolium to formazan. This reduction is catalysed by redox enzymes including 
enzymes of the respiratory chain like succinatdehydrogenase but it has also been shown that Discussion    
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cellular MTT reduction occurs outside the mitochondrial inner membrane and involves 
NADH and NADPH-dependent mechanisms that are insensitive to respiratory chain inhibitors 
(Berridge 1993).  
 
Parallel to the lower ATP level in APPsw PC12 cells, the metabolic activity was also found to 
be reduced. The incubation with hydrogen peroxide reduce metabolic activity in a 
concentration dependent manner. While the pre-treatment of caspase inhibitors at a 100 µM 
hydrogen incubation show no or only a weak effects, at higher concentrations (250 µM) a 
protective effects was measured by caspase 3, caspase 8 as well as caspase 9 inhibitor. Thus, 
it seems that caspase inhibitors lead to some protection of the cells, since the metabolic 
activity was higher as in cells with no caspase inhibitor pre-treatment.  
However, the results from the propidium iodide staining and FACS analysis show no 
significant protection by caspase 8, caspase 9 or the caspase inhibitor mix, which may suggest 
that despite a samll protection of the metabolic acticity, the DNA of hydrogen peroxide 
treated PC12 is fragmented, since an enhanced sub G1 peak is detected. In addition, it will be 
interesting to elucidate how much of the metabolic activity is required for the execution of 
apoptosis, because it has been shown that apoptosis is an active process that requires a 
complex of tightly regulated ATP-dependent steps. Indeed, ATP is required to switch on 
genes that are involved in the early phases of apoptosis caspases (Thornberry 1998). Here, it 
has been shown that a decrease in ATP levels  below to 20% of basal ATP leads to a shift 
from apoptosis to necrosis, whereas these type of cell death has been determined   
“aponecrosis” (Formigli 2000). 
 
These results show that the widespread and easy to handling MTT assay should not be the 
only method used to measure cytotoxicity and that the differences in the detection methods 
should be concerned in comparing various results. 
 
 
4.5 BASAL APOPTOSIS IS INCREASED IN APPSW HEK CELLS 
 
HEK cells overexpressing APP show increased basal apoptotic levels compared to 
untransfected control cells. This is in contrast to the measured apoptotic levels of PC12 cells, 
where in the absence of apoptosis-inducing treatments, no evidence has been found for 
increased apoptosis in APPsw transfected PC12 cells compared to APPwt cells or control Discussion    
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cells. Calculating the Aß production in the two cell lines transfected with the Swedish APP 
mutation, the HEK cells have a nearly 30-fold higher Aß level than the PC12 cells (HEK 
APPsw 5.42 nM; PC12 APPsw 0,20 nM). Thus, using the different cell lines allow to study 
dose-dependent effects of Aß, and it is attempting to hypothesized that the 30-fold higher Aß 
levels leads to the enhanced basal apoptosis in HEK cells.  
In parallel experiments performed in our lab, treating PC12 cells extracellularly with Aß1-42 at 
a concentration of 100 nM and higher, results also in increased apoptotic cell death (Keil 
2004). Interestingly, this effect on the induction of apoptosis was less pronounced in the 
extracellular setting than in APPsw HEK cells, showing that the cells are more vulnerable to 
high chronic Aß stress than to the extracellular addition of synthetic Aß1-42 peptides.  
However, no significant differences in basal apoptotic rates between APPsw and APPwt HEK 
cells could be detected, although APPsw transfected HEK cells have a tenfold higher Aß 
production as APPwt HEK cells. This means that either the lower Aß levels from APPwt 
HEK cells were already sufficient to prime HEK cells to enhanced basal apoptosis, or that 
other effects needs to be considered, like accumulated APP in mitochondria. 
 
4.5.1 The Swedish APP mutation impairs metabolism in HEK cells 
 
Similar as in PC12 cells, ATP levels were significantly decreased in HEK cell transfected 
with the Swedish APP mutations compared to APPwt or control. In addition, ATP levels in 
APPwt HEK cells were lower than the control. Thus, it is assumable that the increasing Aß 
production from APPwt to APPsw results in a dose-dependent decline in ATP levels, whereas 
the effect is stronger in HEK cells as in PC12 cells.  
In accordance to ATP levels, a reduced mitochondrial membrane potential was ascertained  
for HEK cells in the following order: APPsw < APPwt < control, whereas APPsw bearing 
PC12 cells showed a slightly hyperpolarized mitochondrial membrane potential compared to 
APPwt or vector control cells. 
 
Aß impairs energy metabolism  
 
The obtained results show clearly that Aß seems to impair the energy metabolism of 
mitochondria. This conclusion is also supported by other experiments from our lab. In 3-
month-old APP tg mice reduced ATP levels were observed under basal conditions compared 
to littermate control mice, showing the in vivo relevance of the cell culture findings Discussion    
 
138
 
(Scherping 2004). Interestingly, 3 month-old mice exhibit no plaques but detectable Aß levels 
in the brain suggesting the very important role of intracellular Aß in ATP reduction, which 
support the hypothesis that intracellular Aß affects cellular functions and may represent the 
primary event within the neurotoxic Aß cascade. In older, 12-month-old amyloid plaque-
bearing transgenic mice bearing the Swedish APP mutation reduced COX activity and 
reduced ATP levels were also found (Anandatheerthavarada 2003). In addition, it was shown, 
that impaired brain metabolism always occurs in clinically significant AD, and the degree of 
clinical disability is proportional to the degree of metabolic impairment (Blass 2002). Since 
the earliest, mildest changes in brain metabolism occur even before the onset of measurable 
cognitive impairment or atrophy (Hoyer 2004), this also pointed for the primary event of 
intracellular Aß for the development of the disease. 
 
 
4.5.2 Caspase inhibition in HEK cells 
 
As discussed above, the HEK cells transfected with APPwt or APPsw have enhanced basal 
apoptotic levels in comparison to untransfected control cells. This is probably due the 
enhanced Aß production, which increase NO affecting respiratory chain. Nevertheless, also a 
direct effect of accumulated APP on mitochondria or other effects cannot be excluded, 
because there is no significant difference in basal apoptotic rates between HEK APPwt and 
HEK APPsw, though APPsw HEK have an nearly 10 fold production of Aß as APPwt. To 
elucidate the implications of caspases, HEK cells were treated for 24 hr with several caspase 
inhibitors at a final concentration of 10 µM. Here the measured effects were moderate. Only 
caspase 2 inhibitor was able to show a significantly protective effect in reducing basal 
apoptosis in APPsw HEK cells. This point towards a pivotal role of caspase 2 in Aß induced 
apoptosis as described in 4.2.1 also for HEK cells. However, the failure of caspase 2 inhibitor 
to protect mitochondrial membrane potential in oxidative stress induced cell death show that 
in addition to acting upstream of mitochondria, caspase 2 might induce apoptosis in a distinct 
way, e.g. a non-mitochondrial apoptotic pathway.  
It has also to be mentioned, that due to a manner of time, it was not measured if caspase 2 
inhibitor may elevated basal membrane potential of HEK APPsw and HEK APPwt to levels 
of untransfected control cells. This experiment may be essential to elucidate if caspase 2 has 
an effect on mitochondria in HEK cells. In addition, it will be necessary to investigated the Discussion    
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implication of caspases by measuring caspase activities and performing Western blots to 
obtain a more precise conclusion, according to the implication of caspases in PC12 cells. 
 
U4.5.3 JNK activation in HEK cells 
 
Similar to PC12 cells, an induction of JNK activation by the Swedish APP mutation was also 
found in HEK cells. Oxidative stress induced JNK activation in a time depend manner, 
whereas in APPsw cells JNK was found to be activated even under basal conditions. In 
addition, JNK was also detected in the mitochondrial fraction, which may suggest that JNK 
act upstream of mitochondria in oxidative stress induced apoptosis. However, experiments 
pre-adding JNK inhibitor prior the hydrogen peroxide incubation show no protective effect of 
JNK in preventing the oxidative stress induced decrease of the mitochondrial membrane 
potential, as it was measured in PC12 cells. This could be due following reasons: 
•  Other nonmitochondrial effects like the upregulation of apoptotic genes by JNK 
pathway (Morishima 2002) are further  implicated in HEK cells.  
•  The higher Aß load in HEK cells counteracts the protective effect of JNK inhibitor by 
damaging mitochondria independent of JNK. 
 
 
4.6 SWEDISH APP MUTATION INDUCES TRANCRIPTION OF AIF  
 
As it has been described, in addition to their vital role as the cellular power stations, 
mitochondria exert an important function in apoptosis. In response to oxidative stress 
mitochondrial membranes are permeabilized, leading to the release of mitochondrial proteins. 
Such pro-apoptotic proteins include cytochrome c, which can trigger the activation of 
caspases, once it has reached the cytosol as well as the caspase-independent death effector 
AIF (Apoptosis inducing factor). AIF is a mitochondrial flavoprotein which, in healthy cells, 
is confined to the mitochondrial intermembrane space and has an NADH oxidase activity 
independent from its apoptogenic effects. Translocation of AIF from the mitochondria to the 
nucleus has been shown to promote apoptosis (Susin 1999) and seems to play a crucial role 
during caspase-independent apoptotic cell death (Bidere 2001). When released from the 
mitochondria, AIF acts as a death effector, migrating to the nucleus and inducing chromatin 
condensation and large-scale DNA fragmentation in a caspase independent manner (Daugas 
2000).  Discussion    
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Here the RT-PCR data clearly show that oxidative stress upregulates the level of AIF mRNA 
in HEK cells, suggesting that the modulation of gene transcription and/or mRNA processing 
or stability of mRNA are involved in this effect of hydrogen peroxide. In addition, an 
upregulation of AIF mRNA was also observed in PC12 cells. Upregulation of AIF expression 
in HEK and PC12 cells treated with hydrogen peroxide may be due to the augmentation of 
gene transcription changes in processing or the stability of mRNA. Interestingly, this effect 
was cleary enhanced in HEK cells transfected with the Swedish mutated APP. In PC12 cells 
mRNA expression was little enhanced after 1 hr induction in both, APPsw and APPwt 
compared to vector control cells. Experiments performed by Astrid Bonert revealed an higher 
AIF protein expression in APPsw cells after 6 hr hydrogen peroxide incubation. Thereby, AIF 
was not found in cytosolic fraction in the first 6 hr, but after 24 hr incubation, suggesting an 
important role of AIF in the late phase of apoptosis. In further experiments it will be 
interesting to find out, how AIF expression is induced by the Swedish APP. Possible is a 
direct effect of Aß. This could be verified for example using γ-secretase inhibitors, reducing 
Aß levels of APPsw transfected cells.  
 
It is also possible that the C-terminal fragment of APP (AICD) could be responsible for an 
enhanced AIF expression, since AICD has been demonstrated to cause transcriptional 
activation after translocalization into the nucleus hence suggesting a role of AICD in gene 
regulation (Kinoshita 2002, Kim 2003).  
The implication of AIF could be an explanation for the failure of caspase inhibitors to reduce 
apoptotic levels more distinctly. Especially in HEK cells caspase inhibitors fail to inhibit 
oxidative stress induced cell death more clearly. In fact, caspase 3 inhibitor reduces apoptotic 
levels significantly, but the observed effect was far from reducing the levels to apoptotic rates 
of hydrogen peroxide incubated untransfected HEK cells. In further experiments it will be 
also interesting to combine caspase inhibitors with drugs, that may prevent release of AIF. 
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4.7 NEUROTOXIC MECHANISMS CAUSED BY THE SWEDISH APP MUTATION: 
MITOCHONDRIAL DYSFUNCTION, OXIDATIVE STRESS, CASPASES AND JNK 
PATHWAY 
 
Summarizing all the obtained result it becomes evident that different pathways contribute to 
the enhanced vulnerability of cells harbouring the Swedish APP mutation. While probably 
high chronic Aß levels lead directly to enhanced apoptotic levels, reduction in mitochondrial 
membrane potential and depletion of ATP levels in APPsw transfected HEK cells, the chronic 
lower levels of Aß only trigger APPsw PC12 cells to enhanced apoptosis after a secondary 
insult. 
 
When oxidative stress is induced several pathways may occur in APP-transfected PC12 cells 
in parallel. The intrinsic pathway is activated in APPwt and APPsw bearing cells leading to 
mitochondrial dysfunction in an Aß-dose-dependent manner compared to vector-transfected 
controls. Mitochondria may act as amplifiers, because cytochrome c is released and activates 
caspase 9. Since no differences in cytochrome c release and caspase 9 activity between 
APPsw and APPwt cells were observed, other pro-apoptotic factors from the mitochondria 
like AIF might be involved since AIF expression is enhanced by the Swedish mutation.  
 
The 4–5-fold elevated Aß levels in APPsw compared with APPwt cells resulted in enhanced 
JNK, caspase 2, and caspase 8 activation. Here a connection to the intrinsic apoptotic pathway 
could exist, since the inhibition of JNK and caspase 2 resulted in a protective effect on 
mitochondrial membran. The convergence of all pathways leads to activation of the caspase 3 
and the execution of cell death. Thus, the blocking of initiator caspases only inhibits the 
amplification loop and does not prevent cell death. If the enhanced AIF expression is due an 
effect of caspase 2, JNK and enhanced transcriptional activity of c-jun, AICD or due to 
another effect needs to be further investigated.  
 
 
 Discussion    
 
142
 
 
 
Fig. 4.2 Hypothetical sequence of events leading to cell death occurring in FAD. Effects of 
the Swedish APP mutation are indicate by the red arrows. 
 
 
Based on this thesis it can be speculated that these upregulated pathways are also responsible 
for the enhanced vulnerability of neurons of Swedish FAD patients. The consequence of the 
gradually rising in oxidative stress throughout life is a massive neurodegeneration leading to a 
start of the disease below an age of 65. In sporadic AD cases Aß levels gradually arises with 
age, here rising levels of oxidative stress lead to neuronal cell death occurs only over an age 
of 65. Since other FAD mutations also emphasis Aß production, it is assumable that the same 
pathways may be upregulated, which, however, needs to be confirmed. 
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Fig. 4.3 A hypothetical sequence of the pathogenic steps linking sporadic AD, familiar AD, 
and Aß production with mitochondrial dysfunction, apoptotic pathways and neuronal cell loss 
(modified according to Selkoe 2002). Due to enhanced Aß production, neuronal cells of FAD 
patients are more vulnerable to the gradually rising of oxidative stress throughout life, leading 
to an early onset form of the disease. The deposition of Aß in senile plaques is a final step 
leading to inflammatory response and dementia. 
 
 
4.8 NEUROPROTECTIVE STRATEGIES INHIBITING CASPASES AND JNK 
 
As this thesis shows, inappropriate apoptosis clearly underlies the etiology of AD, In addition 
altered apoptosis has also been implicated in several other human diseases like cancer, 
autoimmunity or heart disease (Hetts 1998). The control of caspases, as a key and central 
component of the biochemical pathway that mediates apoptotic cell death, represents an 
attractive step in modulating this process. There are efforts to induce caspase activation for 
the treatment of disorders where insufficient apoptosis occurs (e.g. cancer). Also in HIV 
infection efforts to activate caspases in infected cells exist; e.g. a “Trojan horse” gene therapy 
approach may be viable, in which a TAT-caspase-3 construct containing a HIV-protease 
recognition motif selectively induces apoptosis in HIV infected cells only (Vocero 1999).  
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Alternatively, selective caspase inhibition for the treatment of AD comprised a big challenge. 
The clinical utility of caspase inhibitors will depend on several key issues that require further 
resolution. For example, will cells that are saved from apoptotic death remain functional and 
survive without perpetual caspase inhibition? Will the “therapeutical window” be sufficient 
for practical use in a clinical setting? Can highly selective caspase-3 inhibitors be used for 
chronic administration without unacceptable adverse events occurring?  
In other neurodegenerative diseases there are encouraging approaches. Preliminary 
experiments in animal models using non-selective caspase inhibitors such as Z-VAD(OMe)-
CH2F, have shown in vivo efficacy in ischemic and hypoxic brain injury (Cheng 1998; 
Daemen 1999). 
 
In another neurodegenerative disorders, Huntington’s disease,  the use of  minocycline as an  
inhibitor of apoptosis delayed mortality of transgenic mice (Chen 2000). Minocycline is a 
second-generation tetracycline with remarkable neuroprotective properties. It inhibits the 
production of nitric oxide by the inducible form of nitric oxide synthase, and was evaluated in 
experimental models of cerebral ischemia. Currently it is being evaluated in clinical trials in 
patients with Huntington’s disease (Bonelli 2004).  An advantage is that Minocycline is orally 
bioavailable, crosses the blood–brain barrier, and has a proven safety record in humans. 
Whether Minocycline might be considered for trials in AD still needs to be tested. 
 
An alternative approach to neuroprotection will be the inhibition of JNK, since JNK 
activation seems to be a critical event in the primary neurotoxic signaling triggered by Aß. In 
AD brain JNK activation has also been found by immunostaining (Shoji 2000, Zhu 2001)  
including in association with intraneuronal Aß accumulation and in association with tangle-
like inclusions in entorhinal cortex before Aß deposition (Pei 2001, Savage 2002). 
Interestingly, evidence suggests that JNK activation also contributes to tau phosphorylation. 
Since  JNK inhibition blocks caspase activation, the JNK inhibition is an assumable trial for 
AD therapy. In addition to SP600125, another compound that inhibits stress activated kinase 
signalling is CEP-1347, which is an inhibitor of the MLK family of JNK pathway activators  
(Harris 2002). CEP-1347 is currently undergoing clinical trials in Parkinson’s disease and is a 
candidate agent for AD trials (Parkinson Study Group, Neurology 2004). 
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4.8 IMPLICATION OF PRESENILIN 1 IN APOPTOSIS 
 
As it was described in 1.3, most of the aggressive, early-onset forms of familial AD are 
caused by mutations in the PS genes. PS1 and PS2 are homologous, polytypic membrane 
proteins localized to ER and Golgi membranes. PS1 and PS2 span these membranes six or 
eight times, and most of the mutations identified in AD families cluster within or adjacent to 
the transmembrane domains (Haass 2002). Between the putative sixth and seventh 
transmembrane domain, the PSs contain a hydrophilic, acidically charged loop that contains 
proteolytic cleavage sites. Three different proteolytic systems, including caspase cleavage, are 
known to be involved in PS catabolism. PSs normally undergo endoproteolytic cleavage in a 
hydrophobic portion of the cytoplasmic loop, which generates stable N-terminal and C-
terminal fragments that associate in a 1:1 ratio. PSs are also cleaved by caspase 3 within the 
cytoplasmic loop at positions distal to the endoproteolytic site. For example, PS1 is cleaved at 
D345 and PS2 has a major caspase-3 site at D329 and a minor caspase-3 site at D326  (Kim 
1997; Vito 1997). The discovery of PSs as caspase substrates raised the interesting possibility 
that they may play an important role in the apoptotic death.  
 
4.8.1 Presenilin 1 overexpression reduces oxidative stress induced apoptosis in PC12 cells 
 
PS1 is critically involved in γ-secretase activity and might represent the protease that cleaves 
APP within its transmembrane domain, finally generating Aß. Since this thesis show that Aß 
clearly enhance apoptosis, it first seems to be paradox that an overexpression of PS1 in PC12 
cells may have a protective effect in oxidative stress induced apoptosis. The explanation 
however, is obvious: 
•  PS1 assembles to a high molecular weight complex with other proteins including 
Nicastrin, Aph-1 and Pen-2 that are essential for  γ-secretase activity. Since taking 
away a single of these components disrupt the entire  γ-secretase activity, here the 
overexpression of one of these components alone might not increase the generation of 
Aß. 
•  In addition, the physiological role of PS1 is not clear. The  γ-secretase activity is also 
essential for Notch signalling (see.1.4.3), but PS1 might not only be involved in 
intermembraneous proteolysis, since it has also been implicated in the regulation of 
calcium homeostasis (Mattson 1997; Yoo 2000, Leissring 2000) and in the regulation 
of Wnt pathway (Xia 2001; Kang 2002). Discussion    
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Thus, it is rather assumable, that the over 120 PS1 related FAD mutations induce an 
imbalance between a loss of physiological function and proteolytic processing of APP. A 
direct effect of the mutations on the proteolytic activity may be improbably. 
 
One possible physiological function of PS1 might be implicated in the regulation of apoptosis. 
There is evidence that a loss of the physiological functions of PS1 may lead to apoptosis. For 
instance, it was demonstrated that inhibition of PS1 expression in cultured tumour cells or 
mice strains with spontaneous tumour development induces a higher rate of apoptosis 
(Roperch 1998). Since PS1 is proteolytically cleaved by caspase 3, the resulting C-terminal 
fragment was proposed to have a functional role in regulating apoptosis (Loetscher 1997; Kim 
1997). Thus, the original idea in our lab was to clarify if the overexpression of full length 
PS1wt may reduce vulnerability of cells to apoptosis, and if the caspase 3 cleavage of PS1 is a 
functional step. Here it was expected that the mutation of the caspase 3 cleavage sequence in 
PS1 (PSmut) would avoid  the antiapoptotic effect of PS1.  
 
The results show that in stably-transfected PC12 cells, the overexpression of PS1wt has an 
antiapoptotic effect when oxidative stress was induced. Thus it is probably that one effect of 
FAD related PS1 mutations is the abolishment of this antiapoptotic effect leading to enhanced 
apoptotic rates. FAD mutated PS1 may cause early onset by triggering pro-apoptotic 
mechanisms since many reports have shown that different PS1 FAD mutations sensitize cell 
to apoptosis (Guo 1998; Tanii 2000; Zhou 2002; Chan 2002). In our lab this pro.apoptotic 
was observed in CD4
+-T-lymphocytes from mice bearing the FAD PS1 M146L mutation 
compared to PS1 wt mice CD4
+-T-lymphocytes (Schindowski 2003).This results suggest that 
PS1wt may have neuroprotective activity and that PS1 mutants may be defective in such 
neuroprotective function. 
 
The caspase 3 cleaved C-terminal PS1 fragment (PSCas) show a similar effect as the full 
lengths PS1, therefore it would be attempting to speculate that the antiapoptotic effect of PS1 
may be an inhibitory effect of the generated PSCas during apoptosis. However, the 
transfection of PSmut leads also to reduced apoptosis to similar levels as PS1 and PSCas, 
which now suggest that proteolysis of PS1 by caspase 3 may be not a determinant step for the 
antiapoptotic effect of PS1. Rather it seems that the C-terminal fragment of PS1 doesn’t needs 
to be cleaved by caspase 3 for its antiapoptotic action. It would be interesting to construct  a Discussion    
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N-terminal PS1 fragment. If this fragment show no antiapoptotic effect, this would confirm 
the hypothesis that only the C-terminal fragment of PS1 is essential for the antiapoptotic 
action, which is independent of its cleavage by caspase 3. 
 
How to explain the antiapoptotic effect of PS1? 
 
Due to several evidences of the implication of PS1 in intrinsic apoptotic pathway, the effects 
of PS1 overexpression on mitochondrial membrane potential and Bcl-xl expression were 
examinated. In addition, it was investigated if PS1 has an negative effect on JNK signalling 
pathway as it has been proposed recently by Kim et al (2001). Here the obtained results show 
that neither the mitochondrial membrane potential, nor the Bcl-xl expression are affected by 
the overexpression of the PS1 constructs, which leads to hypothesise that the antiapoptotic 
action of PS1 might not occur through intrinsic apoptosis, but rather due a different 
mechanism. 
Possible is an interaction of PS1 with a proapoptotic factor, whereas the interaction of PS1 is 
mediated by the C-terminal Fragment. Here, e.g. the binding of PS1 could lead to an 
inactivation of this proapoptotic factor. An overexpression of PS1 may emphases the 
inactivation. Since the caspase cleavage sequence site is localized in the hydrophilic loop, the 
mutation of alanin to an aspartate may not affect the binding of PS1 to the proapoptotic factor. 
In contrast, FAD mutations are localized within or adjacent to the transmembrane domains. A 
mutation in these regions could lead to structural changes, affecting the binding interaction, 
liberating the proapoptotic factor. A candidate here is GSK3ß, which has been implicated in 
the pathological mechanism of AD. Recent work indicates that PS1 is able to interact with 
GSK3ß. Interestingly, GSK3ß activity were increased in embryonic neuronal cells and 
fibroblast cultures of PS1 knock-in M146V (KIM146V) and PS1 knockout mice (Pigino 
2003). Thus, it will be interesting to measure if GSK3ß activity is reduced by PS1 wildtyp 
overexpression. The cell death mechanism mediated by GSK3ß was shown to be by the 
phosphorylation of kinesin light chains (KLC), causing the release of kinesin-I from 
membrane-bound organelles (MBOs). The result is an a reduction in kinesin-I driven motility 
(Morfini 2002b). These findings suggest that mutations in PS1 may compromise neuronal 
function by affecting GSK-3 activity and kinesin-I-based motility.  
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Fig. 4.4 A hypothetical mechanism of the antiapoptotic effect of the overexpression of PS1, 
PSCas and PSMut. It is possible that the overexpression of the PS1 constructs may bind or 
at least leads to an inactivation of an proapoptotic factor. The caspase 3 mutated cleavage 
sequence does not impair the binding of the apoptotic factor, since it is localized in the 
cytoplasmatic loop and might not lead to structural changes of in the C-terminal PS1 
fragment. Since FAD mutations are localized within or adjacent to the transmembrane 
domains and have been shown to sensitise cells to apoptotic stimuli, it is probably that the 
FAD mutations result in structural changes of PS1, inhibiting the binding of the apoptotic 
factor and leading to its detachment, finally, leading to cell death. 
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5. Summary 
 
Alzheimer’s disease (AD) is the most common neurodegenerative disorder world wide, 
causing presenile dementia and death of millions of people. During AD damage and massive 
loss of brain cells occur. Alzheimer’s disease is genetically heterogeneous and may therefore 
represent a common phenotype that results from various genetic and environmental influences 
and risk factors.  
In approximately 10% of patients, changes of the genetic information were detected (gene 
mutations). In these cases, Alzheimer’s disease is inherited as an autosomal dominant trait 
(familial Alzheimer’s disease, FAD). In rare cases of familial Alzheimer’s disease (about 1-
3%), mutations have been detected in genes on chromosomes 14 and 1 (encoding for 
Presenilin 1 and 2, respectively), and on chromosome 21 encoding for the amyloid precursor 
protein (APP), which is responsible for the release of the cell-damaging protein amyloid-beta 
(ß-amyloid, Aß). Familial forms of early-onset Alzheimer’s disease are rare; however, their 
importance extends far beyond their frequency, because they allow to identify some of the 
critical pathogenetic pathways of the disease. All familial Alzheimer mutations share a 
common feature: they lead to an enhanced production of the Aß, which is the major 
constituent of senile plaques in brains of AD patients.  
New data indicates that Aß promotes neuronal degeneration. Therefore, one aim of these 
thesis was to elucidate the neurotoxic biochemical pathways induced by Aß, investigating the 
effect of the FAD Swedish APP double mutation (APPsw) on oxidative stress-induced cell 
death mechanisms. This mutation results in a three- to sixfold increased Aß production 
compared to wild-type APP (APPwt).  As cell models, the neuronal PC12 (rat 
pheochromocytoma) and the HEK (human embryonic kidney 293) cell lines were used, which 
have been transfected with human wiltyp APP or human APP containing the Swedish double 
mutation. The used cell models offer two important advantages. First, compared to 
experiments using high concentrations of Aß at micromolar levels applied extracellularly to 
cells, PC12 APPsw cells secret low Aß levels similar to the situation in FAD brains. Thus, 
this cell model represents a very suitable approach to elucidate the AD-specific cell death 
pathways mimicking physiological conditions. Second, these two cell lines (PC12 and HEK 
APPwt and APPsw) with different production levels of Aß may additionally allow to study 
dose-dependent effects of Aß. 
The here obtained results provide evidence for the enhanced cell vulnerability caused by the 
Swedish APP mutation and elucidate the cell death mechanism probably initiated by Summary    
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intracellulary produced Aß. Here it seems likely that increased production of Aß at 
physiological levels primes APPsw PC12 cells to undergo cell death only after additional 
stress, while chronic high levels in HEK cells already lead to enhanced basal apoptotic levels. 
Crucial effects of the Swedish APP mutation include the impairments of cellular energy 
metabolism affecting mitochondrial membrane potential and ATP levels as well as the 
additional activation of caspase 2, caspase 8 and JNK in response to oxidative stress. Thereby 
,the following model can be proposed: PC12 cells harboring the Swedish APP mutation have 
a reduced energy metabolism compared to APPwt or control cells. However, this effect does 
not leads to enhanced basal apoptotic levels of cultured cells. An exposure of  PC12 cells to 
oxidative stress leads to mitochondrial dysfunction, e.g., decrease in mitochondrial membrane 
potential and depletion in ATP. The consequence is the activation of the intrinsic apoptotic 
pathway releasing cytochrome c and Smac resulting in the activation of caspase 9. This effect 
is amplified by the overexpression of APP, since both APPsw and APPwt PC12 cells show 
enhanced cytochrome c and Smac release as well as enhanced caspase 9 activity as vector 
transfected control. In APPsw PC12 cells a parallel pathway is additionally emphased. Due to 
reduced ATP levels or enhanced Aß production JNK is activated. Furthermore, the extrinsic 
apoptotic pathway is enhanced, since caspase 8 and caspase 2 activation was clearly enhanced 
by the Swedish APP mutation. Both pathways may then converge by activating the effector 
enzyme, caspase 3, and the execution of cell death. In addition, caspase independent effects 
also needs to be considered. One possibility could be the implication of AIF since AIF 
expression was found to be induced by the Swedish APP mutation. In APPsw HEK cells high 
chronic Aß levels leads to enhanced apoptotic levels, reduce mitochondrial membrane 
potential and ATP levels even under basal conditions. 
 
Summarizing, a hypothetical sequence of events is proposed linking FAD, Aß production, 
JNK-activation, mitochondrial dysfunction with caspase pathway and neuronal loss for our 
cell model. The brain has a high metabolic rate and is exposured to gradually rising levels of 
oxidative stress during life. In Swedish FAD patients the levels of oxidative stress are 
increased in the temporal inferior cortex. This study using a cell model mimicking the in vivo 
situation in AD brains indicates that probably both, increased Aß production and the gradual 
rise of oxidative stress throughout life converge at a final common pathway of an increased 
vulnerability of neurons to apoptotic cell death from FAD patients. 
 Summary    
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Presenilin (PS) 1 is an aspartyl protease, involved in the γ-secretase mediated proteolysis of 
Amyloid-ß-protein (Aß), the major constituent of senile plaques in brains of Alzheimer’s 
disease (AD) patients. Recent studies have suggested an additional role for presenilin proteins 
in apoptotic cell death observed in AD. Since PS 1 is proteolytic cleaved by caspase 3, it has 
been prosposed that the resulting C-terminal fragment of PS1 (PSCas) could play a role in 
signal transduction during apoptosis. Moreover, it was shown that mutant presenilins causing 
early-onset of familial Alzheimer's disease (FAD) may render cells vulnerable to apoptosis. 
The mechanism by which PS1 regulates apoptotic cell death is yet not understood. Therefore 
one  aim of our present study was to clarify the involvement of PS1 in the proteolytic cascade 
of apoptosis and if the cleavage of PS1 by caspase 3 has an regulatory function. Here it is 
demonstrated that both, PS1 and PS1Cas lead to a reduced vulnerability of PC12 and Jurkat 
cells to different apoptotic stimuli. However a mutation at the caspase 3 recognition site 
(D345A/ PSmut), which inhibits cleavage of PS1 by caspase 3, show no differences in  the 
effect of PS1 or PSCas towards apoptotic stimuli. This suggest that proteolysis of PS1 by 
caspase 3 is not a determinant, but only a secondary effect during apoptosis. Since several 
FAD mutation distributed through the whole PS1 gene lead to enhanced apoptosis, an 
abolishment of the antiapoptotic effect of PS1 might contribute to the massive 
neurodegeneration in early age of FAD patients. Here, the regulate properties of PS1 in 
apoptosis may not be through an caspase 3 dependent cleavage and generation of PSCas, but 
rather through interaction of PS1 with other proteins involved in apoptosis. 
. 
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6. Zusammenfassung 
 
Massiver und fortschreitender neuronaler Zelltod gehört zu den zentralen Charakteristika der 
Alzheimer Demenz (AD), ebenso wie Senile Plaques und Neurofibrillenbündel. Die 
Aufklärung der Mechanismen, die zum neuronalen Zelltod führen, sind daher von 
entscheidender Bedeutung bei der Suche nach neuen therapeutischen Ansätzen. 
Verantwortlich für den neuronalen Zelltod ist das Amyloid-Beta Peptid (Aß), das ein 
proteolytisches Spaltprodukt des Amyloid Precursor Proteins (APP) ist. Die Spaltung von Aß 
erfolgt hierbei initial durch die ß-Sekretase und anschließend  intermembranär  durch den γ-
Sekretase Komplex. Aß wird intrazellulär generiert und extrazellulär in aggregierten und 
unlöslichen Plaques angereichert. Die Mechanismen der Aß-Toxizität sind noch nicht genau 
bekannt; assoziiert werden oxidativer Stress, veränderte Kalziumhomöostase, mitochondriale 
Defekte und der Verlust an Überlebensfaktoren. 
 
Weniger als 10% aller Fälle der AD werden dominant vererbt. Dies bedeutet, dass die 
Mutation eines einzigen Gens für die Entstehung der Krankheit ausreicht und dass statistisch 
gesehen die Hälfte der Nachkommen eines Betroffenen ebenfalls erkranken. Bisher sind drei 
Gene bekannt, die bei autosomal dominant vererbten Formen der AD (familiäre AD, FAD) 
mutiert sein können. Es handelt sich um die Gene Presenilin 1 und Presenilin 2 auf den 
Chromosomen 14 bzw. 1, sowie um das auf Chromosom 21 gelegene Gen für das Amyloid-
Precursor-Molekül (APP).  Die familiären Formen der AD sind selten, deren Bedeutung ragt 
jedoch weit über die Auftrittsfrequenz hinaus, weil sie es erlauben die kritische pathogenene 
Entwicklung der Krankheit in transgenen Modellen zu untersuchen. Alle familiären AD 
Mutationen haben eines gemeinsam; sie führen zu einer erhöhten Produktion von Aß.  
 
Basierend auf Daten, die darauf hindeuten, dass Aß die neuronale Degeneration fördert, war 
es das Hauptziel der vorliegenden Arbeit, die neurotoxischen biochemischen 
Signaltransduktionswege von Aß zu untersuchen. Hierfür wurde der Effekt, der im Rahmen 
der FAD vorkommenden, schwedischen APP Mutation (APPsw), auf den durch oxidativen 
Stress induzierten Zelltodmechanismus untersucht. Diese Mutation resultiert in einer drei- bis 
sechsfach erhöhten Aß Produktion im Vergleich zum Wild-Typ APP (APPwt). Als 
Zellmodell wurden die neuronalen PC12- (rat pheochromocytoma) und die HEK- (human 
embryonic kidney 293) Zelllinien verwendet, die zuvor mit APPsw-, APPwt-, und als 
Kontrolle mit Leervektoren  transfiziert wurden. Die verwendeten Zellmodelle bieten hierbei Zusammenfassung    
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zwei wichtige Vorteile. 1. Verglichen mit Experimenten, bei denen Aß extrazellulär im 
mikromolaren Bereich appliziert wird, sekretieren PC12 APPsw Zellen Aß im pikomolaren 
Bereich, entsprechend der physiologischen Produktion im Gehirn von AD Patienten. So stellt 
dieses Zellmodell eine sehr gute Annäherung an die tatsächlich physiologische Situation in 
Gehirnen von FAD Patienten dar. 2. Beide Zelllinien (PC12 und HEK, APPwt und APPsw) 
haben eine unterschiedliche Aß Produktion, was die Untersuchung von dosisabhängigen Aß-
Effekten ermöglicht.   
 
Die in dieser Arbeit gefundenen Ergebnisse zeigen, dass die Transfektion der schwedischen 
APP Mutation eine erhöhte Zellvulnerabilität bewirkt. Ebenso wurden die, wahrscheinlich 
von Aß induzierten, Zelltodmechanismen aufgeklärt. Interessanterweise konnte hierbei 
festgestellt werden, dass die unter physiologischen Bedingungen erhöhte Aß Produktion in 
PC12 Zellen erst dann zu einer erhöhte Apoptoserate führt, wenn eine sekundäre 
Stressinduktion stattfindet. Ein Einfluss der erhöhten APP Expression oder der erhöhten Aß 
Produktion auf die basale Apoptose (ohne sekundäre Stressinduktion) konnte in PC12 Zellen 
nicht festgestellt werden. 
Die mit der schwedischen APP Mutation transfizierten HEK Zellen weisen eine 30fach 
erhöhte Aß Produktion im Vergleich zu den entsprechend transfizierten PC12 Zellen auf. Dies 
hat zur Folge, dass die chronisch erhöhte Aß Produktion in HEK Zellen auch schon unter 
basalen Bedingungen zu einer erhöhten Apoptoserate führt. Untersuchungen des 
mitochondrialen Membranpotentials und der zellulären ATP Spiegel zeigten, dass die 
ausschlaggebenden Effekte der schwedischen APP Mutation die Beeinträchtigung des 
zellulären Energiemetabolismus beinhalten. Sowohl basale ATP Spiegel als auch ein 
reduziertes mitochondriales Membranpotential wurden in APPsw- transfizierten HEK Zellen 
im Vergleich zu den APPwt Zellen gemessen.  Auch APPsw- transfizierte PC12 Zellen haben 
einen reduzierten Energiemetabolismus wie die Untersuchung der ATP-Spiegel und der 
metabolischen Aktivität zeigten. Dies wird aber unter basalen Bedingungen jedoch 
anscheinend kompensiert. 
 
Ein zentraler Aspekt der vorliegenden Arbeit war es, die Frage zu beantworten, warum die 
Überexpression von APP zu einer erhöhten Vulnerabilität gegenüber oxidativen Stress bei 
PC12 Zellen führt. Auch sollte geklärt werden, wie die Überexpression der schwedischen 
APP Mutation diesen Effekt noch zusätzlich verstärkt. Hierfür wurden verschiedene 
Signaltransduktionswege des apoptotischen Zelltods untersucht. Wie es sich herausstellte, Zusammenfassung    
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scheint die Beeinträchtigung der mitochondrialen Funktion eine wesentliche Auswirkung der 
APP-Überexpression zu sein.  Eine Induktion von oxidativem Stress führte in PC12 Zellen zu 
einer Aktivierung der intrinsischen Apoptosekaskade, mit einer Freisetzung von Cytochrom C 
und Smac, sowie einer resultierenden Aktiverung der Initiatorcaspase 9. Die intrinsische 
Apoptose wird hierbei durch die Überexpression von APP verstärkt. Sowohl APPsw als auch 
APPwt PC12 Zellen wiesen eine erhöhte Cytochrom C- und Smac- Freisetzung in das Cytosol 
auf, im Vergleich zu Vector-transfizierten PC12 Zellen. Ebenso wurde eine erhöhte Caspase 9 
Aktivität bei APPsw- und APP-transfizierten Zellen im Vergleich zu den Vektor- 
transfizierten Zellen gemessen. 
 
Weitere Untersuchungen zeigten, dass die schwedische APP Mutation darüber hinaus noch 
eine zusätzliche Aktivierung von Caspase 2 und Caspase 8 bewirkt wenn PC12 Zellen 
oxidativem Stress ausgesetzt sind. Eine deutlich erhöhte Caspase 2- und Caspase 8-Aktivität 
konnte in APPsw- transfizierten Zellen im Vergleich zu APPwt PC12 Zellen gemessen 
werden. Da dies zwei Initiatorcaspasen sind, die normalerweise extrazelluläre Zelltodsignale 
vermitteln, deutet das auf eine Aktivierung der extrinsischen Apoptose. 
Ebenso konnte gezeigt werden, dass sowohl in HEK Zellen als auch in PC12 Zellen die 
Induktion von oxidativem Stress zu einer Aktivierung der c-Jun terminalen Kinase (JNK) 
führt. Interessanterweise konnte gefunden werden, dass die Aktivierung der JNK durch die 
schwedische APP Mutation verstärkt wird, was auf eine wichtige Rolle der JNK im Rahmen 
der Aß Toxizität hindeutet. In PC12 Zellen konnte zusätzlich beobachtet werden, dass die 
Inhibierung von JNK mit SP600125, einem spezifischen JNK Inhibitor, Mitochondrien vor 
dem, durch oxidativen Stress induzierten, Zusammenbrechen des Membranpotential schützt. 
Auch konnte aktiviertes JNK in der mitochondrialer Fraktion nachgewiesen werden, was 
ebenso darauf hindeutet, dass JNK zusätzlich zu der Aktivierung des Transkriptionsfaktors c-
Jun auch Signale zu Mitochondrien vermittelt. 
 
Ausgehend von diesen Ergebnissen kann die erhöhte Vulnerabilität der APPsw- transfizierten 
Zellen bei der Induktion von oxidativen Stress folgendermaßen nachvollzogen werden:  
APPsw- transfizierte PC12 Zellen haben einen reduzierten Energiemetabolismus im Vergleich 
zu APPwt- und Vektor- transfizierten PC12 Zellen. Der beeinträchtigte Zellmetabolismus 
wird anscheinend jedoch kompensiert, da dieser Effekt alleine nicht zu einer erhöhten basalen 
Apoptoserate führt. Eine zusätzliche Induktion von oxidativem Stress führt dann zu einen 
weiteren Abfall des mitochondrialen Membranpotentials und der ATP Spiegel. Die Folge ist Zusammenfassung    
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eine Aktivierung der intrinsichen Apoptosekaskade, mit einer Freisetzung von Cytochrom C 
und Smac und einer Aktivierung der Caspase 9. Diese Effekte werden hierbei durch die 
Überexpression von APP verstärkt. Die schwedische APP Mutation führt gleichzeitig aber 
auch zur Verstärkung parallel verlaufender Signale. Aufgrund der reduzierten ATP-Spiegel 
oder der erhöhten Aß Produktion findet eine zusätzliche Aktivierung der JNK statt. Ebenso 
findet zusätzlich eine verstärkte Aktivierung der extrinsischen Apoptosekaskade statt, da eine 
deutlich erhöhte Caspase 8- und Caspase 2- Aktivierung bei der Induktion von oxidativem 
Stress in APPsw PC12 Zellen auftritt. Beide Signalwege führen zur Aktivierung der Caspase 
3, die als Effektor Caspase den Zelltod vollstreckt. Zusätzlich müssen aber auch noch Caspase 
unabhängige Effekte berücksichtigt werden. Eine Möglichkeit besteht in der Aktivierung von 
AIF, da eine verstärkte AIF Expression induziert durch die schwedische APP Mutation 
nachgewiesen wurde. In APPsw transfizierten HEK Zellen führen chronisch erhöhte Aß 
Spiegel selbst unter basalen Bedingungen zu einer erhöhten Apoptoserate, einem reduzierten 
mitochondrialen Membranpotential und reduzierten ATP Spiegeln. 
 
Zusammenfassend wird aus den hier erzielten Ergebnissen eine hypothetische Sequenz 
vorgeschlagen, wie es zum frühen Einsetzen der FAD kommen könnte: das Gehirn hat eine 
hohe metabolische Aktivität und ist im Laufe des Lebens einer zunehmenden Menge an 
oxidativem Stress ausgesetzt. Bei Patienten, die Träger der schwedischen APP Mutation sind, 
wurden in der Hirnrinde erhöhte Level an oxidativen Stress festgestellt. Die im Rahmen 
dieser Arbeit durchgeführten Versuche, zeigen, dass sowohl eine erhöhte Aß Produktion als 
auch die zunehmende Menge an oxidativem Stress zu einer erhöhten Vulnerabilität von 
Neuronen bei FAD Patienten führt. Entscheidend sind hierbei die Aktivierungen von Caspase 
2, Caspase 8 und JNK  Dies hat ein verstärktes Absterben von Neuronen durch den 
apoptotischen Zelltod  und ein frühes Eintreten von Morbus Alzheimer zur Folge. 
 
Im Rahmen der familiären Alzheimer Erkrankung wurden bisher über 120 Mutationen im 
Presenilin 1 Gen gefunden.  Ebenso wie bei Mutationen innerhalb des APP Gens führen auch 
die Presenilin Mutationen zu einer erhöhten Aß Bildung. Wie vor kurzem nachgewiesen 
werden konnte, ist  Presenilin 1 ein transmembranäres Protein mit 6-8 
Transmembrandomänen und ein Bestandteil des γ-Sekretase Komplexes. Ebenso wie die ß-
Sekretase ist die γ-Sekretase an der Spaltung des Aß-Peptids aus dem Vorläuferprotein APP 
beteiligt. Die Spaltung von Aß erfolgt hierbei initial durch die ß-Sekretase und anschließend  
intermembranär durch den γ-Sekretase Komplex. Presenilin 1 wirkt hierbei im katalytischen Zusammenfassung    
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Zentrum des Komplexes als Protease. Weitere Bestandteile des Komplexes sind Nicastrin, 
Pen-2 und APH-1. Diese Komponenten sind ebenfalls für die γ-Sekretase Aktivität essentiell, 
wobei sie als Co-Faktoren eine wichtige Rolle bei der Bildung des Multiproteinkomplexes 
erfüllen. Das Ausschalten einer dieser Faktoren führt zum Aktivitätsverlust.  
 
Wie Presenilin 1 FAD Mutationen zu einer gesteigerten Aß Produktion und einem frühen 
Beginn der Alzheimer Erkrankung führen ist unbekannt. Interessenterweise sind alle 
bekannten FAD Mutation in den transmembranären Regionen lokalisiert. Zwischen den 
Transmembrandomänen 6 und 7 existiert ein großer hydrophiler Loop, der endoproteolytisch 
gespalten wird. Ebenfalls lokalisiert ist hier eine Caspase 3 Erkennungssequenz. Die Spaltung 
von Presenilin 1 durch Caspase 3 resultiert in der Bildung eines C-terminalen Fragments. Eine 
Rolle für Presenilin im Rahmen des apoptotischen Zelltods ist daher annehmbar. So wurde 
postuliert, dass das resultierende C-terminale Fragment von PS1 (PSCas) eine Rolle während 
der apoptotischen Signaltransduktion haben könnte. Ebenfalls wurde gezeigt, dass FAD 
mutiertes PS1 zu einer erhöhten Vulnerabilität führen kann. Im Rahmen der vorliegenden 
Arbeit wurde daher untersucht, ob Presenilin 1 einen Einfluss auf die Zellvulnerabilität und 
die apoptotischen Zelltodkaskasde ausübt. Ebenfalls wurde eine mögliche Rolle des PSCas 
Fragments untersucht. Hierzu wurde ausgehend von einem Presenilin 1 Plasmid ein PSCas 
Konstrukt hergestellt. Ein weiteres Konstrukt wurde erzeugt, indem Presenilin 1 an der 
Caspase 3 Erkennungssequenz mutiert wurde, was die Spaltung von PS1 durch Caspase 3 
verhindert (PSMut). 
Die Transfektionsversuche in stabil transfizierten PC12 und transient transfizierten Jurkat 
Zellen ergaben, dass die Überexpression von Presenilin 1 eine antiapoptotische Wirkung 
bewirkt. Sowohl bei dem durch oxidativen Stress induzierten Zelltod, als auch bei der 
Induktion von Apoptose mit Fas-Ligand zeigten Zellen mit der Presenilin 1 Überexpression 
eine geringere Vulnerabilität im Vergleich zu Vektor- transfizierten Kontrollen. In Anbetracht 
der aktuellen Forschungsergebnisse, die auf eine Rolle von PSCas in der Regulation der 
Apoptose hindeuteten, war die Annahme zu Beginn dieser Arbeit, dass die antiapoptotische 
Wirkung des Presenilin 1 auf das PSCas Fragment zurückzuführen ist. Wie die Ergebnisse der 
PSCas Überexpression zeigen, scheint dies auch der Fall zu sein. Ähnlich der Überexpression 
von Presenilin 1 führt die alleinige Überexpression von PSCas zu einer reduzierten 
Zellvulnerabilität im Vergleich zu Vektor- transfizierten Kontrollen. In der Annahme, dass die 
Spaltung von Presenilin 1 hier eine regulatorische Funktion besitzten würde, erwartete man  
bei der Überexpression von PSMut eine Aufhebung der antiapoptotischen Wirkung. Wie sich Zusammenfassung    
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jedoch herausstellte, führt auch die Überexpression von Presenilin 1 mit mutierter Caspase 3 
Erkennungssequenz  zu einer verminderten Zellvulnerabilität. Dies deutet darauf hin, dass die 
antiapoptotische Wirkung von Presenilin 1 auf den C-terminalen Bereich des Proteins 
zurückzuführen ist, hierfür aber keine Spaltung durch Caspase 3 notwendig ist. Die Spaltung 
von Presenilin 1 durch Caspase 3 besitzt wahrscheinlich daher keine Funktion bei der 
Regulation der Apoptose. Eher ist hier anzunehmen, dass Presenilin 1 eines der vielen 
Substrate von Caspase 3 im späten Stadium der Apoptosekaskade darstellt. Basierend auf 
Ergebnissen, die zeigen, dass FAD mutiertes Presenilin zu einer erhöhten Zellvulnerabilität 
führt, könnte in der Aufhebung der antiapoptotischen Presenilin 1 Wirkung die Ursache des 
frühen Erkrankungsbeginns  liegen. 
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a2M - a2-Macroglobulin  
 DR4 and DR5 - death receptors 4 and 5 
ACE - Angiotensin converting enzyme  
AD - Alzheimer’s disease  
AICD - APP intracellular domain: C57/C59 
APAF-1 - Apoptotic protease activating factor-1 
Apo E - Apolipoprotein E 
APP - Amyloid precursor protein 
Aß - beta amyloid peptide  
ATP - adenosine-triphosphate 
BACE1 - b-site APP cleavage enzyme 
BSA - bovine serum albumin 
CAD - caspase activated desoxyribonuclease 
cAMP - cyclic adenosine-monophosphate 
CARD - caspase recruitment domains  
CDK5 - cyclin-dependent kinase-5 
cDNA - complementary deoxyribonucleic 
CED - cell death abnormal 
CNS - Central Nervous Sytem 
CTF - C-terminal fragment  
DD - death domain  
DED - death effector domains  
DISC - death-inducing signalling complex 
DMSO - Dimethyl-sulfoxide 
DNA - Deoxyribonucleic acid 
DNA-PK - DNA-dependent serine/threonine kinase 
DTT - Dithiothreitol 
EDTA - Ethylenediaminetetraacetic acid 
ER - Endoplasmatic Reticulum  
FACS - Fluorescence-activated cell sorter  
FAD - familial forms of early-onset Alzheimer’s  
           disease  
FADH2 - Flavine adenine dinucleotide  
FCS - Fetal calf serum 
GAPDH - Glyceraldehyde-3-phosphate  
                 dehydrogenase 
GPx - Glutathione peroxidase  
GSK3ß - Glycogen synthase kinase-3  
 
 
 
 
 
 
 
 
 
HS -Horse Serum 
IAP - endogenous caspase inhibitors  
IDE - Insulin degrading enzyme  
IgG - immunoglobulin G 
JIP-1 - c-Jun NH2 terminal kinase interacting 
protein-1  
JNK - c-Jun N-terminal kinase  
LRP - Low density receptor-related Lipoprotein   
MAPK - Mitogen-activated protein kinase  
NADH - Nicotinamide adeninedinucleotide  
NFT - Neurofibirllary tangles  
NICD - Notch intracellular domain  
NO - Nitric oxide  
NOS - Nitric oxide synthase  
NTF - N-terminal fragment  
PA - polyacrylamide 
PAGE - polyacrylamide gel electrophoresis 
PARP - Poly(ADP-ribose) polymerase 
PBS - phosphate buffered saline 
PBS - Phosphate buffered saline  
PMSF - phenylmethylsulfonylfluoride 
PS1 - Presenilin 1  
PS2 - Presenilin 2  
PSAP -Novel presenilin-associated protein  
RIP - Receptor-interacting protein 
RNA - ribonucleic acid 
RT - Reverse Transcriptase  
RT - room temperature 
SAPK - Stress-activated protein kinase  
SDS - sodium dodecyl sulphate 
SOD - Superoxide dismutase  
TACE - Tumor necrosis factor-a converting 
enzyme  
TBS - Tris-buffered saline 
TM - Transmembrane   
TNFR1 - Tumor necrosis factor receptor 1 
TRADD - TNF receptor-associated death domain 
TRAIL - TNF-related apoptosis-inducing ligand 
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Amino acids: 
 
Alanine   ala   A 
Arginine   arg   R 
Aspararagine asn    N 
Aspartic acid  asp   D 
Cysteine   cys   C 
Glutamine   gln,   Q 
Glutamic acid   glu   E 
Gycine   gly   G 
Histidine   his   H 
Isoleucine   ile   I 
Leucin   leu   L 
Lysin   lis   K 
Methionine   met   M 
Phenylalanine   phe   F 
Proline   pro   P 
Serine   ser   S 
Threonine   thr   T 
Tryptophan   trp   W 
Tyrosine   tyr   Y 
Valine   val   V   
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